ࡱ>   ^bjbj DRR4h> p,p-.L-L-L-<<<˅ͅͅͅͅͅͅ$l9<9<<<RRL-L- *BBB<ZR8L-L-˅B<˅BB. [yHL- #v| A.@0pc(‹;A‹‹,<<B<<<<<B<<<p<<<<‹<<<<<<<<< :  Medication Administration Lo-Se-Ca Foundation As revised by Marie Gauvin & Patrice Patterson, Feb 2016 As revised by Marie Gauvin & Patrice Patterson, April 2014 As revised by Marie Gauvin & Laine McGinley November 2010 As revised by Jules Lefebvre & Marie Gauvin, October 2006 Original developed by Joanne MacLean per CORE Standards, November 1995 Table of Contents and Course Outline 1. Introduction (Objective of Course) 4 2. Lo-Se-Ca Medication, Catalyst oneMAR Computer Program for Medication Administration & Self-Administration Policy and Procedures . 5-12 3. Medication Administration Shadow Form 13 4. Independent Administration Plan .. .14-18 5. Medication Delivery a) General Rules 19 b) Seven Rights 20 c) Medication Orders 21 d) Individual Profile Form 22-24 e) Medication Administration Challenges 25 6. Medication Documents and Instructions a) Administration Record 26 b) Medication Administration Record (form) 27,27 c) Medication Administration Record (PRN) 29,30 d) Medication Administration Incident 31 e) Medication Incidents/Errors...32 f) Medication Error Flow Chart 33 g) Medication Incident Report (Form) 34,35 h) Leave of Absence (LOA) Medications 36 i) Transfer Release Form 37 7. Medical Appointments 38 a) Medical Treatment Form 39 8. Adding New Medication Instructions 40 9. Discontinued Medication Instructions 41 10. Specific Delivery of Medications 42 a) General Application for Topical Preparations 43 b) Administration Technique for Eye Drops and Ointments 44 Illustration Eye..45 Administration Technique for Ear Drops..46 Illustration Ear47 Administration Technique for Nose Drops and Nasal Sprays48 Illustration Nose49 Use of Inhalers..50 Administration Technique for Vaginal Creams 51 Administration Technique for Vaginal Inserts/Suppositories and Tablets..52 Administration Technique for Rectal Suppositories . 53 11. Common Medical Symptoms/Conditions 54,55 a) Observation and Documentation of a Seizure 56 b) Types of Seizures 57 c) Seizure Record Form 58 d) Asthma 59,60 e) Diabetes 61 f) Diabetic Reactions 62 g) Treatment Guidelines for Diabetes 63 12. Common Medication Administration Abbreviations 64 13. Medication Administration Summary 65 14. Self-Study Questions .66,67 15. Bibliography and References 68 Introduction (Objective of the Course) The objective of this course is to provide practical, appropriate and relevant information and instruction for the safe delivery of medications by staff to Lo-Se-Ca clients. LO-SE-CA FOUNDATION LO-SE-CA FOUNDATION___________________________________________ Approved: 08-01 Revised: 05-15  Replacing: 3-107 Policy Number: 3-14 TITLE: MEDICATION ADMINISTRATION POLICY: The Lo-Se-Ca Foundation will ensure the appropriate administration of medications for the individuals served. PROCEDURES: All staff will be required to take the Medication Administration Course within his/her three month probationary period. The employee will be responsible for doing a minimum of three medication administration shadows before giving medications on his/her own. The Medication Administration course must be renewed a minimum of every three years. The Medication Administration course will be taught by a qualified person. This includes a pharmacist, pharmacy technician, registered nurse, licensed practical nurse, or emergency medical technician. They will have at least two years of relevant medication administration experience and have maintained recertification. It is the responsibility of the employee to familiarize his/herself with the medical condition of the individual, side effects of the medication, dosage and time of the medications, medical history of the individual, foods or medications that adversely interact with the current medication, allergies, and any other information pertinent to the safety and health of the individual. All medication, including over the counter and prescription drugs, will be stored in a locked, secure location within each residence if required to manage the risks identified in that program/home. Whenever possible, medication will be packaged by the pharmacy in med strips. Medications will be kept in appropriate containers with current labels securely attached. Prescription medications must have a label from the pharmacy indicating the name of the individual, name of the medication, the dosage and the times of the administration. All medication records, including those for non-prescription medications must be current. Information regarding medication changes will be shared with relevant staff members in writing. New and discontinued medication, changes in medication, administration times or dosage, must be accompanied by written documentation from the Team Leader, designate or guardian outlining the doctors orders and medical protocol. All medication prescribed and over the counter drugs will be monitored using the Catalyst oneMAR computer system. Medication administration records (paper MAR) will be issued by the pharmacy to use as a back up. Individual and guardian written permission for administration of identified non-prescription drugs will be obtained upon admission and thereafter when circumstances change. These will be approved and monitored by a Pharmacist or medical professional. Foundation staff are at times required to transport medication between residences and day programs. Written consent will be obtained from the individual and guardians when applicable, for those individuals considered able to independently transport and administer their medication. When an individual receiving services from the Foundation is away from their home over a period that medications are to be dispensed, medications will be given to the parent/guardian or designate. Clear instruction on medication type, dispensing time and any other special instructions will be provided. Staff are responsible for having the parent/guardian or designate sign a Medication Transfer form. Foundation staff in each program are responsible for ensuring that medication refills are completed as required. Foundation staff are responsible for ensuring the disposal of all outdated or discontinued medication through the pharmacy. If an error or incident in the administration of medication occurs, the appropriate pharmacist is to be consulted immediately and their recommendations followed. Staff are responsible for reporting all errors and incidents on a Medication Incident Report form and then immediately fax or scan and email it to the office. The original copy of the report will be submitted to the Team Leader and then Program Manager for review and their signature as soon as possible. If a staff member has three medication administration incidents or error within a three month period, they will be required to retake the Medication Administration course at his/her own cost and time. If an individual refuses to take a prescribed drug on a regular basis (two consecutive days) the Team Leader or designate will consult with the Pharmacist and then the Doctor, if applicable, for instructions. The Team Leader or designate will also notify the guardians. All concerns and suggestions from the Pharmacist and the Doctor should be recorded in writing and when required a program designed, implemented and monitored. It is the individuals right to refuse medication. All medication and medical directives are monitored in the following areas: Reason for administration Desired effect Undesired effects and adverse reactions Reviewed by medical professional Prolonged unnecessary use of any medication If medication is being used as a restrictive procedure, medical reasons for the behavior must be ruled out. Implementing the use of a PRN for a restrictive procedure must follow the restrictive procedures guidelines. (see policy 3-10) If medication is being used as a PRN to influence behavior, the following components should be provided within a restrictive procedure plan: Definition of the behavior, its frequency and intensity Positive strategies to be used first before utilizing the PRN Actions to occur after the PRN is administered Monitoring the usage for further assessment and/or a regular prescription Length of time that a PRN hasnt been used before it will be discontinued When using medications to influence behavior, informed consent must be received from the individual and guardian if applicable. The individual must be involved as much as possible Consent is given voluntarily Appropriate information is provided to ensure an informed decision is made. This information should include but not be limited to: The diagnosis How the monitoring of the behaviors will take place The length of time the PRN would be used The side effects of the medication Alternatives to the medication The dose range of the medication The people who will be responsible for administering the medication The explanation that consent is time limited and must be reviewed periodically The individual has the right to refuse the medication Individuals who wish to take medication independently will be supported to do so (see policy 3-15) LO-SE-CA FOUNDATION___________________________________________ Approved: 05-15 Revised:  Replacing:  Policy Number: 3-14-1 TITLE: Catalyst oneMAR Computer Program for Medication Administration POLICY: The Lo-Se-Ca Foundation will ensure the appropriate administration of medications for the individuals served using Catalyst oneMAR computer program. PROCEDURES: All staff will be required to learn the oneMAR computer system during their initial orientation period at the program. At the end of their orientation period staff will sign a statement saying that they understand how to use the system and are able to use it independently. All staff are required to perform the 4 Easy Steps for Managing oneMAR at the start and end of every shift. This ensures that they are aware that all medications have been given and documented and know what PRN medications have been used in the last 24 hours. They will then check the medication strip to ensure that the previous medications were given and that the medications for the next delivery time are present. If they discover that there are medications remaining that should have been given or that there are medications that were due to be administered that have not been signed off in oneMAR they will follow the steps outlined below: Medications Not Signed Off and Missing from Strip 1. Attempt to contact the staff member responsible for administering the dose to find out if the medication was in fact administered. The absence of medication from the strip does not necessarily mean that the medication was administered. It may have been refused, or accidentally taken home by staff, etc. 2. The following procedure will depend on whether or not the medication was actually administered or not and should be as follows: a. If the medication was not administered: i. Phone the pharmacy for further instruction (it may still be appropriate to administer the medication; the pharmacist will determine the best course of action) ii. If the pharmacist directs staff to still administer: Perform a Replace Bag and sign off the medication as normal using that replacement bag. The medication will show up pink because it was administer late, but a comment may be added ie.) Medication missed by previous staff, pharmacy directed to administer. iii. If the pharmacist directs staff not to administer: Manually sign off on the affected medications as 0% given and add a comment ie) Medication missed by previous staff, pharmacy directed not to administer. iv. Complete a Med Incident Report and submit to office b. If the medication was administered: i. Manually sign off on the affected doses as 100% given and add a comment ie) Medication not signed off by previous staff but was given ii. The pharmacy does not have to be contacted about this type of error because it is a documentation error only (The medication was given appropriately) iii. Complete a Med Incident Report and submit to office c. If the staff who was to administer the medication cannot be reached to confirm the administration: i. Phone the pharmacy for further instruction ii. If the pharmacist directs staff to administer: Perform a Replace Bag and sign off the medication as normal using that replacement bag. The medication will show up pink because it was administered late, but the comment Medication not signed off by previous staff, staff unavailable to confirm administration, pharmacy directed to administer can be added. iii. If the pharmacist directs staff not to administer: Manually sign off on the affected doses as 0% given and add the comment Medication not signed off by previous staff, staff unavailable to confirm administration, pharmacy directed not to administer. iv. Complete a Med Incident Report and submit to office 3. Contact the appropriate Supervisor (Team Leader/On-Call) as per the Medication Incident Protocol Medications Not Signed Off and Present in Strip: 1. Attempt to contact the staff member responsible for administering the dose. It cannot be assumed that the individual was not given any medication. They could have been administered the wrong day and/or time. 2. The procedure will depend on whether or not medication was actually administered (given to wrong individual, wrong date/time, etc.) and should be as follows: a. If any medication was administered to the individual in error: i. Phone pharmacy for further instruction ii. If the pharmacy directs to administer the medication: scan the appropriate medication pouches and sign off as normal. The administration will show up in pink, but a comment ie) Wrong medication administered, pharmacy directed to monitor but still administer the correct medication can be added. iii. If the pharmacy directs not to administer the medication: manually sign off all affected doses as 0% given with a comment ie) Wrong medication administered, pharmacy directed to monitor and not to administer correct medication, etc. iv. Complete a Med Incident Report and submit to office b. If no medication was administered: i. Phone pharmacy for further instruction ii. If the pharmacy directs to administer: scan the appropriate medication pouches and sign off as normal. Add a comment ie) Medication missed by previous staff, pharmacy directed to administer. iii. If the pharmacy directs not to administer: manually sign off all the affected doses as 0% given with a comment ie) Medication missed by previous staff, pharmacy directed not to administer iv. Complete a Med Incident Report and submit to office c. If the responsible staff member cannot be reached to confirm administration: i. Phone pharmacy for further instruction ii. If the pharmacy directs to administer: scan the appropriate medication pouches and sign off as normal. Add a comment ie) Medication not signed off by previous staff and present in strip, staff unavailable to confirm administration, pharmacy directed to administer. iii. If the pharmacy directs not to administer: manually sign off all the affected doses as 0% given with a comment ie) Medication not signed off by previous staff and present in strip, staff unavailable to conform administration, pharmacy directed not to administer. iv. Complete a Med Incident Report and submit to office 3. Contact the appropriate Supervisor (Team Leader/On-Call) as per the Medication Incident Protocol 3. As part of the 4 Steps, all overdue alerts will be corrected by the first staff to discover the error. Overdue alerts will appear on the Resident Search Page until that dose has been corrected (signed off) which means that staff are not able to see the next medication administration time resulting in future missed doses. 4. If medications cannot be signed off due to an internet and or computer access problem staff will follow the steps below: 1. Staff will use the back up paper MAR issued monthly by the pharmacy until the internet/computer issue has been resolved. 2. Staff will immediately notify the Supervisor (Team Leader/On-call) of the issue. 3. When the internet/computer issue is restored, staff will notify the Supervisor (Team Leader/On-Call) who will then Release medications for the time period affected. This is an administrative function that only Superusers can perform. This function will be performed right away so staff can once again see future meds due on the resident search page. 5. All Programs and On-Call supervisors will have a copy of the Catalyst oneMAR manual located in the red medication administration binder. A copy of the manual can also be found on the LoSeCa Cloud in the Programs (Q) drive. Self Administration Policy and Procedure Approved: 08-01Replacing: 3-109Policy Number: 3-15 Policy The Lo-Se-Ca Foundation respects the individuals rights to participate in administration of their medications. Procedure Individuals who wish to self-administer their medications will sign release forms, which will also be signed by their parent/guardian when necessary. Whenever possible a pharmacist and/or doctor will also sign the release outlining the parameters of the individuals participation in the administration of medication. Foundation staff will assist the individual to complete a risk assessment relating to medication self-administration and then develop, with the individual, a personalized plan, which will support them in their successful administration of medication. All individuals served by the Foundation will have access to modified medication administration by a qualified person. Medication Administration Shadow Employee Name _____________________________ Employee # _____________________________ Program ______________________ Date ______________________ Time ________________ Shadowed by _______________________________________ Comments/Concerns ____________________________________________________ ____________________________________________________ Program ______________________ Date ______________________ Time ________________ Shadowed by _______________________________________ Comments/Concerns ____________________________________________________ ____________________________________________________ Program ______________________ Date ______________________ Time ________________ Shadowed by _______________________________________ Comments/Concerns ____________________________________________________ ____________________________________________________ Next Medication Administration Course Date: __________________ Staff Signature __________________________________________ Team Leader ___________________________________________ Program Manager _____________________________________ * This document is to be filled out at beginning of employment with Lo-Se-Ca. New staff must shadow a minimum of 3 times before administering meds independently. Please have Team Leader review & submit once completed. Independent Medication Administration Plan Assessment: Right Person Can the person identify their own medication or strip packaging/bubble pack?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Right Medication Can the person recognize their own medications (colour/size/shape)?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area?Can the person understand medication information? (ie. Name of med, dose, potential side effects)( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area?Can the person administer PRNs with the same accuracy as regular medication?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Right Time Can the person identify the appropriate time to administer medication?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Right Dose Can the person identify the appropriate amount of medication required?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Can the person describe the potential risk(s) and likely outcomes if they do not take their meds as prescribed? ( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Right Route Which administration routes would the individual be capable of independently using?Route:YESNOComments:Oral (by mouth)((Pulmonary (into lungs)((Topical (to skin)((Transdermal (through skin)((Otic (ear medications)((Eye Medications((Nasal Medications((Suppositories (rectal, vaginal)((What would be required to increase independence in this area? Right Documentation Is the person able to sign in the appropriate location?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area?Can the person identify a medication incident and how to respond?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Can the person write the incident report?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Right Response Can the person indicate or identify adverse reactions to medication?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area?How would the individual react if they identify an adverse reaction?(Do nothing(Tell staff(Call pharmacist(do they know where to find the number?)(Call 911(Call PADISWhat would be required to increase independence in this area? Travel Can the person take their meds on outings/overnight/trips?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Storage Does the person know where or how to store their medication properly/safely?( yes( needs training, adaptation or prompts( noWhat would be required to increase independence in this area? Current Task Analysis and Development Plan Identify appropriate time for medication, using the 24 hour clock: Staff Role:Individuals Role:Plan to increase the role of the individual: Obtain medications:Staff Role:Individuals Role:Plan to increase the role of the individual: Remove medications from package or container:Staff Role:Individuals Role:Plan to increase the role of the individual: Administer medication via proper route:Staff Role:Individuals Role:Plan to increase the role of the individual:Sign MAR sheet:Staff Role:Individuals Role:Plan to increase the role of the individual: Put medications away:Staff Role:Individuals Role:Plan to increase the role of the individual: General Comments:  Signatures: Individual:Date: Medication Delivery General Rules Always wash your hands before and after administering medication. Ensure all information (e.g. Labels, OneMAR tracking, etc.) is read prior to administering medication. Always refer to the person by name when administering medication. Medication is to be administered within one hour before or after the specified time of administration, called the one hour window. Optimal therapeutic levels must be regularly checked for certain medication. Ensure that blood work is completed according to the doctors orders, whether it is once a week, once a month, once a year, twice a year, etc. NEVER give any medication that is not prescribed by a physician. All medication, including over the counter drugs must be prescribed by a physician or can also be approved by the Pharmacist at Stony Plain Wellness & Compounding Pharmacy. Always check OneMAR PRNs. If you use the last days medication (providing it is the same medication), call the pharmacist for replacement medication or use OneMAR system to re-order online. All medication has an expiry date. In order to receive the most benefit, ensure that the medication has not expired. Do not dispose of expired or dropped medication, these are to be returned to the pharmacy, for appropriate chemical disposal. The pharmacy delivery driver will pick up expired meds weekly. If a medication looks different in any way, call the pharmacy. Do not handle medication. ALWAYS use a spoon, a medication cup, or a glove. Observe individual for positive/negative reaction to the medication. Notify the doctor if there are any concerns. Some strategies to be used to remind yourself of medication times are timers, sticky notes, alarms, counting on double staffing, associate with a daily event (dinner), etc. Seven Rights of Administering Medication Community Support Workers should not have the responsibility of administering medication unless they have taken an appropriate course in medication administration. In some organizations, one staff person per shift is designated to administer medication to all individuals. In anticipation of the time when you do have the responsibility of administering medication, you should know the seven rights of medication. (These rights also apply of course, to administering medication at home to your family.) Before, during and after delivering medication, check the SEVEN RIGHTS to ensure the correct procedure is followed: RIGHT PERSON Check the persons name on documents Check the persons name on med strip packaging/labels Refer to the person by name RIGHT MEDICATION Check the medication name on documentation Check the medication name on med strip packaging/labels Ensure the two names are identical RIGHT TIME Check the date and time on documentation Check the date and time on dispensing container RIGHT DOSE Check the dosage listed in documentation Check dosage on dispensing container and med strip packaging/label RIGHT ROUTE Check the route listed in the documentation Look for route directions, words like take, drop, apply RIGHT DOCUMENTATION Sign for medication RIGHT RESPONSE Observe individual for correct or adverse reactions Please Mind The Drug Rules, Dont Rush! Medication Orders All medication that you will administer will be ordered by a physician or approved by the Pharmacist (for over the counter medications). There are three types of orders that you will deal with: Prescription Medication: A medication order that must be prescribed by a physician and filled by a pharmacist. (For e.g. antidepressants, antibiotics) Over the Counter (OTC) Medication: A medication order does not require a doctors order, but must be approved by pharmacist before administration to individual. (For e.g. cough syrup, antacid). PRN Medication: Medication that is given to an individual when observable and measurable criteria are met. It is a medication that is given as needed/as necessary only. A doctor will determine the criteria. This medication can be a prescription or over-the-counter medication. (For e.g. Ativan, Tylenol) * The Pharmacist can approve of a PRN if it is an over the counter medication. Every month, Stony Plain Wellness & Compounding Pharmacy will send regular MAR sheets as well as PRN sheets for over the counter and prescription PRN medication orders to deal with common difficulties such as colds, headaches, stomachache, etc. Paper MAR sheets will be used in the event that OneMAR is unavailable. LoSeCa Foundation Individual ProfileUpdated: Name:Jane DoeIntake Date:1/16/05Address:1234 Street NameDOB:1/1/61PHN:0123456AISH#:X1234567Phone:(780) 555-5555SIN:123 456 789Email:Allergies/Medical Concerns: No known allergies/Heart Murmur, Limited Hearing Left Ear, Pre-menopause, High Cholesterol levels. Method of Communication: Verbal-use simple phrases (no more than 3-4 words). Ensure she knows what is being said to her.  SHAPE \* MERGEFORMAT  Legal Guardian? ( No ( Yes ( ( OPG or ( Private Legal Guardian(s) Contact Information: Name:Phone:Address:Alt:Email:  SHAPE \* MERGEFORMAT  Alternate Guardian: Relationship:Address:Phone:Alt:Email: Alternate Contact:Relationship:Phone:Alternate:Alternate Contact:Relationship:Phone:Alternate:  Legal/Formal Trustee? ( No ( Yes ( ( OPT or ( Private Formal/Informal Trustee Contact Information Name:Phone:Address:Alt:Email: AISH Worker:Phone:PDD Coordinator:Phone: Height:48Weight:166 lbsEye Colour:HazelHair Colour:Light brown LoSeCa Foundation Lifestyle ProfileUpdated: Name:Transportation:(check all that apply) DOB:( Handibus/DATS:PHN:( Public (ETS/STAT):( Staff Drive:Services through Lo-Se-Ca:( Residential ( Discoveries ( Both( Other: Diagnosis:Down Syndrome Description of complex behaviour: Doctor:Phone:Address:Fax: DentistPhone:Address:Fax: Specialists: NameSpecialtyPhone #OptometristPodiatristPsychiatristDietician Medication: NameDoseTimesDate PrescribedAcetylsalicylic Acid81mg0800Levothyroxine Sodium (Synthroid).100mg0800Multivitamins1 Tablet0800Fenovibrate200 mg1200Calcium650mg1700Apo-Clomipramate25mg1700Apo-Clomipramate50mg1700Olanzapine(Zyprexa)50mg1700Vitamin B Complex1700Novo-Olanzapine5mg2100Orecort 0.1% (Dental Paste)Dental Paste0800, 1200, 1600,2000Apo-Remipril5mg0800Aporomoxi125-500mg0800, 1200, 1700ErythromycinDrops0800, 1200, 1300, 2100Acetominophen325mgPRNBecitrocin/Polymyxin B SulphateOintmentPRNCaptopril25mgPRNLoperemide HCL2mgPRNBetadermOintmentPRNGlaxal BaseOintmentPRNHydrocortisone CreamPRN Mobility Aids:NoneCommunication Aids:Hearing Aids:( Yes (No Visual Aids:( None ( Glasses ( Contacts ( Both Laser surgery Right eye April 1995When? (always, reading etc.): Day Program:Phone: Medication Administration Challenges There are many reasons why an individual may refuse to take their medication. If challenges arise in this area, you may wish to consider the following potential reasons and solutions: Reason #1: Person does not understand why they must take medication. Explain each medication to the individual. Explain the positive effects of taking the medication. Reason #2: Person has difficulty swallowing the medication because of taste or size. Ask the doctor if the medication can be given in another form. Place the medication far back in the throat and have the individual quickly take a drink. Mix or give the medication with a favorite liquid or food item (not to hide meds; individual must be aware medication is inside their food/beverage). Cut the medication in half, if possible (if approved by pharmacist). Have the individual suck on some ice to numb the taste buds before taking the medication. Reason #3: Person shows or complains of adverse side effects of the medication. Have the person see their doctor as a medication review may be in order. If the doctor recommends that the individual remain on the medication, have him/her explain the advantage to the individual. Reason #4: Person may feel he/she does not want or need the medication. Have the individual see the doctor. Have the doctor explain the importance of taking the medication. If the person refuses even after seeing the doctor, try methods previously discussed. Medication Administration Record (M.A.R.) Please note, that Stony Plain Wellness & Compounding Pharmacy currently provides all Paper MAR sheets to programs prior to the beginning of the month. However, there may be incidences when staff will have to update, fill out, or complete a MAR sheet. The Medication Administration Record (M.A.R.) is completed in the following manner: Print the individuals name. Print the current month and year in the appropriate spaces. Copy information from the medication strip packaging/bubble pack as follows: Medication and dosage Frequency guideline (i.e. dosage may be repeated every 12 hours or not exceed 4 tablets/day) Circumstances under which medication is to be given NEVER use white out, red pen, or pencil on medication documentation as these are legal documents. If there is a change or error on medication documentation simply draw one line through the information and initial it. ALL individuals who administer medication for a person will insert their name and initials in the space provided on each Medication Administration Record. P.R.N. medications are also listed on Medication Administration Record. The 24 hour clock is used at LoSeCa for all Medication Administration.  Medication Administration Record 27 Name ______________________________ Month __________ 20 __ Page ___ of ___ MedicationTime12345678910111213141516171819202122232425262728293031A = Absent from homeX = No Medication on this date MedicationTime12345678910111213141516171819202122232425262728293031Print NameInitialsA = Absent from homeX = No medication this date Medication Administration Record - PRN Name: _______________________Year:_________Medication:________________MonthTime12345678910111213141516171819202122232425262728293031January FebruaryMarchAprilMayJune Medication:_______________________ Name: _________________ Year: __________________MonthTime12345678910111213141516171819202122232425262728293031JulyAugustSeptemberOctoberNovemberDecember Medication Administration Incident/Error A medication incident has occurred when the normal administration of medication is interrupted, and the individual does not receive his/her medication as prescribed, or the individual responds to the medication in an adverse manner. FIVE steps must be followed if a medical incident/error occurs: Call the pharmacist. Follow directions given by the pharmacist. Fill out a Medication Incident Report. Fax or email report to your TL and Program Manager immediately *If critical error, you need to phone TL on call (weekends) or Admin on call (weekdays). Re-order the medication if necessary. The Pharmacist does not need to be called if staff: forget to sign for meds pre-sign for meds forget to have a Med Transfer form filled out However, an incident report does need to be completed for all incidents. The Medication Incident Report should be completed once the incident is over, and should be completed by the staff member who discovered the incident. The completed report should include the following information: Name of the staff member who discovered the incident Name of the individual affected by the incident Name and dosage of the medication involved Date and time the medication was given or missed Time the incident was noticed Name of the staff member who was responsible for the incident Clear description of the medication in the incident List WHO (TL/PM) was notified and WHEN Record all instruction from the PHARMACIST The report should be signed by the staff member who completed it ALWAYS call the pharmacist when a medication incident has occurred.(exceptions noted above) If a person vomits within a hour after taking medication, this is considered a medication incident. Follow the previous procedure. You are not trained or qualified to make medical decisions. ALWAYS follow instructions given by the pharmacist (even if you know what he will say). A Medication Incident Report is completed if a medication has been dropped or contaminated even if a replacement can be taken from the current med strip. In this instance you will need to call the Pharmacy and order replacement medication as soon as possible. If you call outside Business Hours, please leave a message for the Pharmacist. Contact the Team Leader in case of emergency only, for example: adverse or serious side effects to medication, hospitalization or requiring medical treatment. Medication Incidents/Errors Here are some examples of Medication incidents/errors  Wrong Individual Dropped meds (by staff) Omitted dose Meds given late Wrong medication Contamination of meds  Administering over the counter meds not authorized by Pharmacy  Wrong time Not filling out med transfer form Double dose Pre-signing before meds taken Vomited   OTHERS AT THE TEAM LEADERS DISCRETION If a staff has 3 incidents/errors within a 3-month period they must retake the med admin. course at their own cost and time. Medication Incident Flow Chart Medication Incident/Error  Non-Emergent Emergency  Dropped Medication Contact Pharmacist Contact Pharmacist  Retrieve a new medication Follow Instructions Follow Instructions from last day of med. strip for individual. Put dropped meds. in envelope and ensure it is returned to pharmacy. Leave note in comm. book in regards to the incident. Contact Team Leader  Medication Incident Medication Incident Medication Incident Report Report Report   Re-order Medication Re-order Medication Re-order Medication From Pharmacy If necessary If necessary **Please note, there is a Pink Med Admin. Reference Sheet hanging in every program. Medication Incident Report Program: ____________________________ Date: ____________________ Incident Discovered by: ____________________________________________ Individuals name: _________________________________________________ Name of Medication and Dosage: _____________________________________ Prescribed Date and Time of Medication: _______________________________ Time noted: _________________________________ Staff Responsible: __________________________________________________ Medication Incident ____ Omitted Dose ____ Incorrect Dose ____ Incorrect Individual ____ Incorrect Medication ____ Incorrect Time ____ Incorrect Method ____ Other _________________________________________________ Persons Notified"NameDateTimePharmacistSupervisor Parent/Guardian (if applicable) * Remember to email report to TL or PM after completed, and leave original for Team Leader to review and sign at the Program. Description of Incident: ________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ Pharmacists Instructions: ________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ Supervisor/Team Leader Comments: ________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ Faxed to the office (780-459-1380) Date: ________________ Time: ________________ __________________________________ _________________ Reported completed by Date _________________________________ _________________ Team Leader Date __________________________________ _________________ Program Coordinator Date Leave of Absence (L.O.A.) Medications If an individual will not be on site at the time medication is to be administered, prepare medication in the L.O.A. envelopes as follows: Follow basic medication delivery procedure as previously described. If the individual is still using a bubble pack, pop the med into a medication cup and put it into an envelope. If the individual is using medication strips, the staff member can take the correct package for the time of the outing. If the medication cannot be put into an envelope then the container must be given to the person who will administer the medication. An envelope still must be made for medication that cannot be placed inside of the envelope (i.e. liquid medication, eye drops, etc.) Label each envelope as follows: Name of individual Date the medication is to be taken Time the medication is to be taken Name and dosage of the medication Your initials Provide clear WRITTEN and VERBAL instruction to the person who will administer the medication. Write L. for Leave in the appropriate spaces on the Medication Administration Record after client returns, or sign daily when administering other individuals medication. Refer to legend on MAR sheets provided by Stony Plain Wellness & Compounding Pharmacy for this and other codes. A separate envelope must be used for each dispensing time. Sample: Jenny Patient January 1, 1998 0800 Hrs. Vitamin C - 1 tablet Tylenol (15 mg.) - 2 tablets Lo-Se-Ca Medication Transfer Release Form This is to certify that I, ____________________________, have received __________________s medications for the period of ____________________ to ____________________. I understand that it will be my responsibility to administer these medications while in my possession. _____________________________ Receiver _____________________________ Staff Witness ______________ Date PRNs Record Name of Drug and Bar Code Numbers of PRNs transferred: ______________________ _____________________ ______________________ _____________________ ______________________ _____________________ ______________________ _____________________ ______________________ _____________________ ______________________ _____________________ This is to certify that the above named individuals medications have been administered or returned to a staffs possession, and are no longer the receivers responsibility to administer. _____________________________ ____________________ Staff Signature Date Medication Incident Report? ( Yes ( No _____________________________ _____________________________ Receiver Staff Witness ______________ Date Medical Appointments You may be required to accompany individuals to doctors appointments. You will assist the individual to describe why the appointment was made, and after the examination you will discuss the finding with the physician. If there are to be medication changes, you will ask the following FOUR questions: What are the proposed changes? How long will the changes be in effect? Is follow-up required? What should be observed about the individual? After returning from a doctors appointment ensure that all pertinent information is documented in the appropriate place (i.e. log book, communication book, medical contact notes, etc). If more than one physician is involved with an individual ensure that each is aware of what the other is doing in regards to medication changes. Have any new prescriptions filled as soon as possible by faxing to the Pharmacy. If Stony Plain Wellness & Compounding Pharmacy is closed, fill the prescription at the local pharmacy and enter it into OneMAR under Non-Pharmacy Supplied Meds using the generic barcode provided from Pharmacy. (See OneMAR Manual). If OneMAR is unavailable, add the new medication to the existing paper MAR sheets. You need to fill a medical treatment form when the individual goes to the doctor, the dentist, optometrist, specialists, medicenter, hospital, footcare, etc. It is recommended that you take the individuals medical information with you, when you accompany the individual. Only give pertinent medical information when necessary. Medical Treatment Form (Doctor Visits/Emergency Room Visits) Individuals Name: _________________________ Program: ______________________ Date: ________________Time: _______________ P.H.N.:___________________________ Allergies: _______________________________________________________________________  Reason for Visit: Treatment Received/Direction Given: How long is the treatment in effect? What should be observed? What follow up is required? Prescription assigned: ( Yes ( No Staff Signature: ___________________________________________ Attending Physician: __________________________________________________ Address: __________________________________________________ Phone #: _________________________________________________ Adding New Medication Instructions All new prescriptions must be ordered by a physician. These medications must be delivered or picked up as soon as possible to ensure that they are started promptly. When these medications arrive, the following procedures should be followed: Compare doctors information to that on the labels/med strips. Check new medication for correct numbers and consistency in size, shape and color. Add new information to the paper MAR. Draw a line from the first day of the month to the date that the new medication is to start. Put new medication in the appropriate place for storage. Document new medication information in the staff communication book. Educate yourself by calling the pharmacist and/or reading the drug monogram. CALL PHARMACIST if: Label/med strip information does not agree with doctors orders Persons name Medication name Medication dosage Medication times Administration instruction Number of medication is not correct for the time period of the prescription. Color, shape and/or size of medication is not consistent. Discontinued Medication Instructions Any medication that is discontinued must be ordered by a physician. When medication is discontinued, the following procedure should be followed: Draw ONE line diagonally across the medication name and dosage on the Medication Administration Record. Write the word DISCONTINUED, todays date, and your initial over the line. Draw a line from the last time the medication was administered to the end of the month. Write the word DISCONTINUED, todays date and your initial across the line. Take discontinued medication and store it in the appropriate place or send it back to the Pharmacy. Document information in the communication book. If any part of the original order is changed, this is handled as a discontinued medication and a new medication. DO NOT throw old or discontinued medication in the garbage or flush it down the toilet. Send all unused or expired medications back to the Pharmacy. (the delivery driver will pick them up weekly) Specific Delivery of Medications Oral Dosage Forms Tablet: compressed powder Capsule: 2 piece, hard gelatin, easier to swallow Caplet: special shape, easier to swallow Spansule: long acting capsule (SKF) Pulvule: company brand capsule Gelcap: 1 piece soft gelatin capsule (liquid) swallow whole, DO NOT chew SR, LA, PA, TR: specific for long acting Chewable: must be chewed thoroughly before swallowing Infatab: chewable tablet Enteric Coated: special tablet coating designed to dissolve in duodenum, used for drugs that cause GI irritation Solution: usually a clear liquid DO NOT dilute in water as this may change the effect Drops: usually concentrated liquid or suspension Sublingual: designed to dissolve quickly under the tongue and to be rapidly absorbed into blood stream (bypasses GI) i.e. nitroglycerin (angina), Ativan (panic attack) Effervescent: either tablets or powder designed to dissolve in a liquid (usually water) before swallowing Granules: some are to sprinkle on food and swallowed, some are to be stirred into water DO NOT CHEW Powder: designed to be mixed with liquid before swallowing General Application Techniques for Topical Preparations 1. Wash hands and gently cleanse skin area with water unless otherwise directed by the doctor. Cleansing should be specified by the doctor (i.e. whether it should be with soap or water, etc.). 2. Pat area with clean towel until almost dry or slightly damp. 3. To prevent CONTAMINATION of the preparation, staff should use gloves. DO NOT touch the tube opening to the affected area. 4. Apply a small amount of the drug to the affected area and spread lightly and sparingly. ONLY THE MEDICATION TOUCHING THE SKIN WILL WORK, A THICK LAYER IS NOT MORE EFFECTIVE THAN A THIN LAYER. **This is especially important if the preparation is a STEROID. These drugs may be absorbed through the skin and will cause untoward side effects. Use thinly and sparingly. 5. DO NOT bandage unless directed by the doctor. 6. DO NOT apply to broken skin unless this is what the cream is intended for. 7. Keep the preparation away from eyes, nose and mouth. 8. CONTACT THE DOCTOR if after applying the medication the area develops hives, skin rash, blistering, burning, itching, peeling, redness, stinging, swelling, changes in color, thinning of the skin, or an ulceration. 9. For External Use Only label should be on all topical preparations and these preparations should be kept separate from oral preparations. 10. DO NOT expose areas treated with topical preparations to direct sunlight unless approved by the doctor. Guidelines for Administrating Eye Drops and Ointments Wash hands thoroughly with soap and water. The medication must be kept free of contamination. DO NOT touch the tube against the face or anything else. Have the individual lie down or tilt their head backward. Gently pull down the lower eyelid to form a pouch. You may have to use distraction, such as looking at ceiling. Hold the dropper or tube and approach the eye from the side. Hold it as close to the eye as possible without touching it. Have the individual close their eye(s). They should not rub them. Blot excess medication around the eye with a tissue (have tissue with you before administering). Inform and ask individual if you can blot their eye. Individuals need to be informed what you are doing, before you do it. DO NOT use the medication if it has changed in color or has changed in any way since it was purchased. Keep the container tightly closed when not in use. If you have more then 1 eye drop/ointment wait 15 minutes between administering second drop/ointment. Know the order, as directed by physician or pharmacist. Technique for Insertion of Eye Drops/Eye Ointment  INCLUDEPICTURE "http://www.glaucoma-association.com/uploads/Instilling%20Eye%20Drops.jpg" \* MERGEFORMATINET  Administration Technique for Ear Drops Wash hands thoroughly with soap and water. Most droppers are now plastic, examine dropper to ensure there are no cracks, debris, etc. SHAKE WELL before using if necessary/directed. The dropper must be kept free of contamination. DO NOT allow the tip of the dropper to touch against the ear or anything else. Have the individual tilt their head or lie on their side so that the ear to be treated is facing up. To allow the drops to run into the ear hold the ear lobe up and back. Place the prescribed number of drops into the ear. DO NOT insert the dropper into the ear as it may cause injury. You may want to ask the individual to swallow, as it may help the drops to reach the ear canal. Have the individual remain in the same position for a short time (approx. 2 minutes) after you have administered the drops or insert a soft cotton plug. DO NOT use the eardrops if they have changed in color or in any way since being purchased. Keep the bottle tightly closed when not in use. Technique for Insertion of Ear Drops  INCLUDEPICTURE "http://www.entkent.com/images/eardrops-applicn150pxhi.jpg" \* MERGEFORMATINET  Administration Technique for Nose Drops and Nasal Sprays Blow nose gently. Wash hands thoroughly with soap and water. Check the dropper tip for cracks &/or debris. Have the individual sit upright and tilt their head backwards. FOR NOSE DROPS: The nose drops must be free of contamination. Avoid touching the dropper against the nose or anything else. Draw the medicine into the dropper and place prescribed number of drops into nose. Try not to touch the inside of the nose with the dropper as it will probably make the person sneeze and will contaminate the dropper. To allow the medication to spread into the nose, have the individual remain in the same position for a few minutes. 6. For NASAL SPRAYS: Place atomizer at entrance to the nostril and close the other nostril by pressing your finger on the side. Squeeze the prescribed number of sprays, no more! Have the individual inhale through their nose and breathe out through mouth. *REMEMBER* For all eye, ear and nose medications: 1. Wash hands after use. 2. DO NOT use more frequently or in larger quantities than prescribed by the doctor. 3. DO NOT use the medicine at the same time as any other similar medication without the approval from the doctor. If there is more than 1 medication, ensure you know the order as directed by pharmacy & physician along with time in between administration. USE only as long as prescribed. Contact the doctor if the condition does not improve or worsens. Techniques for Insertion of Nose Drops  INCLUDEPICTURE "http://pharmlabs.unc.edu/labs/parenterals/images/nose1a.jpg" \* MERGEFORMATINET  Technique for Insertion of Nasal Sprays  INCLUDEPICTURE "http://www.viphealth.org/wp-content/uploads/2010/06/Nasal-Drops.jpg" \* MERGEFORMATINET  Important Information Regarding the Use of Inhalers If the individual is using a STEROID inhaler, they must rinse their mouth after each use to avoid developing a yeast (thrush) infection. Instruct the individual not to swallow the rinse. If the individual is using a STEROID and a BRONCHODILATOR inhaler (opens airways for quick relief), the bronchodilator should be used first, followed by the steroid 15 minutes later. As well, make sure the individual understands that the steroid inhaler will not produce immediate relief like the bronchodilator, but that it is still effective and important to use regularly at recommended intervals. Recommend that the individual keep a spare inhaler in a safe place at room temperature. Body posture is important when using the inhaler. Have the individual sit up as straight as possible. The internal pressure of the propellant-powered inhalers is sensitive to temperature. Store in a cool place. Keep away from heat source. Place dust cap on. If expected or normal relief of symptoms are not obtained from an established dosage regimen, the individual should consult a doctor immediately. Before each use check the mouthpiece for any objects that may be lodged in the opening. It is better if the individual pre-medicates than to inhale medication after wheezing is induced (i.e. exercise-induced asthma). If a respiratory infection develops, the individual should see a doctor as additional measures should be taken to control the infection and maintain potency of the airways. The two vital factors for optimal inhalation are: a slow deep inhalation (a rapid inhalation results in more of the drug being deposited in the upper airways) subsequent breath holding for at least 10 seconds or as long as possible. If the individual has difficulty inhaling through the mouth when using the inhaler, get them to try pinching their nose while inhaling or use a SPACER (or aero chamber). Remember to shake the inhaler well prior to use. Administration Technique for Insertion of Vaginal Creams Wash hands thoroughly with soap and water, put on gloves. Remove the cap from the tube. If tube is sealed, reverse cap and pierce tube. To fill applicator REUSABLE AND DISPOSABLE Screw applicator to the tube (for disposable applicators, place an open end over the tube). Lubricate the tip of the tube by applying a small amount of the cream to the outside of the applicator. Squeeze the tube until the applicator plunger is fully extended. The applicator will now be filled with medicine. If your doctor has prescribed a smaller dose, use as he/she has directed. Remove applicator from tube. To insert applicator: For proper insertion the individual should be lying on her back with knees drawn up. Pointing the applicator slightly downward, insert it deeply into the vagina as far as it will comfortably go without using force. Press the plunger gently all the way and empty the cream into the vagina while keeping the plunger-depressed remove the applicator from the vagina. Cleaning the applicator: Separate the plunger from the barrel by pulling it all the way out. Wash and rinse both sections thoroughly with soap and water. DO NOT boil the applicator as it is plastic and may soften. Dry and reassemble. Store in a clean place. CAUTION: During pregnancy, the applicator should only be used on the advice of a doctor. If possible, have a second staff present for ethical reasons. Back-up homes may be able to provide assistance. If possible, direct individual to administer meds (mirror may be useful tool). Or use hand-over-hand technique. Remember to protect the individuals privacy and dignity Administration Techniques for Insertion of Vaginal Inserts/Suppositories and Tablets Wash hands thoroughly with soap and water, put on gloves. Remove the wrapper and dip the tablet into water quickly, just enough to moisten it. Put the tablet/suppository into the applicator. NOTE: If there is not an applicator, insert the wide end of the tablet/suppository into the vaginal canal. Insert the applicator into the vaginal canal and depress the plunger. Remove the applicator. After each use wash the applicator with warm water and soap. Rinse and store in a clean place. *REMEMER for any vaginal medication: 1. DO NOT use the drug more frequently than prescribed by the doctor. 2. The medication should be used continuously even during the menstrual period. 3. A sanitary napkin may be worn to protect clothing during use. 4. Continue to use this medication for the prescribed length of time. 5. Contact the doctor if the condition becomes worse or if a constant irritation such as itching or burning develops. Remember to protect the individuals privacy and dignity Administration Technique for Insertion of Rectal Suppositories Wash hands thoroughly with soap and water, put on gloves. Store suppositories in a cool place. If necessary, suppositories may be held under cool water to harden them prior to insertion. You may lubricate the suppository by dipping the tapered end in some tap water. Have the individual lie on their left side with lower leg straightened out and upper leg bent forward toward stomach. Lift upper buttocks to expose rectal area. Insert suppository with tapered end first into rectum with finger until it passes the Musculus Sphincter of the rectum (about 1 inch in adults). If not inserted past the sphincter, the suppository may pop back out. Hold buttocks together for a few seconds. 9. Have the individual remain lying down for about 15 minutes to avoid having the suppository coming back out. 10. Discard used materials and wash hands thoroughly. DO NOT use medication past expiry date. Remember to respect the individuals privacy and dignity Common Medical Symptoms/Conditions Fever Normal oral temperature for most people will fall between 36.5 and 37.5 degrees Celsius with the average of 37 degrees. Normal rectal temperature for most individuals will fall between 37 and 38 degrees Celsius with the average of 37.5 degrees. A person is said to have a fever any time his/her temperature goes higher than the range. Fever is usually a symptom of another medical concern. Although the fever will be treated, it is important to get to the cause. Fever can be a symptom of a bacterial infection, a viral infection, or serious illness. Treatment of Fever Have the individual drink plenty of fluids Give the individual a sponge bath. Be sure the water is at room temperature (no ice water) to prevent causing chills or increased fevers. Sponge the individuals face, neck, and torso. Check the persons P.R.N. medications to see what can be given to the individual for fever. Observe the individual for other symptoms that may help determine the cause of the fever. Take the persons temperature every hour until it is normal two times in a row. A doctor should be contacted any time a person has a temperature over 39.5 degrees Celsius or if a person has a temperature higher than normal for over 24 hours. Epilepsy Epilepsy is a seizure disorder where the normal electrical impulses of the brain become unusually excessive, causing sudden uncontrolled changes in an individuals sensory, motor, and/or behavioral patterns. Epilepsy can begin at any time in an individuals life, and periodically will go undiagnosed. Although epilepsy may be attributed to head trauma, excessive fever, chemical imbalance or substance abuse, it may be very difficult to determine the cause of a seizure disorder. Most individuals who have epilepsy are on medication to control their seizures. While decreasing the frequency, duration or intensity, medication may not eliminate the seizures. Medications do not cure epilepsy. It is very important that these individuals take all medications as prescribed, visit their doctor regularly, and have therapeutic blood levels checked as required. Some people will experience an unusual sensation (aura) prior to having a seizure, while others will have no warning at all. Certain conditions such as flashing lights or hot weather may induce seizures for some while physical conditions such as hunger, stress or lack of sleep may be the trigger for others. If you are present when someone has a seizure use the following steps to aid in the prevention of serious injury of the person: Time the seizure Remain calm Remove glasses, loosen tight clothing, and move dangerous items away to protect the person from injury Turn them onto their side (Recovery Position) Stay with them until they are fully alert Speak softly and reassure them DO NOT put anything in their mouth DO NOT try to restrain the individual Most people do not remember having a seizure. Reassure the person that everything is all right, and tell them that they had a seizure. An epileptic seizure is not considered a medical emergency unless: The individual is injured The individual is pregnant The seizure lasts longer than normal Seizures happen consecutively (status) The person has never had a seizure before Observation and Documentation of a Seizure When a person has a seizure it is important to observe and document what happened. This will assist the doctor in determining any change in the DURATION, INTENSITY, or FREQUENCY of the seizures. Record the information in the individuals logbook or, for more details, use a seizure record to check off observations. Record observations based on the following: Check the time at the start and at the end of the seizure, and record the duration. Record if the person fell or became stiff Observe the skin color is it flushed, pale or bluish? Look at the general body movement of the limbs and torso. Is the person jerking or twitching? Watch the eyes Are they rolled back, staring, or blinking? Did the person lose control of bowel/bladder functions during the seizure? After the seizure, was the individual sleepy, confused, or alert? Did the person complain of a headache? Comment on the things you feel may be of assistance to the doctor (e.g. A seizure occurred at a rock concert when strobe lights were flashing). Take the seizure record to doctor appointments. Check seizure records frequently to identify any change in the normal seizure pattern of the individual. Types of Seizures (For Information Only) There are over thirty types of seizures affecting all or only parts of the brain. Listed below are the names and descriptions of some of the more common seizures. Generalized Tonic Clonic (Grand Mal) The person may cry out The individual will fall The body will become very rigid Muscles in all parts of the body will jerk and/or twitch Breathing may become shallow or temporarily interrupted The individuals/ lips may appear bluish The person may be incontinent Absence (Petit Mal) The person may experience brief loss of time The person will likely not fall The person may stare or blink rapidly The individuals face may twitch Simple Partial (Focul Motor Jacksonian) One limb or one side of the body will stiffen or jerk The person is aware but cannot control his/her movement The individual may experience tingling in parts of the body Complex Partial (Psychomotor, Temporal Lobe) The person may seem aware but will not have awareness of surroundings The person will repeat purposeless behavior The person may wander around the room The person may become agitated The person may appear confused and have no memory of the seizure when it is over Atonic (Drop Seizure) The person will suddenly collapse or fall The person will become very limp The person will usually recover quickly from this type of seizure Seizure Record Name: _________________________________________________ Place a check mark where applicable and describe in detail. DateLocationTime and DurationPrior to SeizureActivity(Warning signs (e.g.)(During SeizureBody Stiffen(Body Shake(Eyes Blink, Stare, etc.(Parts of Body (Incontinent Urine(Color- Lips, etc.(Breathing Fast(*Fell, Injury?(Following SeizureDisoriented(Cry(Sleep(Other(Comments  *If injured, complete incident report Additional comment on back _____________________________ _______________ Staff Signature Date _____________________________ _______________ Program Manager Date Please note seizure records might be altered to tailor the needs of the individual. Asthma Asthma is characterized by recurring shortness of breath, cough, an increase of mucus production and wheezing. This condition is usually controllable with medication treatment. Asthma is a chronic condition. The persons airways become extremely sensitive which leads to inflammation and an increase in mucus production in the lungs that leads to broncho constriction (narrowing of the airways). The goal in treating asthma is to maintain normal exercise levels, prevent troublesome symptoms, and avoid drug side effects. Usually asthma therapy is long term with the person avoiding events that may trigger attacks. There are two types of asthma Atopic (Extensic) Non-Atopic (Non-Extensic) Atopic Asthma The airways of an individual become sensitized to allergens (e.g. pollen, dust, etc) Hay fever often accompanies this type of asthma Non-Atopic Asthma This type of asthma may occur due to factors such as an infection, cold, and emotional upset Asthma Severity is classed into Three Types: MILD Intermittent coughing spells Little wheezing Minor extra mucus production Person is able to tolerate mild to moderate exercise activity MODERATE Frequent coughing spells Noticeable wheezing Person can tolerate only mild exercise activity SEVERE Coughing spells throughout each day Wheezing all the time Multiple emergency or doctors visits Person cannot tolerate exercise activity Symptoms are worse at night and early morning Two signs that a person may be experiencing an asthma attack are: Shortness of breath Wheezing and mucus secretion from mouth If the attack does not subside after normal medication intervention take the person to EMERGENCY. Diabetes (For Information Only) Insulin is a natural hormone, one of the many chemical substances produced by the pancreas When diabetes develops, the body does not produce enough insulin or may not be able to use what is produced Without insulin, glucose accumulates in the blood until some of the surplus is eliminated by the kidneys and passed off in the urine The cause of diabetes is unknown TYPES OF DIABETES Type I Insulin Dependent Diabetes Mellitus (I.D.D.M.) Have very little or no insulin and need injections to preserve life New patients may be of any age but usually juvenile Type II Non-Insulin Dependent Diabetes Mellitus (N.I.D.D.M.) May be treated with diet, oral medications or insulin May be of any age but usually over 40 years Usually obese The high sugar (glucose) level in the blood directly causes damage to the eyes, kidneys, and nerves therefore early diagnosis and proper treatment can delay complications. SIGNS OF DIABETES Frequent urination Continuing thirst Abnormal hunger Obvious weakness and fatigue Irritability Sometimes nausea and vomiting Blurred vision Tingling or numbness in the extremities Skin infections and slowed healing of cuts and scratches Diabetic Reactions HYPOGLYCEMIA HYPERGLYCEMIA (Insulin Reaction) (Diabetic Acidosis) Onset sudden, 15-60 minutes gradual, 1-2 days Skin pale, moist, cold, perspiring flushed and dry Behavior excited, confused drowsy Breathing normal, rapid, shallow deep, rapid Vomiting absent present Tongue moist dry, coated, swollen Thirst absent present, severe Hunger present absent Sugar in Urine slight, absent large amount Ketones in Urine slight, absent large amount Causes taking too much insulin or too little insulin oral anti-diabetic drug not eating enough eating too much unusual amount of exercise infection, fever, emotional stress What to do take sugar or food containing call doctor sugar (fruit juice, candy, IMMEDIATELY 2 tsp. sugar) call the doctor call doctor IMMEDIATELY DO NOT take insulin, or call doctor oral anti-diabetic drugs IMMEDIATELY DO NOT give fluids if continue testing unconscious urine/blood at regular intervals Treatment Guidelines for Diabetes Diet A nutritional diet should be prescribed by the doctor and should be followed strictly Try to eat the same amount at the same time each day Exercise An exercise regime should be prescribed by the doctor Try to exercise the same amount at the same time each day Medication Oral anti-diabetic (oral hypoglycemics) Insulin for injection (many types) To be taken/given at SAME time each day Eye Care Eye examination should be done annually (at least) Teeth/Gum Care Special effort to brush and floss daily Routine check-ups by dentist are a must Skin Care A program of daily hygiene helps prevent problems Monitor skin for development of boils or recurrent skin infection or minor scratches and cuts that take a long time to heal Doctors Visits Measurement of kidney function should be done at least once a year BUT if you notice swelling in the ankles, tell the doctor IMMEDIATELY Analysis of nerve function should be done periodically and if you notice any pain or tingling sensations in the extremities contact the doctor Testing Blood and/or Urine Glucose One of the most important aspects of avoiding the complications of diabetes Should be carefully done and recorded daily Foot Care Take special care when caring for the feet, washing daily, gently drying, trimming nails straight across, avoiding harsh substance and avoiding tight-fitting shoes Common Medication Administration Abbreviations a.c. Before meal B.I.D. Twice daily Cap. Capsule c.c. = 1 m.L. Cubic centimeter gtts. Drops h.s. At bedtime m.g. Milligrams m.L. Milliliter O.D./Q.D. Once daily Padis Poison and Drug Information Service p.c. After meals p.o. By mouth P.R.N. As necessary (latin for pro re nata) Q.I.D. Four times daily q4h, q6h, etc. Every _____ hours Tab. Tablet tsp.= 5 m.L. Teaspoon T.I.D. Three times daily ung. Ointment Medication Administration Summary When administering medication, follow these steps: Log into OneMAR online Wash hands and wear medical gloves where applicable Take medication from cabinet Review the Seven Rights before administering medication Right Person (check photo, if applicable) Right Medication Right Time Right Dosage Right Route/Method Right Documentation Right Response Please mind the drug rules, dont rush Dispense medication into medication cup or prepare for appropriate administration of medication (i.e. ointment, drops, etc.) Place medication back into cupboard or storage areas and re-lock. If possible, have client come to medication cupboard or storage area with liquid (i.e. water, juice, etc.) for swallowing medication Refer to the person by name and check photo again (if applicable) Administer the medication Stay with the individual and observe that the medication has indeed been swallowed or procedure is complete Confirm medication has been given on OneMAR system. Complete OneMAR 4-steps as per Policy & Procedures. Study Questions Fill in the blanks: Never give any medication unless it is prescribed by a ________________________ or ________________________. Never use ____________ or ______________ or _______________ on medication documentation as these are legal documents. In case of emergency at 2000 hrs on Tuesday, who would you call? _________________ For which med incident would you call the Team Leader? __________________________ When administering suppositories or enemas ensure the individuals _____________________ and ____________________. After returning from a doctors appointment ensure that all pertinent information is _________________________________. If part of the original medication order is changed it is handled as a ____________________ order and a _____________________ medication. Ensure proper changes are made to the _______________________. Ensure that all P.R.N. medications are checked for ___________________ monthly. What is the difference between LOA meds and a Med Transfer release form? ______________________________________________________________________ Always call the ____________________ when a medication incident has occurred, except for 1)_________________2)____________________3)___________________________. Over the counter medication can be approved by a ____________or by the ____________. Short Answer: 1.What five steps do you follow when a medication incident occurs? 2. List and describe the 3 types of medication orders a. b. c. 3. What are the Seven Rights? 1. ____________________ 5. ____________________ 2. ____________________ 6. ____________________ 3. ____________________ 7. ____________________ 4. ____________________ 4. When do you fill out a Med Transfer Release Form? 5. What 2 pieces of information do you compare before administering medication? 1. ____________________ 2. _____________________ 6. What do you do if there is a discrepancy in the size, shape, or color of a medication? 7. List 4 possible reasons why an individual would refuse to take their medication? 1. _____________________ 2. ____________________ 3. _____________________ 4. ____________________ 8. What are 4 questions that you ask if a doctor has ordered medication changes? 1. _____________________ 2. ____________________ 3. _____________________ 4. ____________________ Bibliography and References Graedon, Joe, and Graedon, T., The New Peoples Pharmacy. Toronto, ON: Bantom, 1985. Kepler, James, Kepler, A., and Salafsky, I., Childrens Medicine, Parents Guide to Over the Counter Drugs, Signet, Markham, ON: Signet 1985. Readers Digest, The Canadian Mental Association Guide to Prescription and Over the Counter Drugs. Montreal, PQ: The Readers Digest Association (Canada) Ltd., 1990. Smith, Dorothy L., Understanding Canadian Prescription Drugs. Toronto: Consumer Health Information Corporation, Virginia, USA, 1992. Zinnerman, David R., The Essential Guide to Non-Prescription and Over the Counter Drugs. Toronto: Fitzherry & Whiteside Limited, 1983. Clinical Pharmacy and Therapeutics. Editors, Herfindal, E.T., Gourley, D.R., Hart, L.L., Williams and Williams Publishers, Baltimore: 4th Edition, 1988. Compendium of Pharmaceutical and Specialities. Editing Chief, Kragh, Carmen M. E., Canadian Pharmaceutical Association, Ottawa, ON: 1993. Current Medical Diagnosis and Treatment. Krupp & Chatton, 1984. GSHCS Department Manual. Good Samaritan Society, 1989. GSRS Medication Training Course. Good Samaritan Society, 1989. Handbook of Clinical Drug Data. Editors, Knoben, J. E., Anderson, P.O. Intelligence Publications Inc. Hamilton, Illinois: Fifth Edition. Manual of Medical Therapeutics. Editors, Orland, M.J., Saltman, R.J. 25th Edition, Little Brown and Company, Toronto, ON: 1988. Medication Guide. Dorothy L. Smith, 2nd Edition, 1981. Medication Teaching Manual. CSHP, 3rd Edition0, 1983. Self-Medication. A Reference for Health Care Professionals. Editor Clarke, Cheryl B.J., Canadian Pharmaceutical Association, Ottawa, ON: 1988. The Nurses Drug Handbook. 3rd Edition, 1981. USP DI Vol. 172, 6th Edition 1986, 1990.     PAGE  PAGE 32 PAGE  ,Z[ & ' 0 ? X u w y |    + @ A U V o p r w  ȻԒȌȆԆԒԆԆԆԒԆԒԆԆ haCJ hBCJ hUqlCJ hUDCJh3a CJOJQJh3a 5CJOJQJh'9h3a 5CJOJQJh3a h3a CJOJQJ h3a CJ h)q:CJ h)q:CJ h)q:CJ hxCJ hE[gCJ h)q:CJ h)q:CJ$h)q:h'91$%&'()*+,FZ[ C D E F o $a$$a$ (   + A V p =  S% S% S%gdUD S% 7%3'dQ]3 6 < A b n y  + J _  ./07Wn +Ka1@`3?Cb} ,-.Ccde| hOCJ hdjCJ h)q:CJ h)q:CJ hBCJ h/?CJW= o  K /0X L & FX sS% S%8^8` S% 7% S% S%2456c-.de S% S% 7% S%@HW^W & FX sS%&$$d%d&d'dNOPQa$ Hgiz{.9;((-....Q.k.m.y.z......ɻɻɻɻɻɻ|n|n|n|n|nh'9h'95CJOJQJh'9h'95>*CJOJQJh'9CJOJQJhLICJOJQJhLIhLI6CJOJQJhLIhLICJOJQJhLIhLI5CJOJQJhLIhLI5>*CJOJQJh)q:5>*OJQJh)q: h)q:CJ hB#CJ h)q:CJ h)q:CJ'FGgdLI$@&gdLIGHXghiz{snnngdLIkd$$IflF ,"   0    4 laytLI $IfgdLI -.:;WXmnuv12^gdLI & FYgdLIgdLI  !!""""a$b$+%,%&&''\'v''''''( & FY gdLI & FZ n`gdLIgdLI & FYgdLI((v)))*k***6+j++ ,,M,v,,,, & FZ #`#gdLI & FZ nnW^n`WgdLI ngdLI & FZ nnW^n`WgdLI & FZ n`gdLI & FY gdLIgdLI,-l---.. . . . . ....O.P.Q.a.k.l.m.y. $Ifgd'9$@&gd'9gd'9 & FY gdLI gdLI & FZ W^`WgdLIy.z........z/{///snnnnnnnnngd'9kdz$$IflF ,"   0    4 layt'9 $Ifgd'9 .{///(3Z3_33445C5E5G5q55!6,7`7878?8c8g8x89990:3:5:a:g::;<<==>=|=}====>2?Õ"h'9h'95>*CJOJQJaJh'9h'9CJOJQJaJh'9h'96CJOJQJ!h'9h'9B*CJOJQJph"h'9h'96>*CJ OJQJaJ h'9h'95CJOJQJh'9h'95>*CJOJQJh'9h'9CJOJQJ./00'3(3Z3[3445C555%7&7778898c8889999p^pgd'9gd'9^gd'9 & F[gd'990:`:a::;;<<==}=~====>>,?-?q???@@^gd'9 0^`0gd'9gd'9p^pgd'9^gd'92?s?w????@AAAB,B0B[B`BB*CVCC$D*DwDzD|DDDDEEFGG*GiGjGWLXL`LaLbLcLeLrLtLLLµµ൫|v h)q:CJh)q:h$-CJOJQJhLICJOJQJh)q:CJOJQJhLIh'9CJOJQJh'9CJOJQJh'9h'9CJOJQJh'9h'95CJOJQJh'9h'95CJOJQJaJh'9h'9CJOJQJaJh'9h'96CJOJQJaJ-@AAAB)BWB[B#C$CCC%D&DwDDDEEFFGGiGjG^gd'9^gd'9gd'9p^pgd'9jGHH5I6III J JsKVLWLXLYLZL_L`LaLbLcLdLeLfLgLhLiL^gd'9^gd'9gd'9 0^`0gd'9iLjLkLlLmLnLoLpLqLrLsLtLLLLLL$If&$$d%d&d'dNOPQa$#$d%d&d'dNOPQLLLLLOMPMZM[MNNOtomkkkmkfka/ & F & F$a$kd$$IflF ) t06    44 la LLLPMZMNOhPP.Q4QXR^RSSsTTTT_U=VhViVuVvVVVVVVVVVVWWKWLW]W^WWWWWWWWX~XXXXXXXXFYGYHYMYNY˼˱˱˙˙˙˱˙˙˙˱˙˙˙˱˙˙ jh)q:OJQJ^Jhu5OJQJ^Jh)q:5OJQJ^Jh)q:5CJOJQJ^JaJh)q:OJQJ^Jh)q:5CJ OJQJ^JaJ h)q:5hh)q:5CJ aJ h)q: h)q:CJCJh`>h7CJh`>h)q:CJ hCJ h7CJhZh)q:5CJ h CJ h)q:5CJh)q: h)q:CJh"wOJQJ^Jh)q:CJOJQJ^JaJh)q:5OJQJ^Jh)q:OJQJ^J*QfRf^fqf$Ifgkd<4$$Ifl4)) t0644 laqfrfsftf||$If|kd4$$IflL0d4) t0644 latfufff||$If|kd.5$$Ifl0d4) t0644 laffffyy$Ifkd5$$Ifl4T0 4)`h 8 t0644 laf4ffffyy$Ifkd76$$Ifl4T0 4) h 8 t0644 laf4ffffff}s}m$If &dPkd6$$Ifl4T0 4) h 8 t0644 laf4ffff+gkd7$$IflT4)) t0644 la$IfgkdY7$$IflT4)) t0644 lafffffffffff^kd[8$$Iflr  #4)` "X t644 la$If &dP ff g g gNgOggggg}h~hZi[ihjijkkDlElll & F  & F gdX,9 & F & F & F & F & F & F & F 'dQlllDmEmmmmm n!n2o3oppppppqq)qTqqq$a$$ & Fa$ 'dQ & F  & F m3ooopppppppqqqqqqqqrrrrrrrrss,s-srssssss uu;vNvVvwvyvPwwwƽz h`>CJ hXZCJ hXZ5CJhXZhXZ5CJ hO 5CJ h)q:5CJh`>h{CJ h)q:CJh`>h)q:CJh`>h`dCJhdZ h`dB*CJphhdZ h)q:B*CJphh{h)q:CJ h{h)q: hO CJ h)q:CJh)q:,qqqqrr rIrrrrrsss,s-s8^8 0^`0 & FQ & FQ 'dQw*xGxHxxxxxxxxxxzzzzzzzzzzzzzƹ̨̹yjVB& jxh03h)q:CJOJQJ^JaJ& joh03h)q:CJOJQJ^JaJjL>h03h)q:CJUaJ(jh03h)q:CJUaJmHnHuh03h)q:CJaJjh03h)q:CJUaJ h03h)q:CJOJQJ^JaJh)q:5CJOJQJ^J h03CJ h)q:CJh`>hKCJaJhKCJaJh)q:CJaJhWRCJaJh`>h)q:CJaJxxxxxxxxxxxxxxxxxxx $$Ifa$$Ifxxxxx $$Ifa$$Ifxkd8$$Ifl02" t0644 laxxxxxxy|||||$If}kd9$$IflI02" t0644 layt03yyyy y%y,yuooooo$IfkdR:$$Iflru2" Q>. t644 la,y-y.y/y0y5y=yuooooo$Ifkd:$$Iflru2" Q>. t644 la=y>y?y@yAyHyQyuooooo$Ifkdr;$$Iflru2" Q>. t644 laQyRyYyhyiynyzyuooooo$Ifkd<$$Iflru2" Q>. t644 lazy{y|y}y~yyyuooooo$Ifkd<$$Iflru2" Q>. t644 layyz zzuo1o>kd=$$Ifl2"" t644 la$Ifkd"=$$Iflru2" Q>. t644 lazzzz{ { { {{{$If>kd=$$Ifl2"" t644 la zzzzzz${%{2{3{4{5{L{M{N{O{P{Q{{{+|,|-|.|F|G|L|M|R|S|T|U|]|^||||}}۵۪w۪۪cە۪& jxh03h)q:CJOJQJ^JaJj@h03h)q:CJUaJjh03h)q:CJUaJ(jh03h)q:CJUaJmHnHuh03h)q:CJaJ#h03h)q:5CJOJQJ^JaJ& joh03h)q:CJOJQJ^JaJ h03h)q:CJOJQJ^JaJ& jh03h)q:CJOJQJ^JaJ&{{{{{${%{rlllll$Ifkd>$$Iflr82" f  t644 la%{&{'{({){0{1{rlllll$Ifkdq?$$Iflr82" f  t644 la1{2{3{Q{f{g{h{v{w{rppjjjjj$Ifkd@$$Iflr82" f  t644 law{x{{{{{{uooooo$Ifkd+A$$IflrpH2" hT. t644 la{{{{{{{uooooo$IfkdA$$IflrpH2" hT. t644 la{{{{{{{uooooo$IfkdKB$$IflrpH2" hT. t644 la{{{{{{{{usmmmmm$IfkdB$$IflrpH2" hT. t644 la{{{{{{{rlllll$IfkdkC$$IflrpH2" hT. t644 la{{{{{{{rlllll$IfkdD$$IflrpH2" hT. t644 la{{{{{||rlllll$IfkdD$$IflrpH2" hT. t644 la| ||||||rlllll$Ifkd*E$$IflrpH2" hT. t644 la|| |!|"|#|$|rlllll$IfkdE$$IflrpH2" hT. t644 la$|%|&|'|(|)|*|rlllll$IfkdTF$$IflrpH2" hT. t644 la*|+|,|.|g|h|||||||rpppppjjjjj$IfkdF$$IflrpH2" hT. t644 la |||||||rlllll$Ifkd~G$$Iflr82" f  t644 la|||||||rlllll$IfkdH$$Iflr82" f  t644 la||||||||rpjjjjj$IfkdH$$Iflr82" f  t644 la|||||||uooooo$Ifkd=I$$Iflrpzw2"   t644 la|||}}usmm$IfkdI$$Iflrpzw2"   t644 la}}}}}&},}WQkdJ$$Ifl0l  t644 la$IfQkd]J$$Ifl0l  t644 la}}}}},}-}F}}}}}~~/~0~[~\~j~k~y~z~~~~‚Â͂΂ۂ܂RTyϽpjfh)q: h)q:CJ jxh)q:CJOJQJ^J jh)q:CJOJQJ^J joh)q:CJOJQJ^Jh)q:CJOJQJ^J& joh03h)q:CJOJQJ^JaJ#h03h)q:5CJOJQJ^JaJh03h)q:CJaJ(jh03h)q:CJUaJmHnHu h03h)q:CJOJQJ^JaJ',}-}:}F}G}}}}}}WUUUQkd;K$$Ifl0l  t644 la$IfQkdJ$$Ifl0l  t644 la }}}}}}$IfQkdK$$Ifl0d2"  t644 la}}}}} ~ ~$IfwkdL$$Ifl\ 2"x  t644 la ~~~~~*~+~uooooo$IfkdL$$Iflr 2"x V . t644 la+~,~-~.~/~>~?~uooooo$Ifkd'M$$Iflr 2"x V . t644 la?~@~[~~uoo$IfkdM$$Iflr 2"x V . t644 la~~~~~~~~@>fkdN$$IfleF 2"  t6    44 la$IfSkdGN$$IflS0 2"  t644 la~~~~~~~~WQkdcO$$Ifl02"9e t644 laQkd O$$Ifl02"9e t644 la$If~~~~~~~~RTkdP$$Ifl40"`9e t644 laf4$IfQkdO$$Ifl02"9e t644 la~~~~~~~~~~QOOTkdP$$Ifl40" 9e t644 laf4$IfTkdvP$$Ifl40" 9e t644 laf4 ~~~~~~~~~okd?@ABCDEFGH $$Ifa$HIJKLMNOPQRSTUVWXYZ[\]^_`abcd $$Ifa$FfFodefghijklmnopqrstuvwxyz{|}~FfWv $$Ifa$Ffh} $$Ifa$Ffy $$Ifa$ÏďŏƏǏȏɏʏˏ̏͏ΏϏЏяҏӏԏFf $$Ifa$ԏՏ֏׏؏ُڏۏ܏ݏޏߏ $$Ifa$ Ff $$Ifa$  !"#$%&'(Ff $$Ifa$()*+,-./0123456789:;<=>?@ABCDFfˠ $$Ifa$DEFGHIJKLMNOPQRSTUVWXYZ[\]^_`Ffܧ $$Ifa$`abcdefghijklmnopqrstuvwxyz{|Ff $$Ifa$|}~ $$Ifa$Ff $$Ifa$ÐĐŐƐǐȐɐʐː̐͐ΐϐАFf $$Ifa$АѐҐӐԐՐ֐אِؐڐېܐݐސߐFf $$Ifa$Ff1 $$Ifa$  !"#$ $$Ifa$$%&'()*+,-./0123456789:;<=>?@ $$Ifa$FfB@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\Ffa $$Ifa$\]^_`abcdefghijklmnopqrstuvwxFfr $$Ifa$xyz{|}~Ff $$Ifa$Ff $$Ifa$‘ÑđőƑǑȑɑʑˑ̑ $$Ifa$̑͑ΑϑБёґӑԑՑ֑בّؑڑۑܑݑޑߑFf $$Ifa$Ff $$Ifa$  Ff $$Ifa$ !"#$%&'()*+,-./0123456789:;<Ff  $$Ifa$<=>?@ABCDEFGHIJKLMNOPQRSTUVWXFf $$Ifa$XYZ[\]^_`abcdefghijklmnopqrst $$Ifa$tuvwxyz{|}~Ff $$Ifa$Ff  $$Ifa$’ÒĒŒƒǒȒFf*' $$Ifa$Ȓɒʒ˒̒͒ΒϒВђҒӒԒՒ֒גْؒڒےܒݒޒߒFf;. $$Ifa$ $$Ifa$  $$Ifa$FfL5 !"#$%&'()*+,-./012345678Ff]< $$Ifa$89:;<=>?@ABCDEFGHIJKLMNOPQRSTFfnC $$Ifa$TUVWXYZ[\]^_`abcdefg|}~$IfFfJ $$Ifa$$IfFftQ $$Ifa$“ÓēœƓǓȓɓʓ˓͓̓ΓϓГѓғӓԓՓ֓דؓ $$Ifa$ؓٓړۓܓݓޓ  $$Ifa$$IfFf[X $$Ifa$!$'*-0369<?BCDEFGHIJKLMNOP $$Ifa$FfP_ $$Ifa$PQRSTUVWXYZ[\]^_`abcdefghijklFfaf $$Ifa$lmnopqrstuvwxyz{|}~Ffrm $$Ifa$ $$Ifa$Fft $$Ifa$”ÔĔŔƔǔȔɔʔ˔͔̔ΔϔДєҔӔԔՔ֔הؔٔڔ۔ܔFf{ $$Ifa$ܔݔޔߔFf $$Ifa$ Ff $$Ifa$ !"#$%&'()*+,-./0 $$Ifa$0123456789:;<=>?@ABCDEFGHIJKL $$Ifa$FfǐLMNOPQRSTUVWXYZ[\]^_`abcdefghFf $$Ifa$hijklmnopqrstuvwxyz{|}~Ff͞ $$Ifa$Ffޥ $$Ifa$Ff $$Ifa$•ÕĕŕƕǕȕɕʕ˕͕̕ΕϕЕѕҕӕԕՕ֕וؕ $$Ifa$ٕؕڕەܕݕޕߕFf $$Ifa$ Ff $$Ifa$ !"#$%&'()*+,Ff" $$Ifa$,-./0123456789:;<=>?@ABCDEFGHFf3 $$Ifa$HIJKLMNOPQRSTUVWXYZ[\]^_`abcdFfR $$Ifa$defghijklmnopqrstuvwxyz{|}~ $$Ifa$Ffc $$Ifa$Fft $$Ifa$–ÖĖŖƖǖȖɖʖ˖̖͖ΖϖЖіҖӖԖFf $$Ifa$ԖՖ֖זٖؖږۖܖݖޖߖFf $$Ifa$ $$Ifa$  !"#$%&'( $$Ifa$Ff()*+,-./0123456789:;<=>?@ABCDFf $$Ifa$DEFGHIJKLMNOPQRSTUVWXYZ[\]^_`Ff $$Ifa$`abcdefghijklmnopqrstuvwxyz{$IfFf $$Ifa${|}~$IfFf $$Ifa$—×ė $$Ifa$$IfėŗƗǗȗɗʗ˗̗͗ΗϗЗїҗӗԗ՗֗חؗٗڗۗܗݗޗߗFf $$Ifa$Ff $$Ifa$ Ff$ $$Ifa$ !"#$%&'()*+,-./01234Ff, $$Ifa$456789:;<=>?@ABCDEFGHIJKLMNOPFfD3 $$Ifa$PQRSTUVWXYZ[\]^_`abcdefghijkl $$Ifa$lmnopqrstuvwxyz{|}~Ffq: $$Ifa$$IfFfA $$Ifa$˜ØĘŘƘǘȘɘʘ$IfFfH $$Ifa$FfzO $$Ifa$C4Ù!BKlrߚ Cx'.OYz֜͜%O3C򚔚 hxMECJ h CJ h8?CJ h)q:CJhe~ h)q:CJh|B*CJhphhyB*CJhphh)q:B*CJhphh)q:5B*hphh)q:5B*CJhphh)q:B*CJhphh)q:h)q:B*hph5 456<U[\fghijklmnopqFfWU$If $$Ifa$%d'dOQ^qrs$If $$Ifa$ 2))) $$Ifa$kdX$$If^   d!'5|67L9*hhhh$$$$4 a: $$Ifa$ÙřǙə˙͙ϙљәՙؙۙޙ $$Ifa$$If$IfFfmY $$Ifa$  !"#$%&'()*+,- $$Ifa$$IfFfJ_ $$Ifa$-./0123456789:;<=>?@ABKLMNOP$IfFf'e $$Ifa$PQRSTUVWXYZ[\]^_`abcdefghijklFfk $$Ifa$lrstuvwxyz{|}~ $$Ifa$$If$IfFfp $$Ifa$šÚĚŚƚǚȚɚʚ˚$IfFfv $$Ifa$˚͚̚ΚϚКњҚӚԚ՚֚ךؚٚښۚܚݚޚߚ$IfFf| $$Ifa$Ffx $$Ifa$ FfU$If $$Ifa$gdy $$Ifa$ ,yz{|}~$If $$Ifa$ ~2)) $$Ifa$kd$$If^  d!'5|67L9*xhhh$$$$4 a: $$Ifa$ $$Ifa$gd|ěǛʛ͛Лӛ֛ٛܛ $$Ifa$$IfFfO $$Ifa$ܛߛ  $$Ifa$$IfFf $$Ifa$ !"#$%&'./0123$IfFfї $$Ifa$3456789:;<=>?@ABCDEFGHIJKLMNOFf $$Ifa$OYZ[\]^_`abcdefghijklmnopqrst $$Ifa$$Iftuvwxyz$IfFfS $$Ifa$$IfFf $$Ifa$œÜĜŜƜǜȜɜʜ˜̜֜͜ל؜ٜڜۜܜ$IfFfծ $$Ifa$ܜݜޜߜFf $$Ifa$$%OPeQxyǟٟQgdxME & FgdxMEgde~^gd  & F$a$&$$d%d&d'dNOPQa$CPQyٟPˠ*6BC !̢֢ ٥wxǺЫ}}w hCJh)q:5CJ\ h)q:CJ\h)q:5CJ\ h)q:CJhxMEhluQCJ hCJ hKdCJhKdhnCJhKdhnB*CJphhKdhVNCJhKdh)q:CJ h8?CJhVNhnCJ hnCJ he~CJ h)q:CJ hxMECJ.QR)*_ G{͢k٥xy#$d%d&d'dNOPQ & FgdluQ & FgdKd & F & F h^ !nkd$$Ifl0)064 la $$Ifa$ !"#01A $$Ifa$nkdC$$Ifl0)064 laABCTU $$Ifa$nkdȺ$$Ifl0)064 laUVWno $$Ifa$nkdM$$Ifl0)064 laߧ $$Ifa$nkdһ$$Ifl0)064 laߧ $$Ifa$nkdW$$Ifl0)064 laDѨJMUjstvwU\ruK\wxyRfg\dʰľĸތއތ{ތ h)q:5^J h)q:5 h)q:>* h)q:CJ h)q:CJ hqDCJ&jhe~CJUmHnHsH tH u hCJ he~CJ hCJ hCJh0Djh)q:CJUmHnHuh)q:h)q:5CJ$\h)q:5CJ\ h)q:CJ hluQCJ0 $If $$Ifa$nkdܼ$$Ifl0)064 laBCD¨èĨŨƨǨȨvv$h^ha$h^h & FW$a$nkda$$Ifl0)064 la Ȩɨʨ˨̨ͨΨϨШѨJTUtw $a$$a$#$d%d&d'dNOPQ B`wUrQKLMNOPQRSTUgde~`gde~`UVWXYZ[\wxyJKٮڮ&$$d%d&d'dNOPQa$$a$#$d%d&d'dNOPQڮ OPQfyįٯ^`bd $$Ifa$$If°İưȰYSMMMM$If$Ifkd$$Iflr  &H C :04 laȰʰYSSSSSS$Ifkd$$Iflr  &H C :04 laʰ,>ڱ 8>mnpȷ̷)wyAܹoܼV V &0mnoľh"IaCJaJhu CJaJhhZCJaJh|vhhZCJaJ hhZCJ hhZCJhhZ hSCJ huCJ h)q:CJ h)q:CJh)q:CJaJh h=l hCJ h)q:CJh)q:7 ,.024YSSSSSS$Ifkdh$$Iflr  &H C :04 la468:<>"#$%YWWWWWWWWWkd"$$Iflr  &H C :04 la %&'()*+DųƳbc nopͷηϷ)$a$ &dP)*+dAB & F 'dQyzл#$ 0OPQRST^ & F h88^8 & FTUVܿM} $a$gdu $a$gdhZdhgdhZgdhZ&$d%d&d'dNOPQgdhZ =mnopq-.f !"#8 'dQ $d N gdhZ$a$gdhZgdhZ#8[v5{2I}~no)*/04:=>?V ?S緱 h)q:>*CJ h@tCJ huCJ hOjDCJ he~CJ jhN CJ hN CJ hxCJjh)q:UmHnHu hzCJ hCJ hX+CJ hH CJh)q: h)q:CJhhZ hhZCJ jhhZCJ689ghDE !"#$%&'()* & F*+,-./012Iopmnpgdx&$$d%d&d'dNOPQa$ 'dQ456789vwx &d P gdN gdx>?bcVWpq>?ST & F h88^8 & F & F 'dQSUdg )5F]BL+Olp*u67wxjk$%h" h9CJh9 h95\ h)q:5\ h)q:CJh}h)q:5CJh@t5CJ\hOjD5CJ\h)q:5CJ\ hOjDCJh)q: h@tCJ h)q:CJ@>?yz{|}~gh $'dQa$ & F & F h88^8hivw*+[\] & F+,VW|}O 'dQOPkl;<op&'()* p^p`*tu67wxij#$:^: (^` $p^p`a$+p$d%d&d'dNOPQ^p`=>ij & F 'dQ=b,S<FknoWxK./0123[\]ܪ܎ܸjh)q:OJQJU^J h)q:>*CJ h)q:5\jh)q:OJQJU^J h)CJ h(CJjh)q:OJQJU^Jh)q:OJQJ^Jjh)q:OJQJU^J hSCJ hCJ h)q:CJh)q:8BC !\]^_`abcdefghi#$d%d&d'dNOPQ & Fijklmnopqrs !"#$%&'( 'dQ()*+,STU :;< & F ^ & F $a$ 'dQ6789:;<=>?@ABCDEFklmn 'dQ & F *+VWCD & FL & FK & F!$a$%d'dOQ>??Bbc%d'dOQ & F 0^`0  & FO & FN & FM23[\QRAB & F" 'dQ$a$gd))* DGP"#stsv56kl65 ¼׵ױ׵רע׵ל h sCJ hzCJhzh)q:CJhr h)q:5CJ hrCJ h)q:CJ h)q:5CJ hzh)q: h)q:CJ h)CJjh)q:OJQJU^JjAh)q:OJQJU^J=k_`ab* & F$$a$gd8v $'dQa$ & F"gd8v & F# & F"*+yzk'DE[2$b$% & F$  & F' h8^8 & F& h88^8 & F% h88^8 & F$% DEFG & FP[kd<*$$Ifl($,04 la$If$a$ & F$PQ45LMN"#st & FP^ & FP & FPgdz^gdzstuv67  & F( & F(gdz & F( 'dQ$a$gdr   l68st$a$ & F )^gdzgdz & F(gdz & F( Z[4 5 H I t  - .     6 7   & F) 'dQ5 H I F S    6    01OPcdz{     E!L!M!S!!&&'(s(((()),, hi%CJheh)q:CJ heCJ hYCJhq jh)q:CJh)q:5CJ\ h sCJ h)q:CJ h)q:5CJh)q:H        CDE{|ABC & F*)Dl78de 'dQ & F+ezk,- & F,xy(` /PQ & F. & F-$a$ 'dQQyz$%RS [\rsJK 'dQ & F1 & F0 & F/dkd*$$Ifl\ )H 04 la$If lffff$Ifkde+$$Ifl\ )H 04 lalffff$Ifkd,$$Ifl\ )H 04 lalf]WW$If $$Ifa$$Ifkd,$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkdw-$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkd.$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkd.$$Ifl\ )H 04 la   lf]WW$If $$Ifa$$Ifkd{/$$Ifl\ )H 04 la !"lf]ff $$Ifa$$Ifkd0$$Ifl\ )H 04 la"#0234lf]ff $$Ifa$$Ifkd0$$Ifl\ )H 04 la45OQRSlf]ff $$Ifa$$Ifkdc1$$Ifl\ )H 04 laSTcefglf]ff $$Ifa$$Ifkd2$$Ifl\ )H 04 laghz|}~lf]ff $$Ifa$$Ifkd2$$Ifl\ )H 04 la~lf]ff $$Ifa$$Ifkdu3$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkd/4$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkd4$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkd5$$Ifl\ )H 04 lalf]WW$If $$Ifa$$IfkdA6$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkd6$$Ifl\ )H 04 lalf]ff $$Ifa$$Ifkd7$$Ifl\ )H 04 lalf]ff $$Ifa$$IfkdE8$$Ifl\ )H 04 la     lf]ff $$Ifa$$Ifkd8$$Ifl\ )H 04 la        lffffff$Ifkd9$$Ifl\ )H 04 la   ^ _       E!ljjjjjjjjje$a$kdW:$$Ifl\ )H 04 la E!L!M!!"""####$$$h$$$$% %6%;%X%h% & F6 hn8^8 & F5 & F3 & F2 & F4$a$ 'dQh%%%%%%%*&+&2&V&l&&&&&&&&/'C'k'l' & F9 & F8 h88^8 & F7 h88^8 & F5 n & F6 hn8^8l''''''''''''''''''''''''''''''''''''''''''''(((s((d))))))* & F; & F:gde & F:$a$ 'dQ*K*L******+++++++,,9,H,p,,,,,,,,, & F= & F< & F;,,,,,,--L-M---------(.).O.P.l.m.....` 'dQ,,,//090:00000"1111172@2220393m3|3334455K6U66.7O7d77777788A8B8C8t88888889I9J9N9p99999:::=E=F=|=====> h HCJ h&FCJ h)q:5hYh)q:CJ hYCJhY5CJ\h)q:5CJ\ huCJh)q: h)q:CJJ. /'/(/Q/R///// 0 0:00#1$1s111111262 & F? h88^8 & F> 'dQ^ ^``6272@2v222223/30393l3m3|33333 44 & FD h88^8 & FC h88^8 & FB h88^8 & FA h88^8 & F@ h88^8 & F>44455556J6K6U66666666.7/70737J7 'dQ & FG h88^8 & FF h88^8 & FE h88^8 & F>J7K7d7e7x7y7777777777788B8C8Z8[8o8p8888888888994959I9J9K9L9M9N9p9q9999999::J:K:u:: & FI & FHgdY & FH 'dQ:::::::::|;};;;E<F<<<<<==F=G=|=}=~=1gd&F & FH $^`a$^ & FI~=========>>>>>>4?5???!@"@@@=A>AAA^ & FJ & FJgd H 'dQ>>>>>3?@@@A>AAAoBBBBBBB#C$C%C&C[CfCgCC/DdDeDhDiDDDDDDDDGEIEJEKEEFFFSFFFFFFFFGrGGG HxHHIBIĽ h)q:>*CJh+hX~h)q:CJ hX~CJ h*CJ h)q:CJGPKQKKK[L\LLLLLZM[MMMMMMMMMMMMMMMMM*h]h*&`#$MMMMMMMMMMMMMMMN$ !h$dN]ha$  !h]h  &`#$ !h$dN]h >)&#$+D&`#$ Attach Picture Here  EFG[\]^ $dNG[\]^ h)q:CJh[ɾSƷ3c6j]' Q@o,\hX\?``7c?4Wiگă3 dɲr{9q'9@ҵ/zJ:돦HT= >PQoo(([R|qkk'c)s1x3c19ٖP( U֖?KG^B+|c{俗Zde& H|٠ .A9<*\Pׄ~"|Cm%Te|;mT&ω4`!:wAHyj!lۻ׹PEPE7'2s7:v3*O^Qߎ$2k]*>u|{[jZf5~\ϋu[&}GSh3--ZZ?,A:H㺼Q##cDxCⶅ"~ɍ,1)oj{z n(7=.?j}Q@cjz}qm6hghjyV~ʧODVWLoqH?UZɕ8Uwuz'3#ig +]7G[m 2UʽV_EO\/)>'tEIp.FI =<-HmVulI%R .ChyRxX<3ecEvEFQI7t [Śd]2[]BIʍ`3)9+W=5ƕ|v\28ȵk>ԛMl0IٸnPX׮|2O[)%-Sw@\ǎ4K{Amdถ :F7 6Af4`ֻTw AVv`j~k:o/t녵c#̶Ha (ɵZޣwoJQߺ̀rÛ޻"*[[3J,^YAc ?hgKXYjāiBtc=𕜤A0V/X>x RiUm\,oD({v׾ -LQI# FurhoXYo ܹ>ˤ8dqR|GͽΕkiqqܚr&Yrzu@nMK(o"(g|Ddӧߒ[|&5?W(?WMtYtXKlaAX@bӫc;O^ W& qHNI$<Em8(_sW} . IK%P$ՑK$" : t K$BiDJ 0\6 nWSx{Hnmpr8;I|o6_ RUG?/`B BǗp@(舵O-4(o]` TrYx?qA4os\ȈH@{@$W~֢Kyb1?8wz (&,s  < fD̾dO0(`sfxPM57$g|&CgbOVك(Mľq$ᵌ<-uX+$QjҹXZ-St% '9A:?_ȓAc6eSQ,y]},J]KI./uMmpc1Q"$lRQ\& xgڣ}M+#0ff@d K >[}2vw6K%|wSy7ۛw)~ wȊ&o ͅy|څy"H)|Q[>@CRVo$+|Yh ኘ`WE8G>ր^WCxjfٓTb\FIS"͎@z|;(Y:ޞ:j:|X9 {Դt:Nk_k/!1>:dP淒8c6G^k<1Zj޿qڒZW2 'd`|Fƣt?W 0~ć~"][ge4s+XʎO ?=${ޢ#l%-romC⋁=B ?gKi#]ĂZRv+ P𖍪իF".$ `h03"':ioeSh6>1Ͼտ}\Z2v_>5м+!{$_vNr61K^M}n[]lWO0Vcp"C}":iZZWVc|2lFG ǿە^QPo.\0ׅ|5$P4SWf̐$jnc' Վv5/Ghk]ڨlIu9lin&jI}t{k$9KhcW&xFJԢil6[0z\O _q=ťp'fܡE;dQw:`KDvFNhgJevTBʠ$8 h2]ңIZMVżP_xonQ6 ?UZ{K7 ''z;ʺ ơH Y\74~U}Hz?_4Me^YI4Z'̾Z'Irwl4DdI̚KI(\9$1WѼSgK$ *Lr6p{`۸纝 F =I<UJFAu_+m+{Fi|2k#i@P`23IdEoS]~4 o_Úpmu;hJ18'vΧ9mC7Ny]'Hxk8}t4F/h6CK d.LzF~=i?#{h.&<zP-Pw?#/a>0%ٚR p?z΍{՝WԮ%_{I^'YQWiA(4Mrk2{} z.i<0[jCw3YX,O 7MH7׺N6$` GVwbK;㴾3j4$PPM,pQ@^<)ciA (Pn; ݂7wgV~Yi^<`YF{s<̂cm$)PrCPx,e6~,{e%Bp8 ?6/{XS}ȁ#`:R:40/y 4s콆u7Y`WRqkYǦ7R/bkH!h>#Iir<1iS%O<`쪬URˉ>i?@CQ@r$ vIŕDOє* rUHd|x#G#L_rm`|@iHt4I;hĄ}w=;8 4C.#E8 !g?6xn ^Ąe;NPa"SK{ %G'ֺTk[Ih ſ ~^wnE"#RB[=GX.na" #ؠ/ x]t ׳eJG>|'6GOpۯn;(zw!BG$m!0Kc$1 *wMAqaZbݤSNĨhh6~oqs4PE&ќ1@ ڐ=: q`qҙskown0G<׎E =GrsV$2zIh0Pi:X+뷒v2[W]|Gu2[<8 yoc b {zUހ>⌟Z\ 0(hK@Q=-.^Awnmp XUb˂S?ĿZ"En$K+u\<Њ@lIY@xuƹ=%FHn?:Ȳz&)@M/0nj?SM=c%"2F#Ka\:܅w1$FORCaA#$;Xa1^GN𝕮%[iYY̊3" u=( ( (񝞡}VJYP[qS$c.|!ˍsWM6kjuS]+3 |.>nþ1$ .?ݥF쏺XHO[}Ayf[o@mqր4kͼuwWuFL+c 3p c;1@<[~Euy,ɼ>Cj싖YU%| ZX_Kioᵍ.Z@wzހ6((LJ1@ьb ?7Z>HeaUG,sǗ??ڀ1(윷$}l[eٳ>{:GPEPEPEG)h ( ( ( ( ( ( (!NPhotoshop 3.08BIM%8BIMHH8BIM&?8BIM 8BIM8BIM 8BIM 8BIM' 8BIM5-8BIM8BIM@@8BIM8BIM[clock_24hr_mil_timenullboundsObjcRct1Top longLeftlongBtomlongRghtlongslicesVlLsObjcslicesliceIDlonggroupIDlongoriginenum ESliceOrigin autoGeneratedTypeenum ESliceTypeImg boundsObjcRct1Top longLeftlongBtomlongRghtlongurlTEXTnullTEXTMsgeTEXTaltTagTEXTcellTextIsHTMLboolcellTextTEXT horzAlignenumESliceHorzAligndefault vertAlignenumESliceVertAligndefault bgColorTypeenumESliceBGColorTypeNone topOutsetlong leftOutsetlong bottomOutsetlong rightOutsetlong8BIM( ?8BIM8BIM8BIM  JFIFHH Adobe_CMAdobed            " ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?61cCִ@hI%)$IJI$RI$^mo 2=[OCkfF^>5~fCꢟFN/'ӳbJ}%%'܌])~[->͵~fOP=^/o^I$$I)I$JRI$TI%)$IJ\oU_[ju8B`7X6ՒϬ__#W-+^sվԘYv ;S{+o[c=\Zr=$w`U4q&7},w?n1}mڜJn7MWC 6ΑgPǩ@.,iZkK%'ɰ׏mc /2Sv/>^%/>q˛40ۋQ^i =<[3-^FI%>R~/L.qqxqpފznݏ7=Y$Rk%8ٶvӌ .sv,g٫0=~1y0L;z#FX gM[ݸ a߯5= C^ܻuU3)~Kc8$zhk#잭m'쾇}o"ĔI%)$IOTI%)%}kԺnU}6Bm8cvڬk[6kV&VV;qeoOS *={eظcIk[n몢{U54CZִn{{Zֵ%2$'@ mt>ctO$hmk]=7\_׿t׿0"ZK9豿:U:[cƩåme ?`2[Zʛ*INRY!ƭ4R\=LaeZ|mʵzE?VљUJ,Llȹ=fއ+8"gaU^Y]x/޵{e8uY?ٔG`mrzGɈ#!h=<:czNVbUv;*KfV#c~M?⫣nYs8l{sjj+zi)꾭.k'=ya?;;WPm^8S}9UcAsߣ sWMw| ,5_)$jSo*ۏHEQڮu=k-k>X ך}cwWSֿۃ:_Ji#0=QZ~5%,{͵1dcc.ewO_S $JTI%<'U3:UΪ~ݘ?St^=JkpKS6aֲ֜ uZe'.׻ *, k^JrtOFS,c~ 5[u,S쥗6^y7>oV_ն ?1_?=+z}]7u D׉Ksf ٴ)W?7\Wk]%=o'c.v,l¡s6y'GLWYDz|jc, 6'ӳծұz}ebKouԏT۬g[ij^Wu Ρ̌ћn~6FF~kjmLojgls3eۏoq%$:N8WDy<7.+gIov}c߃EW&87nE}9箭a}wvߪV?ζt:fps﮳-즽S+§THU6+ݩy صlsNGuJq:Ժkve-O|CFھZ,{긵K+2΍o; 鵢/C6}w_ծX`9}X7ۓԯ{]n3M}ߤ?W*3sq w=ؘߣǣӥWkn%$Z]y9vzx-6ck zgBBKH`s;a#u/6 {q/CGJ|޵r2qrq 9s؟Y:OI7usԎ:ɺea+m ~{?fڤI$U+f?2zU,5մWIc.mgOnʽV}c>` UZkIS2h˱q1}ޢJGְX[[w cSk+]oF_QߩmkwuNnF5vhUxh{lhcIeb].+y\ιtW[ڲcs},2WE_oUtIwNǷWV^LVW#ckwi)fvH>EO^m#]Z]V)vCi¿qVP+ʩeOj>UWSkjuongt~Jt\~~Mfd &OvCsk_ZS쵕^C{ZZ647=o޹߫ٽHd_e #22 cnk.ǻֶU[+ȣ;j'd IL+acՋ}wُm5dT6}?\G(􌾻 qi-uXִ=)\yYC>_q0t;ϳaO}?㌜ ّT,:v[ZQ)>hOOXYVYkfk=7}7nmvʽLv?Gg+{{sHk;i#GmwڹllDZDccYUvK3ǹn/"J|RCղa&hgsU3ٍQq&eM:a?32 ~7Li~7/*nX)vasgg,~,ul2ǖ`( qEWweul;+qe{F{l kɳ.h~Oyx/nz_L}ZSo]\͕m[ETûhnn7uq_SuD&h~N-f-SUe7ֻTUwgu*zE.9k*\5Dz+zI$U ZÀSpYi6[w5NCXZ?btVa=8:^ouQVLkv} 6i]ҷtE+k2 `v~~f|_T:+?̍I473ד}YCԉH}>HW^/tw\˗џ-w:s^O~+h%>z_E!vtoqgo˿(V_SŽu6v;5˝F#+\LoJn=Ae+>F9ebwK=7_kn'Mc.eZݐ6)@~&m,Ƕ=J0C۹׷r 'V2ˍ54lW/Һqu6%Q]%_ֱF^~%4uк;ަm̽6926ȭhgڮ{*G̛}:=Yu6}Ge:CXXN=7*m{U}}F\i 70loȿƗ*zˁPO~;~ߡJJxJȲ׉˭w/. GomwЎ_Y׶hquKz1?u5D.6b߷`sN6-cVVO_yV]mZos>vzTWuXki jW:M6qvXXZn?GkCc0n󟍷6Z,JAnvf^5/vCQS,NZ$TI%>OwԼF{wYVD~sm򅿪7w=;cvm])ıսN{hUo_Voβr;UbKheǣgP#Ы_r}UY\WArwᆵze}I)z^阘MWH¶6S}=*t]dW1I qlk}m5O鸘ĢFM~ݵZIOσg`f~كհ_ m~fY۶SE}V̮C)ɺ׷f^}wYVWgj%MWꕈ-w%jjg}_^0lUcOn+?aϩG7216Qf=Yrm 00X :]T")ѕHޅ!{ggnw8W2Znkj!i#lw~t>xM7eec]"{Zc]E>ٗ+랚?S:/\vEeYK?Q_%6>}]>J_<mW J}Bl4 `'IO?aϬXnU.Ħ[h>[eK&z2[fE>lTM_X:cߔ1hceaѓި{+~.3[[2OQeDU纶ޓ>} Uuܡ-/ˣ-B<[㖃V3m~JWYg_%=I$TstI%)%t_O"_M6َXrSuo.QV \3 iڕRU]gGzddrJ} (ȩdV۩m}ops-rؽke凜cE1k?qٗe?sYx;Y/0͍[u WRJPI:aXmԯOI%>a%ÿX7S]gҿşծ潸mȵr u$SU@y~:Ktٽw.7 &3Ea5ݔVMyDKˏ՟}V?gY2kٙeȲٛ.'P8KxaY9uYKg㺪INI$I$TI%)$IN_֌l쿫89ٶ?viu{?\?T2(m`[wqNf>V\26VFkg_/LI%C       }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz?S((((((((((((((((((((((((((((((((((((((((((((((((((((((IQ})wRp))h((((((((((((}O_]x^WŗMF_yE%cmVQ?^:F"g^A/5M<Πsk̿cgG=C-OUTIq+IC(//)jtQo~.`ۏ[*k_/_\^jvڞor_nЬ**>$~u[f_Z2%[̑Fu~QEmTQEQEQEQEQEQEQEQEQEQEQEQEQE~)h~,!O=#㙠6?\ U|U|M񞥣/E.tV vKx˶R<ע~ 㯄~|2[&x3QZ]j~J,?vI=o4 |{w_t VvWX̻\gV]e?$ӦL5|;Ǯ+7AEXBtVm^9&Ċ@~E4RRREQEQEQEQEQEQEQE֍7 7]n)h)7W ?{_m?!Ogv9O? BQ{mCPquu[$ɒ{ևy:)F4my#r(8J?f&|6!WL #NIb]xχA4=:CUmŲ< Z]D??~OӢ\1 A:Ө*6p4ʐF^F k+KLJu˯i\cMr*I(,~>e BKY2z n5-JOn]N'Si4FRzβ=9Rk>i64>KfVEUVTQEQEQEQEQEQEQEQE~@~?Xڿ$UCv?#ΤڲxWT.o:[~}ۢM0Ixb]QG1Ǵ+ڛXJ>|lmc!x+IX,RVdb-aP^Zĺ't_ڢ,smșp H5r| ^KHF)[?p>/_fZx ;׉vK6=^EQ_?Z:/~r[]'V'+4)UkW_<& xzgjU4\ ̭(t]>BNŇSJx}7EQ^+`Pվ ~;k:u+TI3v=7Ú!_\|A}kڴۿ>} ]w(FҾ=_o3k|7t=1-nRDOf.uV/i?U>o36v6>;8QE{akznxU-hn7|ּCh-*'4cmNNt9xX(jb} 1w˚egZ_c%iя#]JQAkj(|/'|z6qi7e0-Ppl+kZ>uO]wDH,k󸺇MR .@Fweh#iǶ>^O |^ռ?^RmcJ֭&r@s?ޮ7o՟>(M?_ز]C2C~!yqzWxWǗ ~ [KxcU4S4F3fֳȌs:Wឿ_CMjƩ F9VHFe<[((((((((+~ ZƩx'úqҠi 8zw~Z#7.m藪7G ^J~u~mCXڦԏs36>ם~?/M[$ןj/ 2}i9뻚,(ɬ&/Zddс`=zVÿOi].aQ1y߳P? |=۶-g9U{閐ZA(,h^(U  {^ՋAo ,x&5 UgZ)dgi+r}zWKVݮ:p7J((((((((o_To(eCc}ukJIl<6Y6;|㏌oo5GC-Dž%yRU򸐏_ڏf{ot}&]SND+kO86wBsڼu>/|(5k>6?Qeo>9~o,:Jw2\?h?ZxBR(e(Q_kRA |CqI( ;xN&Mj?ٿPke_&o%[_^sj~ \x^e^'ZgVwrr6k7 _#]0PT5:;$0襻yh(((((((@|qSxOUEuZ=7햪xy|~|(/~&]kuO̹+A9P^>G~N?jC;Zox)Si7jmoum &;U#u>?ڣGusOjZ>6$Pckm?/4?<;j0Xk#Ѵ}6L.',mƹ~zf|H_^D/p(v~S]!F}'wh~JНr{il|7Ng(z0@j(JZJZ))h(+i6nu ~_][5?C?g> ƷSE8dOFEW~#xG&=G>:I(.i< 1ğ{jpqĻ;,KvuWN7tiDj_iړ޿>M.Wq-;"-g}ם1535֬/׼W"feWOOeg-fVn#%c@=FWTQEQEQEQEQEQEQEQ\oď^3y|ިJ&k2Ÿ"Qٓo7O?t}ZO DP:ᶁة~ \\'zOn˖ W7؛_˭cXaj7Miޤ# c2OGo4_ـsϿZ||q }sßtM3V9ai#~šRǧr! #J $an??m<]ĭk f!Y_Ky-3.u+kwtݨF46#\u@FA&sFhȥ4; zAX[j+F(a|-rXiV6VoolYg/hj)X&zUi|Mj-u.UVܰۤ`E;EޕȚ-'L=c"S(|0I}]CӡG>IRR8jTpjEQEQEQEQEQEQEQEQIKE&hݎ'~j)tM75Ŀz~*XB{ Y_5q[n?wo|uD㏴GAal~!|P'5dfQpQ(J䷺p84ӯ+WuDO7Ktof3>}\˕Agbi6Cya6֯j?َOuVK:KwTCW?5|=T%ꗟlDW? ୞*b,5%Μ\}_]|/~|KM=F ?\_':2aYbt'DlPEKtKKIKIKIE-QEQEQEQEQEfEQEp>3x3ெ|gh>S;S|~ ٩j|-E\Ʈ-܃ACW4zk)/mۯ2+kH}»|8Q2y+-iˋׅPA.6ے>M g_x^PKyFfU7J?E?:;cT x^'J}r?uV\}?,gx/,4/!6yc=KַJHVVXbG8"wC'|G-aOS?M+- mdm>j+]Z++e]F [-QEQIE-&{RnQEQEQEU _UFUg8 fc7[R|.٫^^񅟈/"ln˨@~xO_G2yRIi ^7ߴ?}7nRLekYmݺ b+-̈́ց|ZeOmSovG mv-sOO&fYv0N+h((+ƚ|:u+WxXn /&(֓wp P #ͿJ__u}2CTc>q0mIqe;Er7䟲5T307N+[ǁu ˋ}Z+@?Sɮi!٣т)ܪ߅uJWIK 4F'}O8 (L'aÚ5B+Fi.jDԓ_?co<3e,+47r?};D[6}C&~T!Z| \\d6kѤ,J}9 c3iVpsOUI#W?seծ˯xXv-fL_?4Rm?z宕H#ʞVǬkG<%sNW~C rȇ8>x:h>mmoAjqfB,O tr) S~x_7z<7kK4|ld"//Ƹ1H ?_L_}Cq%eqGw־`aFnfG,Ůdn3rOgGšem7fi"0ד+ *+eFwS7m'pu#5^%,M Kvj|1}h:վWZe\[? nҿQc/c='ψ-,  +mZ(+D|CŬxe! m O|7o eWzHMo4x.>2;O=5{EXFlk /xC%Γ;[U";]Fѧ~n WiӠMokb[WE8iV.׉yW1ee_F_Pu;⭣KRgEQEQEQ\x+۵ޢ}_/B(e#xƾ Դ—ZMƥu2nG 広^G}g? xt۝Rd0u2m߮ <~Ƕ. ;2k2K2f{t N&?C|5ƵO i-.s۬Y^W/O->X~jֱy&j{TeXx@㟄mm'eQgwگ>s$:6ݱvάW[jlyZvGufMb:y^D?aۖ Mbu Ү8c'W pڧ(+ا~-xPqKo"tC?y H{U9~1h?txPҼoVդfi$g 2w+0s~̗6io^<Wz'UhOk?=](m*J,#6o簬߆?V3-<%cewgs|DƉKXb7}~xVĺ7q#iL_Z3d?~NXm< M!67K1sҾߢ(((?xC^5{~ƒXZP|% #?|9jmK;}F?5싐\/|+(|_óHB#vsq>0#լ^hb :&hzG\?k/^L>%xvPGYtֻ۟Kyelj4|1k.y3OG:7"xXզUiozd߅zZ(cZu7QYi40T$;m+[_ٚ%Jio OJ"xM|"ns=*o%fAޘG'˕F[f~Ҟ&:G6o~Uُ?OѤAxEkHpF>E=Zɰ{D_0|'חF+-iO$U HfS_Fj|}iW/TU"`6+-hEO25_'_ Ԟ'<+jku5Ή0YC)9,_E^&yڅCu}-vSVz ~)xs#jO:G;V+deOnf&~:oĭOᧄ#kgxk 2ċ d fQ>:f/vMfJn&8_Nm[8'y/MV,|%_ ԙOݙ-U>{B+sNmux4/ Z[݉i 8 +Wi(6Y]*4xxI<'>So ~էM6Lvk[ñUl ,]]|`}[6$w2zWg}͇D[vЧҿH`_B ï޼ ^qB~_ =ќ(2G|3+i7ȍż7ۤMw k|CxAִ븮d6$z*I/gŞ,ΏGu˟[A!i$8>\~'}u4_Muf]bI$p[o]>9xgKzƇhArm3(qk?|ՓL↊'U=zSg;5XKYd?\bxr|FKEko3w G"~q^G7/4Ux"Z貱KhM$_f?|_xǿ\kҴ6uʞKY$8䪮wz>mc^mBVaٱAp:?ݱ/]gM - k¶ڎmzHcϚ2~\+C4]>i9KhݏQZ4Rnɟ*w"֦9U廘˟Ÿys4nT|s+U4VivlXEkyo^?꿴%ķ7O6{9U/7IC~|1o¾ҬϖmF͎ZB~lқ{Y!5/+ F'2cŴ|⍺75I}$0}#Ħ[ (tD6"26ض*3*G_Oÿdu%"dC1㡯Di_4tfyy=?Ziʟ]7 }S#iWfoxw/!:3B+@+~ΖqjWZYU.t09;y{W7i?CItVnd lzd~_sh~gO|UR,k_ݡ[hYEBeB+&a?c{^'ᆟN-Zm=BMbhѫ}o:u}>0N$𨈿}zΟ'7ڃLޞx˺[u?iN"|8j>Z\ݒ)>M̜}x7m:.0Q½Coe3Cyfۚ[YV=pѺW'eMCmx VG,vqҾ[U槢iVQz] ̇^تQQ^,~|/[ i<{k&4z4r+|}o}^36i-vf68qkKGSzG-#tGCrp$1$2ػݯ ;R/ƛ ;- OxVT3]5|:>֫f"}C2g-ĭ3У8ؗ"E}-EQEQEQ_WOO};ZHUܢn}kE.oஷ%Eo>zy4Mhr=['?z_\1?/ GA'ᱹ5ݤvmf.vSSk_5\v[lXػ7XN[|ɡx7 |RY{:׋lu kʘɾ6Ye>k?kOHԛ׍[}~@_Ge%p [1ֲuj-OᇅZ>_ V2l!7R<_mhcT-[a?j+ٷx|W#0sZ-'ׯI49f.y̹/FF7_K~_6Jţ_?M29_:?4]?CaӴՔH̪ ]~i6^3u}cRHF10v~Pv|}6݃֯?ౚO۾"xE۳OzY?goSKKcT~Յ,nόVѡXc8FB+[Kv'֕q;vWV3rF$ uiqx(/5FdEj9e9^G?'V_ោc[Amvi#$j:iQ_-K77w5\ilq]F3 ?}2/)ѷ?%}MO5ѼYm ^cDi$0E+y_C X/i Ѵn5{\[=+GucD\;a@d7Kiq1Fe5[~ ZMcYNM ɆR+U>O]y^o6E1?{׵_>9ISe|hͶHs_|eöZq:$){mnR_VO?>6O,MH,6zI OΗ~-+gc`HAiWZ?7K߳(82F)qL~v0eS/y]]j762%R[݉0W_3j|>McR4Is"\Etsv|k/|2>YZxM|jMfѴ#O~? |ښ]ۿ,D#/*(((namMMsFlQEW;hdgEy*ý~ܟ;~5 zWoYӴUf:|74q_v:;C5oY3úE5 Vl*,}6ZQ+AO-5XN~9xޏ#M]?TF0N\'zIߜu9'2nO+8q)ݏo+vZ]6푭ǔ²p{1^  z@-7Ie}FP_ d?_&<͍寈/[&K{uAټ[+oDO袊"|6ŏ xsŚ\:މp3rrT/^[x[LHmٚ+8ln$5RVl-el`Ky=޼ū}ŖۏM8 >ٛ'9Xu~Z W Zs|LœU=nmKyyYG//~Um\W:^G lǻ>;uq:.ܨ_Ñ/G{佶)x(AZ6Z6Ѷ֝EQEQEQEQEQE|.~BӥۯAO_BJFkyMU6_}i,٤꯷5P}Fw7;zc_??|IIotRѵfh.e6>CfmدϏW)oZW}^|ݻ|! z6[l+XٸH,?`>+i|gKj7]n)G62׫?߉~5]sF9\{h+?)߇e q['?}ERb ׺yX]NR4^O5/++}Q=vHC`_C񻒾k#^+5+=OA5Xv~Rnf?WzW⯏#] XoxhsIJy#2'6OM_ >UE_5ܪUw+]'KƷ3>0^*|A>.t*~U&g隴 ud+3KEQEQEQEQEQEQEQI য়$JZmGKۄh!Hs|2SB%?.Ɨv>g:ɻDjegkkga :yͲFx"/x+ G^??+ozuOcYe̙UWhvB} ,l/?-h\ؒ5tq7_aاߌ?g#^<`x$ tZܳ*g*u/6W0j2WTxc`CY?`W6V(+ U$|Tu+{!4 }Uqc%0|b4f{[mnMYMe.eĖ,d2a~/=IjMgyܻa諞w"Ũ/n6aqd; -|CO·w4ygyǠdj w|OEQEQEQEQEQEQEQ\ď;{}Jp>U_uboxQ.|q+ﻳ7=cQC̚&d=ꖕn,SJjd_ . y-_4I6 UǏ ߳/4ksKu ھ[^keȯ~7AsXd,Rj #{U+H/ҿURZ(_⟃ݦ=VXf+)h(,9iMkƚV+k(ÜGǩW'-WßwH|_4kZ; -ܠˍq#s/?xíΏh(M;GN[>"h^ VEZgDp)sw!/ {i۾DBҕBJ++t~\\iKOP@eG'K k;yp? o4]F˲}>Uds5=o@>?xsϸ0ڦt>e;?࿙_mڻ*袊((((((+/* u[uAtɒA|_r][GVݜW,3Lcd;cڽ5M[7&ʷX~gY~~' >Z;Zh<п9tRX9Mox.o62GS]midt>rx[_}g_zEƖ5ۗ^WJ~-5̱vVWmu|yM/>^['?w⾋7x/N;i/ϹڸW=ǷtQEyԡ׆[Ӈ¿O-\Im /e~U=QE;χtOM+u+q$;dFSגög#BT_^a~ͯO;8|=hK4mwY|ҙzzףH[.w tvzm֠sޥAg0H&ռSiFyH%̒ wMQ\s|~| ř.6[ѣ?y Oڿ`|B|}kK7~E~1_dԿiKM>IݧʧW r x8VcFw}z ԼZODU-}.'ZX鷺*]i7pvqi 8ƳbDmn (P9gsxׇo?^(Uk$ڕB1562Zv__ojj(OO+k:F曫YVp\.-G"oo|BҤUH:ƣ<>mb1_ZT6dB~E^(+~?Ѿ ((ȵO6^>X#8feᆥCis>mH\FF}o/j5/CkB9amBX1+En/-ƥk=ADgLro,WKjvMs,G}er?Y&@EvݯeҤee8ܱ' |͟pafz:m*Xbi~ߴOO7_zu֐`"9iOki&_ٗX[.{{ޘ#$oךjG] ׊]5Os}$"ȁ_F|N7࿄ͦ~_tɌV3yxh56w ߍ$o^K]N㺳Y +DLn"+;_t F;X6ēLR5_26i$gk{0[ïڄeڦeDq \=((˭[Ckio%,\k*{*x"z 񯃦!6Mt, mZ7JA Ik.Ji`0{VxgNulKn, 8X׍7F7G|_h"ҷ+T=vq^oº2\--%VX?̸Qzޮ7<;~?oC/tkX4)$܌݈=gA_{uh$R|H5Q_T2_tkX*BJLَ-ȰD҄X<_g6k&cˑ~zo&ψ_mgZ۩h(hb}߅|ExRxhݧ(7ைZo)O U4oC֢}OU KKEO, ;@ZƘhx?<:j{N?1<wkxOcCF+bky]nl.r[~ l_3ΊRSZ!Z,&|+C xb7c۝7Яn~WCESԣ2Q? ;0mã=ǀ<}@(ܲ?5◎]^d4 #HNsqb޽ |OiE/3?]B{0QJ6qV( 4os$ӱ'?ʼ_oZ|č1m.n~w_}+ط?{]j֋m)>G}6Cz׉4sC|k,ߵG \jG9Gt~i{α'H&']Ѿ&|aoYn-c@^ko%?<'4}=zcWĮ?Zj7mj(iڥ[A-9P0xeZOp0ɸ>;_uBRی Ծq)ۭO,uSmM+_r~z1XAu'Q/?f'O/w_Ep(mڣa,(Rv%oƬp .Z^]ؿ|54c슱2*q2Tpi ~4x<X%6vYN\x=S&e3Oׇ[+m1,͈Fbvd/?gj]a5(UQjǾ+XhᏉ~*VEa,-mo]T)$q+]Q_VX\M<~K_7|{{nɁi%}6k2n1,ʾn[/I|ȹʿ_mCO׿Kek>fC? '¿<&'4ŽIkqPs^%][5uշeel 1f:|YZo(GA[;n֥QEƯ(˯"]ړ=SǂC,/ c [s9R\֎Q\d[84w+(9K><~Kmc:N$G7vݴ57LjRì> ?{^׻њZ(k_73CD^a&B u<'#zZEK|mp\"7I?z·Zʪ^)Baee>xWNqMk'5-Z{~O9ِqroxI$nwz/N?JBM{wJ*g'7Geg]ڜ93o+(Ml1:.0Ri<|2Oθ /l S@oxB^}/%?2ǶA߅GK|nׅmN~pw'Y^06 Wk_Rߏ|U)wA׆.uy,1t/FӵEv^j_ֿKD麬TpΒ:MAs+?柴_t xŚgO|Hd.W%vBX<_x?Bլa8$((DߵƏxS\񵇂~isΖȵ,2|/SE jg^57yq^"VEj5_l.?goڟN@w7 Q͑z%7÷::Zi2 Fyps~ YZ? /yq*  cWi:oۯ<7m3YLr,&+чq_QE~Lf|2֟<%GeeGWPbjg࿗-|u^īĐ׵{g~n[%`W突S _Si .ܶ-쫅 y~5me!w.!vew$fT*֝?=k6#qVt9QEQ_R'h$HȒlo/ Ѯ3_Hx#oed+XtB6iqvѶ_0Y<+k5A9O+ t'Ƌq_6u+0ɫCFǙ~?x/vn1Ga8`~G^qEv=m.-cK6MjH1?9_{jZ]6̒ܶʻQ>j5ԗK4vc5G }!9nN?{&l֚9Z佱iZx6yEd~s[gkw4vRIUHTf}%M6x`+ܵZ_ cOَ57 O̽W_rϟ Qԣ4UǼutQEQE|4jڕυ.FWغ;1<ݝu^ ~.4OitZ&Fp>g;O=E_E*}xGÍi6flo>y5#(VF#WKV՚[ ~2_z?e:kWoJ]t0f),բHuc>~e I&g)P墐w{5Q__<6þ#sz,&B",?~>Bf7(n㘷+~Utt[PntpP A]jKV@0j)|%C5ۭ|V$iHUX> H*UHFw~W5G4pǬ[.$M<ŐG{W]7 r^4߆sn} I>ZV'mM:7]]m*'mm|z'ЫTЍ}!Okn+s]m#[~\vgiwƛ 'sψNC+/ttjR;u$onجoL?|uckkZ֝'`yVπ7s{~' +k诼Cּea8vlU&#?Z~|?WScq>\ ۻnڞWjL$+($?}^_ZŔ-tۻ-g %%Ot> .%5((QEQE%RQKEW~ GǞT5ޙ+{Ϗr xKv\>rV.vߵ} *ϒGr2>Y+oEh!D ֯ 1YJڿJ?a/v]u ,}6o,up+Ỏ+iIJ&Yރ"[ͦ<U Q_|wg+6?'feJřyR6zE|YJvۛsjɱUڿWܴm+Vc> fh)1KEQIIk¾ΩxInn!UdQc[ka4 ]I2]b?]׀8}KJ<>j ٸ+U>v_̚]̺bCqtafYraOZx:֥sw%ב^X]v*d ˥~Z[66ӥtڢ\) Č*u]yRp] ?z|vz:2ʶ+'~&MDA}W|׌*x3M~Kؤu'_~xNԬ"& 0WhVmojJ֢)(Z(((((A_w_?W:Ϸ؜MsUjPԼ;"F}o$qՀ_ֻ6hⳖx>`p[w~$/QG|Ggr-dyOB^kk|m7涗V\Z\[SXψ6 o.wxo6?24'm[ڿ5c^GִhV6rqarG+'Aq_wW_yx5IZLH23¹z+GUok'wEr>L<7kYđeUWYljQEQEQEQEQEQEQE~o_ . SY'Kh)i)?~_WWRjJv*TE}y 3GŖV`p}2iFYʛE1R~(o~^ O6.+Enu{C#R?85=4mf7i]ۖfe2k\xᏎ?6^MqrB8=8?ÿ"[~+~ RR$dw}_dGnvCq#:ϗW3KEQERnfQ]axź?o]Kmvח8 nczVVWxa|Fo߄ -= ):F⹺ٲ8Tg;q+hauwޛ>V񸳱' y:W3#|>݁g?Z&:﹚5eϙr}Em*nmvQEQEQEQEQE7ppFIR4W%7[:um7XPT6Æ+aҿ O^8׼#.5 &O{H첅?z_Myt-ie'I_+nMn$PҞ[-+r>LUo>m墷?պ_ֿGI /iWwIFi1Rr`yeE~9[VDbTƩS<& )|H>;|i%ΕGg۸/8q_*+8.\r~׬~ΟiOhzvry,{Q;sWԔQI7ޖJ|s߃~7to^1dH1~Ub W6s{[]mj𴫶fQG95V+ 9go*Qv? duJzwc Yu q׀ ev7WʺN.%4;F_3Vj#ԦYٟ,NI'X!FFֽ=. ҧwMZcde>۷0W~ c|T}J/\6S_ٴmרПʫI7 7Qn)h(('_~p4v. kdJ(_ _ {gş.c-|3WVC^E%~yTfqY|\4q-eBdk< sʭ/x^y{Y~oq_D[\,:)&_g6Y>;)-y4т0py%d9=~f'CXiZZ ʶQ yLYuyů~ߊ4/_:n+Oi+.mꎒ;WY|DNm8kQ_B}஡~L?o1F##{+(a6Sʑ^oY>yBw1>-&H+~)~ֵO[of-?OFm [Vi]]~np}ޣog([x^<5y ׊5W3j{B3ncW^ Gկ62IH_Pbi[ٻz 'IX~1V j!nm%ćQ?ڍ_j7 Iw7E^0V&E$ZGM/?jG#zR7Y<_<||~!|X߇7Zjz|ZڢQد刿]ώw DGg#u _׋|>ռ-IYηq Bኍ yڴՏɼ-oyFnB#5_CրaF dUlqEz-QEQEQ__\q)x#nl9y \~^|6r|/oby,|>8tԦ?~'!Fo*Ӈ[z_7 o}[dgO-es}:|ǽ}1Xil38%vmt~ER}b'0A/;K~'Ux;TFIȠw׎;xVo][guܪTqґ^ho2"\[II9hEGް2Lqp&U}>"mףuzh9אfؿ  Xֵ jIgcvUx"64/a^a o v8Vǥ~_AEQ Gދ-D>" bg1Kmqڋ|6!x7tXvD26'bIև~]|G\Ѿ[K%2|ϻ*+WC>OJ$I22abǖCbK袿=>7'so2B|Q _ o|&$ԡE <4ȈKyc2ao|;[Id!I҈Ww7~-["ff7t g3#R~V uRկZml711\c ot~Z`\ͦxWO 4%7)I)y;_#KhkAofMUyTԭaolVIg٭xdxS־g˭I'kHok*|ۂ}oDP^#~^kHޭ+ǿk/.V 7~>| DܫxyyCdW>6k~ts5xUP[̊5GsX< ž(𞝩-M[Ko;~]a}WW)o# 'ʾxuύavoU^6|~ov$\+s ;)7о}u;\ }EQEQEW每:_|,m {q$*6 !Dx>#%m>ƖOnX#V9qsּ'RGwK2 P\Eʒ:Y|mON&Թr^Yg̏30#8S3FO[+tcVL*FW(Qk?J~:&M|?$Okyqyqۓ*q1-?djzaz֯qơyI]I =( /ᮥD;? Bƞͷ|T?uZ ȣiiʴmbj Wic7 wzX%]e0?o#c;%U-(HNQA2{?[]xڍ4[w+M&A/?Zkt3^T&߳r$D4Y]Ӳ{keXeW{n/n"Fu֟ Gt8am2"~^`v^˚IEbx¶8Vi71D*5u ?ßW62L{%T¾f  iux$y/Y.>Q_-HZ_|BJo"{b=Ni^b۪Ȯ#e6գE0߉~s]~Qqpn`2G"H*½ ƐxRPF.|g:?m?秔$/ue~)?O x_Ķm,hI2(oz\)^?nB++%٘һ]Vef9h]uTY #l:yP٬Τ6Y8׏V`)5mdGXosrtdFppFM__ <;hXլYO>D4-Ұ>M~M(OX]cq~y n]*ҾZN)om'##uqҿ7>"|@5SWjڝ㖚ywHkHVϯYwl)3,/c';׮1ZlzٕNFT0+#G]~koCw׭{Fmnv&6*W({Ÿ:7KZ֡յ$?T(GϏտڃ -ٷ=[+ XcHVA eSO|t օ} խ.oBoAv2&6@O̵庿jӮ^մx[kjR]o v`?a^)/O'{ӭ=vH 9 P(wzH~w4> !gHéssYȬ{ԔQEQEQE~:|~G:⯈_Yjiӭn.>Y sհ+㟂ƟL:ƙi:mU|NJ;UWw<687Ҫ"&t^U.|5Ke//?)i@4]cV0.m?k,s*<,mS!ϕC?(LWwړf;J]di=cў_>w-mL~+ErU+j3"n~SV;U{efW8>~> Z>VҵOĸ^*?i<1qJ#HLWOh4$Ѩbaht}kI)ḔJAD0,Qc~_'eK;xv6^E3QT?i/*} dޢۗqo!z/R~+y,K2G8І u|)m5ğ?ƟoxSbŖm5T_`+[I_|jyn+:i)M{n޴'ݸ-p;3Oʹl}2~%EwHun\yQ}_ > =m:J?oVZ AdUdסZ*CtbJKEWy|(gF=ιR2LW[/?4VҚ`ſ;.>(g6y.wow4vmoEأTr gkg3ovw:t1Y`1,?7s%xOQž-z)'{=DQD#E݆'.QERWh0b->Y#~k}pִȮQvveԭbf{eO?+?.O.mcY^jAWv?Pq2Ց)ZLIͿ*9 {,׶?*/½'Oۣ.,(.=p+Ҵ)'mh>:hTcuZ cGE$mŵspSQ੿6t8ULGq\|mLn3 V1m^6_J_w&ioG_/F{mז5;ٻJO1ٹϹ|ͻ?^j[U9o:%{|jX<8;OT}ΡE I=ɄX{3n}7:"ƙH|شW¼ԨPtW<mZ-K5@q#ܹ=뼵[N[(_ڧ wJ񦃥Y5y򫏾 pj[Wϊ_{O~5ȾWX~nDw 7p+ᑹ/(l5/ٯBeԏzV>Զd9#1P,0 6W %cxoöXC_D[hFR QQ*j(LEQIm&Z^i6ӊZ((R`WYIc,2+s } ,C^2OɟUQK~a|]~ |$ƃ>f}$ckZ̛WC#WʿgFvĬ/l_MZ[5XQF"jpѲi6t.֨ẒJM8AԿhel:yA0T pW9#eg}+~>]GbYpu]QVF#|~Wx+ड़7]z&ƥwq ?Mwt,_ptgiX1)h(b)6Ө(f΅ɹH:QEQEQEQEQETRF$B7+ps\<c&L-m4ۄ5+4rBG>6[\VÉl=AJOG FźT}/4gʾ :-nMմӵ+wnK>+'[O1HYCRMqy6޿5Y{5m-ߗgMTr)OFQ~f?n*>f u> _oj kai<`ξc׋6x%|bW?|}tmwU[KR6AOʾ%#H|v_;ts+~=º]7KyZz uQEQEQEQEQEQEQEQEQEQEQIL{x۽AҲ?o2|n# 5 +]Z~ok.i_bˑW̾6prJG wfb]̈NGҼc\NY̿~.mдId+\-l/iO t\?2/ ʝ6:ELK?&;:mGQMK!Vcs+7u,ψN_~J+|% )|kulUҽJ𵮛kQEV"G(g4; SoYmaIcboxִ!XEQEQEQEQEQEQEQEQERgڍnuFKEQMd[>Vm#?Y/nk6SN%Y7>`H<.*ퟆd}j#cވ7 :6vҊ)i7RnRn.3IS((((((+ڣggaoyڂ4ֺFh׃#pח| M?ڏuZ62jNG$m'kԿ^ uMVO'ߧJuܫ7 We_*ý{ᏉQ2 ; 8)_QEQEQEQEQEQEQEW)ha!Oz 9o&FYum=> xC:oԵ]K^xdf,kX6vU漿GY=]E}c&:̷acPݿjSʢAr;[}+[7Cpk}Yl[uO^O5O?kuy EQEQEQEQEW'ITK6OּƖo|BZnnIO_1ڠk |{? n}!lXҼ9s%ė{"#'s]S7խuXK6hsa+` sz/Ъ>߶?x=/zdM5gs3.zKwi=qw}{ QEQEQE(((:aک4=kú͞m&6o70\.k>7>%_|v:|C.uotى& vs? MO-׊4[odwڒWa78죧~|kuuΓ;GE F Oʼn6<-[mo)"{^B6xm ?jKE 6ݝq׏vox-_[NFOk/~ ~ GÞ!uɵKoKI,<ʪ˖=k IƐSLV5˖+gl-tv~3\/*޽-o5ޗhXgwGr9~ B;x׳\'qou=_P(o `47 j̭[w҆TeޟREQ^MG~|KW[Eb˥ĒJbcּ/>|--;q3|w1Y-œ>wN+6i~@k^ֵ.V].V%v;wtg Ե* KšΓk-z"/#mV%^I Kߋ;{"!LH}u޻((()QEQEQEQ_>G/{LKg;[!Џf9?do_`O#Bڦ&c,vVK+"2Ī߈\tm>x?Q,?}Oz.tx䶆מϿ/τ/jW+e=步wQBeJd\?Q>OuշOկR1{Fj>.|S¿~ 6}^Wе6 _uīlaʢ4NOgi>*n xOEV^inb/>]>?:|>,>4|N7W}c7lF\*GWsݴQEQEQEQEQEQEQE|^eKk[mm<[ɺLao |]~?=.V{y`] ^Y~?<3k^>B-Pj{gY2~s [=K8~W"wy ti'ю~8 kKi3DB;kqq|FUSspڇ_?xx__Ӯt p#Z ?|@|QZj$p+dR0ݫJ((xck^.宕wHcRG7r~#ğڟ4ˋ8 #28#sWa?g]O:LÿxTn4 V3馎7ܾuC` < g}-(>kD% ]Ҹ>6[ƖVVly;F#lu?t>"X˿Z"mYʙYֿOh(mπ'>x'š_\_Aq4$q}Dsvkf_/FPЮ%Zi^kt\^5?W'o ֳj>bM`Y_̞V.~&ko'ߏ> ֿxJuk[Է[$2!W!+ kexF|ao\ӯu=vQk]5v2)ܻQ{i'x#: Bڗ4yKH_~ȿ~˿l|u%ծK˫ѥ}n(((((((mOiqE&N(ExQ5 M֒<.i84o ًMI, :ǛO& О}Ls[ƅxu[ mNɱ6Ǫ"x{~>/EN(v`|A¾.KsZF<_-čkڕLbd~7>3]>IeLH<μrڗwX%.Z}Jw%}*7ˆkl-Hl⵶v (z8n((((((((((((((JZ(((((((((((((((((((((((((((((((((((((((((((((((((((((((x$$If!vh#v :V l05 4ytLIx$$If!vh#v :V l05 4yt'9{$$If!vh#v#v:V l t0655H$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTH$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTR$$Ifl!vh#v%:V lO t%6,5%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTR$$Ifl!vh#v%:V lq t%6,5%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTH$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTH$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTL$$Ifl!vh#v%:V l: t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTH$$If!vh#v':V l t'65'aT|$$If!vh#v] #v#v:V l@ t'6,5] 55/ aT$$If!vh#v] #v#v:V lT t'6,5] 55/ / aT|$$If!vh#v] #v#v:V lT t'6,5] 55/ aT|$$If!vh#v] #v#v:V lT t'6,5] 55/ aT|$$If!vh#v] #v#v:V lT t'6,5] 55/ aT|$$If!vh#v] #v#v:V lT t'6,5] 55/ aT|$$If!vh#v] #v#v:V lT t'6,5] 55/ aT|$$If!vh#v] #v#v:V lT t'6,5] 55/ aT|$$If!vh#v] #v#v:V lT t'6,5] 55/ aTR$$If!vh#v':V l( t'6,5'aTn$$If!vh#v#v$:V lT t'6,55$/ aTn$$If!vh#v#v$:V lT t'6,55$/ aTH$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTR$$Ifl!vh#v%:V l t%6,5%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTR$$Ifl!vh#v%:V l t%6,5%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTH$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTR$$Ifl!vh#v%:V l t%6,5%alTn$$Ifl!vh#v8#v$ #v:V lT t%6,585$ 5alTn$$Ifl!vh#v8#v$ #v:V lT t%6,585$ 5alT$$Ifl!vh#v8#v$ #vH#vT:V lT t%6,585$ 5H5T/ alT$$Ifl!vh#v8#v$ #vH#vT:V lT t%6,585$ 5H5T/ alT|$$Ifl!vh#v8#v$ #v:V lT t%6,585$ 5/ alTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTH$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTH$$Ifl!vh#v%:V l t%65%alTn$$Ifl!vh#v8#vP#vp:V l@ t%6,585P5palTR$$Ifl!vh#v%:V lN t%6,5%alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTn$$Ifl!vh#v#v#:V lT t%6,55#/ alTr$$If!vh#v):V l t065)|$$If!vh#v:V lL t06,5v$$If!vh#v:V l t065$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4r$$If!vh#v):V l t065)|$$If!vh#v:V lL t06,5v$$If!vh#v:V l t065$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4r$$If!vh#v):V l t065)|$$If!vh#v:V lL t06,5v$$If!vh#v:V l t065$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4r$$If!vh#v):V l t065)|$$If!vh#v:V lL t06,5v$$If!vh#v:V l t065$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4r$$If!vh#v):V l t065)|$$If!vh#v:V lL t06,5v$$If!vh#v:V l< t065$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4r$$If!vh#v):V l t065)|$$If!vh#v:V lL t06,5v$$If!vh#v:V l t065$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#vh #v8:V l4T t06+5h 58f4$$If!vh#v):V lT t065)/ $$If!vh#v):V lT t065)/ $$If!vh#v` #v#v"#v#vX:V l t6,5` 55"55X/ / $$If!vh#v#v:V l t0655/ / /  / $$If!vh#v#v:V lI t0655/ / yt03$$If!vh#v#v #vQ#v>#v.:V l t655 5Q5>5./ / $$If!vh#v#v #vQ#v>#v.:V l t655 5Q5>5./ / $$If!vh#v#v #vQ#v>#v.:V l t655 5Q5>5./ / $$If!vh#v#v #vQ#v>#v.:V l t655 5Q5>5./ / $$If!vh#v#v #vQ#v>#v.:V l t655 5Q5>5./ / $$If!vh#v#v #vQ#v>#v.:V l t655 5Q5>5./ / H$$If!vh#v":V l t65"/ N$$If!vh#v":V l t6,5"/ Dd }D  3 @@"?$$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / Dd SD  3 @@"?$$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #vh#vT#v.:V l t655 5h5T5./ / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#v :V l t655 555 / / $$If!vh#v#v #v#v#v :V l t655 555 / / H$$If!vh#v:V l t65/ H$$If!vh#v:V l t65/ H$$If!vh#v:V l t65/ H$$If!vh#v:V l t65/ $$If!vh#v#v :V l t655 / / / /  $$If!vh#vx#v #v#v:V l t65x5 55/ / / $$If!vh#vx#v #v#vV #v.:V l t65x5 55V 5./ / $$If!vh#vx#v #v#vV #v.:V l t65x5 55V 5./ / $$If!vh#vx#v #v#vV #v.:V l t65x5 55V 5./ / R$$If!vh#v #v:V lS t6,5 5n$$If!vh#v #v#v:V le t6,5 55/ V$$If!vh#v9#ve:V l t6595e/ V$$If!vh#v9#ve:V l t6595e/ V$$If!vh#v9#ve:V l t6595e/ a$$If!vh#v#ve:V l4 t6+595e/ f4a$$If!vh#v#ve:V l4 t6+595e/ f4a$$If!vh#v#ve:V l4 t6+595e/ f4$$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / $$If!vh#v#v #v#v#vf :V l t655 555f / / r$$If!vh#v :V l t065 r$$If!vh#v :V l t065 r$$If!vh#v :V l t065 r$$If!vh#v :V l t065 $$If!vh#v :V l t065 / $$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v #v#v#v:V l t065 555$$If!vh#v#v #vh#v #v:V l t55 5h5 5/ / $$If!vh#v#v #vh#v #v:V l t55 5h5 5/ / E$$If!vh#v#v:V l t55a$$If!vh#v#v? #v:V l t55? 5/ $$If!vh#v#v@#v#v8#vz:V l t655@5585z/ / $$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! 44 a&kdhf$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9    7    '    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    քքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd]m$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdnt$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd{$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V A5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd×$$IfA!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! / / / ! 44 a&kdԞ$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7 ' Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z քքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd&$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd7$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdH$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdY$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! / / / ! 44 a&kdj$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7 ' Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z քքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! / / / ! 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7 ' Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z քքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd0$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdA%$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdR,$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdc3$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdt:$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdA$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! / / / ! 44 a&kdH$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7 ' Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z Y Z Y Z Z քքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z44 a&kdO$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z44 a&kdV$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! 44 a&kd]$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9    7    '    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    Y    Z    Y    Z    Z    քքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdxd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! / / 44 a&kdk$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! / / 44 a&kdr$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdy$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ ! / / 44 a&kd͇$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdގ$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd($$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd9$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdJ$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / / 44 a&kd[$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kdz$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ !/ / / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v h#v #v^#vY#vZ#vY#vZ#vY#v Z#v Y#v Z#v Y#v Z#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v Z:V 5 5^5Y5Z5Y5Z5Y5 Z5 Y5 Z5 Y5 Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5 Z/  44 akd$$If J [ht( 4"#$A&'(N*+-[./1h235t67(9    ^    YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZրրրր4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/  /  / /  / 44 a&kd$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'  YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/  /  / / /  44 a&kd"$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7' YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/  /  / / /  44 a&kd*$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7' YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/  /  / / /  44 a&kd?1$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7' YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/  /  / / /  44 a&kdl8$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7' YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z/ /  / / /  /  44 a&kd?$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9  7 '  YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z44 a&kdF$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If!v!h#v #v7#v'#vY#vZ#vY#vZ#v Y#v Z#v Y#v Z#v Y#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#vZ#vY#v!Z:V 5 575'5Y5Z5Y5Z5 Y5 Z5 Y5 Z5 Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5Z5Y5!Z44 a&kdM$$If!J [ht( 4"#$A&'(N*+-[./1h235t67(9 7'YZYZZYZYZZYZYZZYZYZZYZYZZYZYZZքքքք4 a$$If:!vh#v#v*#v#v#v#vh#v#vh:V ^55*5555h55h44 a:kdT$$If^z  d!4$%<+, .t/0D235|67L9*hhhhhhhhhhhDDDD4 a:$$If:!v h#v#v*#v#vh#v#v#v h:V ^55*55h555 h44 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V ^55*555j5f5!h44 a:&kdX$$If^!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V B55*555j5f5!h/ !44 a:&kd^$$IfB!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V 55*555j5f5!h/ !44 a:&kdrd$$If!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V 55*555j5f5!h/ !44 a:&kdOj$$If!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V 55*555j5f5!h/ !44 a:&kd,p$$If!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V 55*555j5f5!h/ !44 a:&kd v$$If!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V 55*555j5f5!h/ !44 a:&kd{$$If!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#v#v#vj#vf#v!h:V 55*555j5f5!h/ !44 a:&kdÁ$$If!  T$\,d!"4$%'l()<+, .t/0D235|67L9*jfhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!vh#v#v*#v#vx#v#vh#v#vh:V ^55*55x55h55h44 a:kd$$If^z d!4$%<+, .t/0D235|67L9*xhhhhhhhhhhhDDDD4 a:$$If:!v h#v#v*#v#vx#v#v#v h:V ^55*55x555 h44 a:$$If:!v!h#v#v*#vv#v#v!h:V ^55*5v55!h44 a:&kdċ$$If^! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#vv#v#v!h:V B55*5v55!h/ !44 a:&kdw$$IfB! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#vv#v#v!h:V 55*5v55!h/ !44 a:&kd8$$If! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#vv#v#v!h:V 55*5v55!h/ !44 a:&kd$$If! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#vv#v#v!h:V 55*5v55!h/ !44 a:&kd$$If! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#vv#v#v!h:V 55*5v55!h/ !44 a:&kd{$$If! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#vv#v#v!h:V 55*5v55!h/ !44 a:&kd<$$If! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If:!v!h#v#v*#vv#v#v!h:V 55*5v55!h/ !44 a:&kd$$If! jT$\,d!"4$%'l()<+, .t/0D235|67L9*vhhhhhhhhhhhhhhhhhhhhhhhhhhhhhքքքք4 a:$$If!vh#v#v:V l06554$$If!vh#v#v:V l06554$$If!vh#v#v:V l06554$$If!vh#v#v:V l06554$$If!vh#v#v:V l06554$$If!vh#v#v:V l06554$$If!vh#v#v:V l06554$$If!vh#v#v:V l06554$$If!vh#vH #v#vC #v:#v:V l05H 55C 5:5/ 4$$If!vh#vH #v#vC #v:#v:V l05H 55C 5:5/ / 4$$If!vh#vH #v#vC #v:#v:V l05H 55C 5:5/ 4$$If!vh#vH #v#vC #v:#v:V l05H 55C 5:54PDdp!Dsq  S \A2 Instilling%20Eye%20Dropsil_fiR|c%Ä}LrhXFPc%Ä}LrhJFIFHH6 ExifMM* z(2i%PCanonCanon EOS 450DHH2009:11:25 12:01:11 :B"'0221J^ rz   |!$0404040100 %%>%F <8 2009:11:25 12:01:112009:11:25 12:01:117 /z"   .p  &v&&0.@5@4@" @"@ "@"@ #^07L 7o"!DXnCanon EOS 450DFirmware Version 1.1.0h0h0Xnnpw7@ 0) #aipu P 0[07u1.1.061ed dfdᆳᆳᆳᆳᆳᆳᆳᆳᆳᆳᆳᆳ K(%VEF-S18-55mm f/3.5-5.6 IS p`   ssssssii^^gA[A0p0)EF-S18-55mm f/3.5-5.6 ISK2330887 8,8P "<  6 $C;}{qk] 3$x[ Q-{l ! &EEiuEP7 X *pDD E B/s`*j'l ^Xp9[P\oh<=3c s   E{n` "68Q8&"'**()('$Y6(+.1671-)&!p81><929=:0,&#U+4CJKA=73)$ yI>CGD>=:71 8WXX[b^OG?:0 sxdoqhQH<6/!q{i\G=41-'IoG>DGD>=9703zTWX[b_PG?9/vweprhQH<6/ u|j]G=41,#_7-00,&$!5h@?==>:.("cj]RCHF=.'^mpmjVM?5& 6KXs2  ^y!D]dn&s c . %$  =bxSe| . Xp s0͝W~+v  +{  c{;'II*R980100A/n+uH%%(%iHHC    $.' ",#(7),01444'9=82<.342C  2!!22222222222222222222222222222222222222222222222222j! }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?Pp#!9̇*\w=(+ %~Qx#f\#p@{Rdq,@9 0xԮe:Yep@#Zi[2XzjPmω6ozW9;9`.(iNY`)n"R[[ƃ.G)~dڀH`'ZEYB#,2p*]b+ `gjp{Rab鵘sҫR=0*K'!x4Le-AL-@j, u9>q$Ga֡IS͈_RHddE—=t-/qw?}#B(h8* }"/H~l{Ԩ *p>`x~euC$H#}I82x6u @g]ϛ*4 H-ucf{ڢ2,4hx>N7g|цߟҷG?+Q1YRFjE(K?JD]j(566 mhǯex=F1LsZJ| ԳBr;>\۝2~ [7885."02*:s\T̙l~L{_'`K,/NH緵i3umZ"1FUj,u",цKMGzjا/(\?k&!t%ˈ㸬s40>_nֳp=={}8?Zls S[YYPA%0 qLf$vHf9??3|Kc5N $ck$ S\.l*e?9'\-OwsM/#t)^W:6;3Y]uf3wH'j,T˜kP0=Ӽ3jܥwV3p+08s:c"6X3,+:8av>;D2`Θir`qU==;Iݍ{t?άDFf:tH̕ǚ3jPv2 #B= KZPj;hCBk%ĽAj 7FXS q j.-[k`*i fǠ$l7HGkX̘J7ةHM0n%WA +2J{ QBqT4۩.aDYO:co隦с1G\)SnsΞZMPWq^[sU~b:2[+#$=W}ޝ&C }K3_8N(Dk:_^<X*+k}n!9µ-4ElyW4nȥe:aM*jind%?xzR/BӺcZF$ ^O:DpVnkկns0==ZyQ*.G@I3I^\,J˂G?S>8eF zV\~zU 4Ld*3PL1g& %rjFs9&sz+\ٵH"5gkpJjƊG]{##sltk02%4HPC_rmcQH?0 f5m.gR k?:)cn?*vȦ[y湝kVuaLzڽɩ݇ٻiX$h9Zm ݙɶB͏NZ]Հk8rxmZ;ge,gOl?SU3v5 %pw5Я,x##&d xorS/P;M4/eS8[,>Pqڷr"F~gg ݎiP,[p:3{zzH(LaRBHV˷gP{۝\KOjjՑӥ˜^٫I iR٫]TŋzRfijRbOzfW"R]Jƚْ"ˆCHL}:e;Rܱ*>2ܯ2Y-[)9S/C҈EcUD(1iu?7 VcI]&%b˞&AtATWxpر2{'>^9]揨of 'ꖵ[_MFS=M(ja r: @n? ]bxHr|1Br'pq"cVjxON]L!:x(dT87͚|;OK$W9Z'+._\$m}̍5|Oy_Ws ' ptW=^vUi~g̥$go9l ׯ\!0$?&WzgƋ%^"/&MgOóiI[5˜ 夊G?tp{WW_vm,.a^6~GXQMCDsѭ'/n6}Q7zO7|d< Il.fjEaQ) ?`Q}Z?|ULfm+ХW:18]t^$YBn`ֺ>kIbkuP ^'oZa"B|iw처Q*GEz4qv_،-dۨze& rZ9z1Uu&m6WT@#xfh$eO`P0L)5/FmI6C1$ÜWP=NӚs>2Yf$ cּƷ bm޵ r Iw<7Oqqz0#`tՌi!+L##sWMi/AnETnnr: 4.6 n1ep tE>H Q1n+HNIjM؍^Ԩ2CnE7Oel v$pF}=~1^k,<`cU~notQG-t8msM[bAb?mjghPJzWgO66Ǟ2 s&♗at;FOY}LTmA\T`8ʓ5=QPX`cUhJQoֱkfyA ?OY)kc*ejUG9?js&}}ņ@^eC9eb3|^dj2AWw6 H3J+\Dt۟5q3[ݙkĿm, 8\V>RVǗ3/ bD&>d]Z[a$m!$:#*z%iJx[WuW<%ߒ ?|xE&F~Yi뽉9,tę+юZ6igE NO\k.ޟ *s-GuۧxκTT6Lg->t[{hFJ" DS#: d?­^R$.VDT'2aN>KyO#ZDC?ζmD @UhN^Ê2fmWL? u\Z| d]]HB)3ʍkp%sx˹>6Ȟ"]u߄lnl}gG瀾'{7^:d?;ȮW:ttLcaj¬-%;ouٜ![Z]%2"c +Vc2J=:u^1DFzÕe' =I #c;}>K ~ge <#R: ZI(.k~2|L[ pkt$$rsҼ~%\ɌvMravz4pK=N+:Ԯ^Boa\nlB@ S(\*cp1z,aH=k'S;8<6eHP@(W'`SQRO]#NG8<^BK) ; e۾4Q;nw/j_.J8Z6-Hr9ޟ+Z{Ƴ OjGR+wNbF4CTC-j=Ҡ -EK9^ $tDw19\[X1#.SzcWg,YcMt`03as}2359u3hƺ\`Ml\a'_I>LAfۘ37OC #_=9DYvyWN8"Iv I=LkLwgI<"8杧YrGGVS{fV.e>x6"D?'9j푠F󡝏ciHu^O1Z!auFD*> x?SXUXp@'?s^.7olRǞqB54Ě:H3:WHϹFvZ4njZ\˳Rw pxW"ӥ,a|:b`1Z}lkrDhIfLj;L$69+RG)4N$^sOB9dU*)7mjҩX`qU}&H1W`N fl|ʌ 3U5-]0ã\&pcD_Tk|(:}6.QHPT ZG#54JS]WZ]ů̼aykNd xWdƫ1AڣVtX.ڢ6͖"v&fUptx$+\e*TnSӥr>0I읎22xxjЫ(TM#|gH@#'NA~ 7r ;ctߴf͕rkŴ$anGQ\vHg{ǗjEQL|-7.A$`z]0ҒbI9t ZIyQҢx$+0\2g C}o/߈^ bxnཷuKTtuq7]jzQkyH#؊[iiEӦuHLYlVK6 'u()V1%*XAҒ;?k]+1ÃfM @}/{260R7M9EgqghH^1 .zQ}MM;AR$6qUa$voc+SVH'uBVEW=70DjbCۀOq]&&C Saqr'qZޠ*D u_}[m̖9(ʴn "N1zV]mR7 BƈqS@[ , rFx{]OfRJ|HCq)U cQ:T p{֤z%dBxfݕ('W(%(\'c/>.P#6>\'d~bwEE5i- s ǟ·GJEWf ĎS :I/5Ah$X 䲁}?t,a wa9ik0Ȫ38gkIx_u)6рc%ǁTZOќ1fo GS~>%cdg^қlEqjCq O Ub[/ژ' 6Ůba} ?O-#nFBNI=zSxeHY[Z 'XZ Pș <ֻv.((@7?5H|VF@C%_ޑj7On@F/;}9<;4$HK3 >0>?h4ƺf Ƨ/jJY0RJ]QZwBvW1 9$gW4YoA۳tϵ"9wygΰu..XNUps)HR\Ҭbf(IXnr㟺O~5pX{i718W^I"F)ܮF7[J|̎0r+i}Usmp΂a59Q8jkz0)2 #n5C#H"*?Sx 3[eGEDj^ȆG[c$e*bO)x\vHȬou!5 z\J{,G"$L'F{VgIo4[tmrɴ͜Eghz܉b.d`[MX.4>{A, \M%$*ع#=sְ- {tuecfiB=+JC4qKR\jPW's|ɷtT{Yk @8`xRś9b/z\2%0H`i hHYqrHMzJ G#2+^V,}xIu"u=fSnB"dnXb.ɶCQ.T1Yb 6j쪌ǯ˴-JbM"%~)K>?JzKImҷ|WI`_ZWv0_;F_p_Fuʦx G$s"x|2Oj{Oˌҭ[7C0b=gmM^=NZ0ږ.1\uEt sSr+K?ZY __e|*1]ZFK4ǿJMR>JveṙYcێi|7m yǯz%>ۤV2UA=knυ€2=?~&"|/=+ߋ֕1^`Y¼?i堊Bz]?e@A )~%|5NjJmZqs8V}\Ԩ䢮 yyJ9ٻ?ghc@d]tfH\𽀙#f"J)nG?Z:/ctt{3e#dix|]ݫZi _ֳk;;mo[*69~كO/if2]ߴF9M[Ѵܢ+*25ނQ:$1 @q ^uprqTJg#[ತ<`u!Ee'~Kv*lX=k-.>WKwχ)ro2Q;H񢐀H@c+{Oڕysu{X V;(2Gv)tTϷORNܯւUfv]p@s݃VU*&(x?Zn<}4 ?Z^h y\; $2.#pq }E,@1oO|~uhۘt6E+pzǚ£\f.4c~Se8SFQizGߜSeӐNtf#h٘NMY4q)u&OPğԵf.%\ch."] i@enp8 ߼&C#2Om)X GM(Ri+pDʦGrq*g2[GI!cx#Y7$/õrZ,R `!Yמ nf^:Y=^oKX,7.0rHePG#\$uʥn#ѽBsvb sNHJ]V7w^FH?u!La4I? v֚hY]++_.E56Џ?x~_ֹr5ne=eOSjDckE8Hmߏ|?di3:c/r2ߐv!m͔礃fࢆr= F\<(38*}Ywiq31ks m1 i]=D΄?@p}듼>XF@+qZR^;4~7yY-҉+^<$Zs33̧=/Egiqk3,:?5( Z*N Ilmv3KR-W( US($d=mz+զ17*5XZ OĤ!z4[y~O>r/tZ?E_>$\\Z{֬3 *SZE5i}ߧhۛ̇Va&fҮo-%xOPEnTMODkvx Rp8? M,0xk^b)giI_K{4M܉30wa܊5="#%4y9XtJXǚ'B?o[~Ŗd*-u(a1Y*_ R uRy޷]yE`zѬi.̊xo${ك>gh ݭcb=22+ON׊֌) :?mdɹ5%O I/%,?(:~5\y  c 6<>sI>z޸>6[MO=xt5Y0;5vKu,z, 1(Wﻏ)ПdRJٳ-5(d$x9w.cM8e8k-FNgʖv<+[u{@'mK~H)^Z.e@u'mZ[VuvwN4F4g~x roϓ *@SX;SkBPמxO혜o.e\pkkH1ggG w sTբ[iY|A`BLgv&q#<\{qs} )Ar wRL䕍rlqAx]H%f 0c+a ]0G/𼦥\ ^rO\*٬TTpv[0ɔƅI/dsZ>tqDZAQW*p1Hk/¨86t+9]4c$;@ fBȣ8vbrXw׎N|FҨ(c'Q$T/$VH*J9]E\H۳\N1i@U>8?t'3ecj,AqiT2H CR{ؕd'uQϥ`j̬1 ~`Wa!O xUۡphUaVN~lpG?Qso~+xg|ņ֍/XX|ᡳ|z*vL=cM-Nٶ"-f$j9Si$􍕴7{VGM泷~|[x׉/ [h\\ǥk|10 rbKhOKϑv@'c'W'_1pFp ^oQ?|=.b͸s>* ƤeTfn=L>%rF/K6~zgi|8𿆤'3[zـ| dpH?ׂHaq%֮Hݩ3)$cҽ,aZ= ~cѴ/YI\*%!_4'_ jz\ oГ׌f+䘄C1j74։e?ς]R&ʣk7?D{׎<|'m~JwhqU#=1ZPJ کK¾h.E]r Hl@@c|p+ [$*P2c;aS+uw۳(Jg{~{G"3C`^᫼M)\TBBYΌuC֖à*ƼAԴ`i헅Y _U]yN!Pqx)܆NTrH"[N]9Y\N pu8-2$ d,NwNn~:x^SRUor cy\uτK{aIh?yu==+ɰr)TNVZkoSqӒyu<[Xd"|M}.*P}7O8o>A_H5QJ mЕ]='c>4(jYؐ3ڽdԛ쮻./S5N6~n|)G佺YL4mDu5Iu+u^(ľ?ָA{NP,}}o?av ķ%n5KTGRka)Ҧd[ɖ"S4~՟ɠ!YmguP~5Nm2/P }L|UcK:ˬga?|3VRL |6?>Ӈg%Em}?S.vjOJw;ճyy"0+ϝ+_ F=˒'٨1&?OJlٲvx z|.*rp*,ˍ^jZlw *AYמ[df">`A#'R'!!1KCXj9tЍ KX#֙okidhquWmquM ֏t?|=pm%sn<;so{Ĩ]ةԮ<9k}OF du5Zimc32$xϨ/ş`ya, t')'+ {ԣ3,/ )gyn@Vf6ז$zdTxeWb{ 8@=1sVNZpvq=mwݻY;/O5;$,) 5\_h$G$AW|JX4TMЁ~ʽ7a;e(^FvȨۦxl9Sg!%Cȃ#6N?5_ja.Ug ji+3,<\+vABh010O\/ov1 =7q3Tb;J;iK0 ˙H''+Y$5p7ˏkHՓxOBqGAmUB1n9?:n~T6cvFw~{P߼Ah˞#iQ#~>`>s\ 䌆2gi4pnl!6XڕID {ՋR?κXtݯrׅ4\cRw!H__ֹSMZOC"Ha9eļms -q4)=І+]R~N==kVsbo"=\mU9ʚID2z¨kگ4Bq*<cgJ4ksgl?F)hr^,\XeaM:({IYa=$WקYu hKwʪgwJnog¡ 3EodaVID"MKae%'9םs^9e8&9V zIxf(zL}X_2~UpGu614hvH$Mgi/(hPD'B`\Wz#w  !UzkԼMj_*f ugaW&%X,9랿ַQFxiYCmtDw|g޳|[bW$28V^8Aa}c8FEkoEw;Gou{ĩ7DGv9<jNu~_B?^YTfIԘ)p`Z>!:RFն^NV|zn5wk}/m|_A_>ԼI-Z$V{]VH{&Ij'VpYQ=ֽ:kS {k8-;}NI H{Mn֋Iz$E6߻ԛ 79iP[] U@so~3ssupzgJAx5M)|7kxXn!"x@T)6;AO4;OL17lPCRANL A)wf1N4t޺ۣ>Ema 4t$؏w۴eHkx v  %&@U-r}9$Ol,ⲷ%V ryV;jpXMۊWio/2|gk /SG[Id?)3_<=q(t"0DӰiI_~4n$ʐpG^r|)ususCm.ʻr^!Wm_ex]|VKٟ HҴZ J鸒ؘAϰVO?h+j&йE}XYKntM<|E%+I)o5 AuH] \94ss.qK7 .EvC_Rߢ{vVǾ ^zޠ-R1TuytR4S۱ ~㼵[ W?xx9&`7oJ#Rl~ HQI W$Ϩ~";gV .HlA/WC7˗d7v#ؑ^/>T-?> z}qwGM Q˗8ԕU랝}m/x2'AuW_ h[,'s w1x°j9d_ G9RQtfTwRs&09F7dԩk=R)-"p_V%/''֨I dpˀaZS lSm6+ٵ 4=6;Zi Ǯ+&i>#t {ĺvkpxjbKxQr1cO|9O+|-by^UwCQ:7#ːKdw+ץe~TտS/9KMozio'~+u4K=~ >O3p?^=g߉'KY<ap$aB|q~ұ|.tU4{ș:G?tٺYx/5\Y{0>P2}cj8Au֞YҖkjw푭i0[Zljc5>MC(A*~ngZg:a+gX- *$!Ao C> S]%R¹FquV7¿Z }=j^j+⅙~PHFxc%JIiwQIZ>[~xKTi~m$5 8|Wsoo`=+ gVPDv~ֽNU׭tG݊c9M-:v I'Srck Ir5 ثpyVJnc'Z4|󏊿mt]eP+[Fs0SEsk^FHK<~|bPZ ;cߌ{y `4AJ'}OR[X8Q\_8-4#}:Iw jeʃƹ0XJuR=MIaz,]xnH W)VP ^6Z%*νBs'٩WrWht;ºgbBخv5O~,KIɘ`#uxSNMr7-L"J7MƬ$(ׂE3jʹf';dϦ=kcWkMMH_+?I}:xr _Jj^yKOjfϖG~g|@!Eo_j|B$!:k0`y?|)q^m73޽hEtRPT/hCrwU[F;) Eu{j6O@kM#^6"OOF*<{㟍Z֣5v6vX[O3rU gse[K~QNd1}+rWhT$$~os:3'r }#űx@G Svu>\i7"8ݾg9$һٳƳ&%̌ (Y/wmh}m"BUP<;}+д;}c<Ec9+ļ3?Sq(ܸ<{׫x~a[ 52y:u;}R]KOY1,^+̼(A$6H[,O`2W{{mn !5]Ņ) Xڗ)O7- \yROA?+Z.jޟ^XK/"lm{״*~`xebN9"MN ^0 ;0;NGLh#FAJq<{W)K_d)}Vy_E_DxϨ>CRSʼn|e=CN}\Ή$խ#pZx铻oA´w= R¬Cգ8>@IΖJaDRFJ ʟVI1'0OCLo4v'9~5ީQm bI4^S\#U*M#y*k}Ft%Km~o*6-"iѝ<)A#Q[rw9O)zcsymktbLYd_Z$:u>`x'?\OBn^ VmyY]=Ee;Z=JaXG]Ľ ?JdĨu Ok|U@-`{08 }G+o"[< )9XVr ֣WF >>Q>J{JjyRF$?u>$қ85$s8$߀MmL£檎cڞ%>>]a?VʹWOm'fR^#be-zM- H-rq}琲@4WW QYsRvc7 ʡ* @꦳T1۳se@ {r ݀_5ϋz^at`QWO$ ZV^ /|% !c8e1H@<~k/m/Ŷb$1aYO6Gyԓ[IxXc\9⯈饌ŽH+>b%SY6ۮMp|aD#B漥s5%\gh?oź 9q?\sAוQmRV;dH8}*TebfDLW_z׼tR:TM0 ]v|h/Zc"76/0IܹsW~ҿ e䘶TJu_1_ (9'G9^681{s+۳Z2/n-.bg2=C:?}]V6Ңrɔ(v|%wHDM рmE{mUOXFEg 2RdzTە+>m fS-% =WI{v5-0j(Үb#x?ԧKe+o0%GP=>w,m§ {œed>&塁 OjB&wrk-.lQ+瓠+`xYI#op1;~|LHXisIv-i%v CFq8y^q%upZ X?9GA ?QVuZ f1w 8c*WIeJ7 EWwPLe= +>fT;a錑޴3&`VYsGp~$i夎hY#wYAQN)8N.٢jvXwM|c~#M| ΥI uR-e囦GӟrcW7C9e# Rvvf_$ ;HHI s+.sZ$)yj> ~5]5-D68 `}=kEu A6$2 `~4Gb%++/Fؒ'^B'5t u1uHG< Mt&LPה0,5kW0YxdV&A)\uw&>oq*A AIy"c6y#k/ʽ[{!+Ē5+/IB1WYX{Q0= kc:i[6$;Svı[,ԫ<²%Z jݓ 5{%Ҟ6|\-eq-9=ʻt,t尾ӚbKs c"9kXSW^BjWOSr[Z#)r֬~F#5z+"w ҷQR7sb -r"a!\NkM%%dU\43Ԟف՘5Ua& nCF}б ҲsqїI8P__- +&;¨KiV;$#"T.A۲+cڼ4YK Ŕp5 4mq"!OLd_$@`G*TwGM*>jmGLb&Gӥ> |onKARn=s~x_MC4鈖08 |߂):SVFGʚ-,kqu0~ҮJJJ,;V^M‘WM8EhNSh?RxsPI㕕oJSƈ5Ktt'8bko4]PCͤ#'8vila^+ϭM+$AFH'Wے +ͼ8T H XvXJMIr̝CNӬx;[*;FʧZ[!U^yTIiR R mױ^9G}du*}Lji?Z[Cˍ;ksA ÿ]'=EzY!O5ؒ3Ïm}If^T'E=[.1et=k~aO+/֯mz; @s\W&-ZW->zٯvh^*VѶJ+B:Җce`E[4vd |xGpc3DjWhD,#^×>ew *|=3]z}Jmr)9fQJq\o1Ͽf;/ I٭gj. /e?ֳ|2Mp^ΙC^WU[5oL WA¢jI_s,-_ZI!R?)@r^QOb+ƾk;;;f}o5-9$Ҁ4dw5^ZSKzx @`{[Gl>#X{HRA[7lTmigfW6Z4Bs6pȺ#\"X[*w{לx} + Gm70֡=dd69[*nWd 5Is^Odx=9RJ3ii'eC_SyT#HgD{ :>ƹ_?x XqՎx)I=Û=V)-,>񫺝Zj6ʏ(Q!HJLxX2p p+"0㔴OuBOogs\)n%aBAm c?4c]WU(eEyYs }Jzh&;KHAVN}=GlӖ驥h%g( ::+(s7%&bl5O-h#3QL/g $K+v9yv;vQy,5iAY2pBXzƄt=Z=Fܼr)N8'pG#}3X6zZUPE)0QQ|e]'VZHyNĜu tyKEt8?: 6F ilg?bYv+_iNK&ISt@fpFA6TpūX۴f3ou@ }cJc3I4 C#V]#y7qm r݊Qrjݏ 8ioO"Ny6T [O=+ڥI'RgaEq2K/5ԋ/_,S3iZ~x#u2neeF>_2@o j-B%\bK@q#k LFΑf q8bqSԦ|kahאMTγsP8$*^X:/ocv9Bg#Y{sᲆ܄ Fx^'SP^H4ev䏥GCG($E|r0z=͜r7ֽtn^ 3~xO-%ŝ[W:V5Ŕ{}N7U{BZg<)bV}k;a89eaL2T85[ ̮(aC}+r*օ>+.9p++ AƟx- $bt <4x/8Wia Htlx3Ii k#HV<@A[e)y،<>ů"CW|ZĖk:+#gSm#yc0A]Ι7{1JUې1^1P|jI$yώ3^y(kM$jrT:^J\洯xB rQ;iJw0EĞy. 03ĜTLAYC>?'ޥ2e-$ąצ4A9z 5Ɲozb :JR5~iGr*p+7*GADJ;~Q3hݭt15 n;\rxƸ)k`=NrkהyE56ig9 VNZo\9m372@V$j!ъ灟T4N;H#=i]%]KM$7 OSKK;`ŋ95kz#FOV1t`0w =~@EyWҮ3G3 T.N6LO+y\6ָ v1K ;#8ΩHZ\[.큉"W[=Ga_*;E>ͪ3 ⧛z-hIH†ʑ~UMeum>4XQ~NW@?15#ѯ ܰVL9+rPm-M%݉^a* +g\Yf3\6prX}?jxeR%)e_p|?E9d4=ƚdFA v**\}kYͺcaH >֯M@ cF8܀SL{ou &ë&GUӧ= ;p>SX2'!I\9>Ջ[щd_NNFz~5  ?IR'!, ̀1%G??*./|iIb%&0e'VcGXb.lX2zˏƵu]thZ֙V9&O&#cx$SZ/ަh[[i,-f"grމƛdH!L]Zū?ZAxɬS+)<B߁dY-žtқRLl)=~\v8E~/ŅBxvZ-F:Luy{Os (?Q_2/*54JsZ93^° 7ʕ^(ԏ;ѭoNo nشVEzq7y B3ȏ_Z-YmؤW%zA`;ƥO#A=rvpWNTvcED~S-KIQoz~,Pħ% g޻\[iʀS^~?Hq|hze0HӚGx0'&Sid|9]:$dB?\W}hp<QkƖW4OncDdЦ,q&G@?U$LX=*yS U-8SB}%G+񏕊kQ&6E/k 憏k_6U u4OFy&JSU?fo5o爴ӹ5Y> *ݳ6Nx YXNZTP6A]wʝO+/qRZ3Z7uJIaI r~:]-}^O]<3q\JY p+e}7>kEk)2m`Y7pr?]G dݷ }kڼkWŰաfy`xsUC[59eMSԞ`eO Zsx2[V]Sx?dEΝems*G\Aj-)59P22jP%ƙ TTR}rRjmՙ# urZFbTk^30IY4/ "d?+Đ| *HY Nw9Q&DCrǵegՌ{0 9 tݑI~:ft,ɹ f8VrW3mř+DA޹ E_ܨ Ax~g5xRn?`[ϸdM69Hcwgs /_[rp .?\7I 9R::f70Ž g䜏\ω[Pҥ]ۀa.{Fn׺s%gή RYvgY܎>W:73+> R/"ZjƎFrgRdgW%T2d}sr݊R:Fcur.(}dVBi'o5 QY1qVvKƞ $.˵I=R_՝zI«yۑg *dri#vB%N[dzvI=9\?z9佌Lu ᇧkV[>aYcPqvlg³Z2u{¶]3d@ 7ms 88ӵdro wOQ*jzRJUUFf' ?kdXJ\RQi׭j[2c'R:I{-9KR,dRJ_i&'I"|mW}=.mbdjK '%F9C\x{Wzk{t.II5'l-#3iHÂ(uWK|_hO@?:ÊJ#Q!Ȭ5c,1:nkΫ5tdz o'$41Z;ߕsߌ/E3a>ýcX 1 _H#<~J ƀ|*I1ּ,Vb߹O= 8h[Юlnj3!<=8uu 8j>^+%u=kڴ [PI0Y6Ocz٭[%uƃj uxÍ~"~$נxwG[)F`7&ܗ6켪>Muu,Oρ"{%s #W%q-J`{ '^&LnrI39O#PQg2,/PǮ;^2-Q]sC|CW]-[~Y&碩?}O)[(E3B"qG w6]>b)*F6]+*wq+74.0 :cq+"pT+gҭi3gpC#M)I'XZiABD~/{H[==/BЀ[u+XZ8vqHJl|!VM"<滹ݽ+['R̳ldPP =.5R\w6u{j@ԡE, A޴yg1Uc G.1qHq+AG]FU@`wƸSmo+ɜ^y+4d`lU$) KL\:?ɥ%f]::n? *VGS1;V_,F[7|1ҕ3_uƢcX:7+q4N*PeIZԥ򕑰I6#;F={UIo3e`I87ZiZd8gУWg3LEw˵W8b((ןcZLs)$v:;ÕL+_?gHhZ^g{cc>R{\.|شȒ.rv;{3rI(߆h -(;F8'w}9qmTPr zW>å骶ЅBLG"^q\?1xF50cڽ>1NF>PN;¨+-|j.tM}C8XŌ~ӥJ?7%ִt,I=RYC;eA;jΦah!wiPvfsB|vG⛯ ,JwlYуҪщXK IKYPO] (Eq[Zq]\9qҹM:'VdZCJ9 tNzSe[ Cߠ.x\ TP0Î+k\,Y fn*Cպ&J.V;H&S%ƒV5Y PIQNkZWa3Y&Ag^I Rr#k ZR2scҫxDcp{V( 8,zRm,5u'SqR93ަoN!T+OzφvYQCď$:j;je1#pwel]n&RAnL&oU ְգQW35ນ*xF?!筵u6r@lg?/ȩu=DjW6ARTOZl#波Nm-eu'#c-K~**,t>d2I!r@,}Ol"tg{x+ ޵sO A f/0̝~z-E#"IDo-zB︮>NԦu.0A ҲFaSxu8G!2\קƸ۽6k"Ѭm&Pu,6KB:~I7;vُȲP qv>ج7M Y0F'}GZ !']X8ϮGVV|h%WFk}GOdI\4|H Q"zY:H!28/Ů%08#QmGk#-D:>ֱSOC? x]FkσNtx'@7̻>zܚλ (`n'Ŀ7=oXO,Wa(0CuBx8$SO>(¶ p ؑ19㯦 ji-%Հ-~DQνρOAXxzM)}v:eʚ+^Or;Wk;;D#K[c#G;D;F2퓍@ g^#_Kq5X$q 5^XPо뢚0H9Ws:7Ŀ`Д%7y>)ZiZu3{gN疻u=ܿ~]5l@R rcҼ~ΖY@@S ۛqF'u+_6CYIwßhd־?8 jǮ}s߮jg.X$ZucIzw烬|)j%ơDj6+8]8%X.[%UeySƲ(Oo֞,͠`𑌂IQGqYE5g?Mz!};s1GQYf;F,'˃:SYi݅xku^QCdqVuU͖Y-BzqUww*_54C,)pv=cz_nȧw`ֵorD/sWڲ@|('gQikJ/dvVѪ,F}WF8  =ZώV7wH G?_0~_[YK_ ?rRQ[w?}Oy^v@. ;?}A1 G$G|'kQE~4Iܜ'%߃ }RHa׻ªtdx){oHgxz %Hdqn{^>hl]R"Sm Z}&fRI(V^xWEi%Q#çkRG*2h 6CsdH`xT)?+1QTH*I  h{}1}+M䅖,.B @>ҐlAzcY:JXYBWFΧ;K I$жX8=1\e"<Pkqb wZr ȸ*:uЃkY- T| $3fDKvRSkis$qlQQYh)wF@'A`1!f:VV9ǧjx8F?Jum1nrUd28o֏x}͉[ BA}1«[_ w}>JH@]=6zHL(S]ͤR) l=mа#Ü%wkUӼM1l/@;[;#`c]~1Ѕ1ƺG{ $sC5ȣF]oiމXrX?6Z3 6<؁4b EW||"ĭN*=Z 2$q\K7Ob L標ukC :.*GAƛZธy.JN}#5kT,rb[u +eUzuW9{^Mc u>`?վ)jytWۈ%.%#; \^؍~0G+,\,(Bx#ۀ~T O" E'C_sI4ch?4ƆBUPC՗gm&xdx x=ss[*M-P'с)OC t΂F^q>Ĥ񟆣k8d@$@ryڹ ";n8RҺM> mjpNvd w8S<"٘#|OV*[4mE!oD sn8|.mV JGUZI0IB;p'%mjIWP'^Ī|R3 k8amy>x -^5 ^][r $ $l xe-HFWpuzFKp;<=0Ar:zhK54cEC,7,'<6Gnp;Pp7cp9fV,33ª2I`LOb=HwBFd=JtOg*yO'i;! ,n@ sx<`ׁgῆ~AP{[V7bynvdd}K/#,AX#ӿ_.sQµ%U!bviWIM-HL1@+O\ 2^^Ӝtr?q6R+Khv+=ʍjLKabJào?YhZ%d 1(&$IIчp]j~KϱNuZ׻o.+)a~[XKBs'5^pFH޳,s$J5$h9_C\ݜ%.[&F Vٲb[\UK V<.ߡ޴e XKg洋c)4Esq (̪#pFk>)]ѱ r@": Iʜ~+c|d*۽g)G]4Cyg9:sSxq+H8Ϸ|A|`II%knJȵE&y~wR5l3WΞ-,r$F=q.$xm2sggx IMRta kӡT׿?]cj~>oh8aœubS1~^-E1?9[ H@ h2D%k=Vm\!°`yk:ϼD`!&r`$ykEV(N8^Tr_LߋSI +gvstK{\r8q+IPzUN&GVkR.ESoY@P8¾O&/d1kѼD&I3/'4"ݖv6yGwڧcf0 {ʎ98*OlYeNqП񨛶0ͬu1pVc4ĹucU-Y\ֳu C XA\J綷gl9mI_!#`%4ꮰFBHRGQ%@[bu$FN7I"mCSO4A+/S6)=9 tȌR8$qUo6b:Aٴb690TФ}Z8IYT'N]K2r[+'6(SrV -żbBQ[ۉVgbs }k}U4rk{PqϚ*3 ^)F WYX9F4MM)eUp6ʞȭeY `tk̯nIM6rFye(&x_U 9m/$}+gס=*MڅQ$7 yG|$v<#i>b8}8'k4Mtͭynm4w`` +H{+tTWIlʹvL/|=k|`wJܞ|>'˙M2zyR.6XA]nysi 4^|.tgsZ2v^Oa~@O+a(ی\glg3(RNE5:mͥ ݖXn ݟ 1\煵+VW^+; w i{هe%au16u@] QI#HelI $ sV[t0HC(Y§;y?0>$VA?=HX`ןe&c|@SyTgrGu?"_+kNZ_ÂԩOz&]R\8zzbSDGR 6fA$U%%rVԫ[&^I3҂ 7)7ڥ]BHԑP+=B*C^GujYUwp#98*{Ckݧʁ7~15=GBg Yx/5SXBP*<nUjܢ"As]}pLbD%򘜜uR;sjg.:g'{Dn qNyhiIܩ`2q'4ڂ1Vl񼓜g,^@v0%ϥc<Ոfx.٥g: 3DRQ2>ҵ5a{4F`Nӟ3^}ői.. :wuj5P9OC5n,|qZG>&xAͪGﲫ/ `k7~3iN! "%r;}}I9$}^#֪k1gZ/Oidm=rp䑱;X~=ZKn0P]&i'X1 O_ |`q7ō"VV:#5~fҴcC6x>^-CR^fGk0#[w1犛_~e/u~xȈa85m4ffkX8|3KT68R +׼6rHe#\5TL>9_ *8GKLEIgh>^Qq&C ֥~,+o,X0kJy|WQmƈpsV->"yY.o91(2|rG?ƼԵoiɨ^88tp;Kn%'ezG!a݆͸kx_DB x]a۩o ܷxJڞ|Zlamb|Տ\_0$m2k*x\Vic%M.u|Y/"V$n~Fo&!20KC GTr _lٕVǐ1j_d" 60 yyZҚ4OV؀H55-Xkù40pfP85.VZfĻobq85DB쥌89>ul<bYJ~eь2']2v4C<0`>sWiYrVɥk N}p}~bV\4dvkhx׳xP]Q0HsOu_]z1 z$L>Ow|%a>)t6H.`m9خN;zq9B|fo:EH[ WD)Ֆ7,H;ojcKes Nv${&$z5rBI:qf x wzFW\ʌTVX@G$y:UOZA{fpۢ'q_|G5*V#zރ  v,ʹ>ol\]Ʃ--٣ur0IO*F+sIգs,`BK`HO$}9Ođ2?',=N+K1a/Xt 2FW"Q*^z:sۚƳԤw2.mkU#E^FNˎHiOPz…tD}Ζ'[S% euꚆ -"7G(RJ5/ H܅1֬Omr+ڲh.Fqֵ-n~Y閖F&a Qݖ& QoTO{wD7}dMeb B$VR7R]P ';/Үm[ⱺU隸;Xθ9 )={Ӟ;}exK1l*[+C"1€psTu5w9X䚋1M}\`^yiHZ@oZ=|׵yuY 瞸Y68.[;v !=-Ě121r~➋az?WM߇5_$k#YY1ξP5㗟RGb2dbrIz?QɸЦ)ufojw70RG=}|VPDD|-cFUPI~СQry-x(o([؋~5.5>e-\O] ܞ2־+)e+`/{ٚ—^,׺6nZI=b1`7צ56!e!sHIQ盻:S]Q\YZ}:->*m8ıN W& c)$$jlr43ϧEJ6W&R qU`{dv9T!E,S75T0=s;lC=@v}B%rx?Z\J~v*̻$iAfE^ ju10D:PƘFw9jCvG0A*͐s׎jO,q3<8Ȭ'u,C'PF2=c+  }j hD}1Z\˕vdF5Z=P\CjD  ǩ5`DZR[1 F4)7iwwv,`o We8,1ҷ?3)Unm>ij剆MV5A6vt1@R,lWqQk;U9Eܯ th֯=m}-neudy3->zfNbZ'(yRbB>:IԊuJ-Vv`jٳFHJtoGjܹ^s11wʑW;W$:Ѳ ½'Jxo9@S{7ק8Zu1JMk,7(ɎEp61=kfU}.-y ~W(HB%U``!>+ku:"}ASp? ;ܭYnoŴ"H IPx%IA,Lxr'*Yبg 27c~ z{X+!8r?Δ.60Nt IDǨkӼC/U*/$;#[0* co=bH2ō*ǒQZꋝ=9_~^QQ;:r1^ys'IA=hmE>dd1lDe~ҫb  A]]I֥fSֻX}¨.۲.ֈմk" P;]Nj$ǵ;"s噝M {g%qޜKq^Jw8^.Ha$>w-^F'q8Fc?Ur@Mt$JQא@]}jxf7GfR}Z~?JHRlrNkѭXc_֢[hzcv*ķv|Y[劆P=t=818澘}CV~Nq+!bP8Vk)YX-` @2&W&0,8ҦF(b#܊05;AE]px=sez+ 9Yt9W:vx`zhOwaoLAWYrr:Wx2E @I޴r՞E-3Z@tVU_¥ we Oq) Fx=Ek)nO:p 6( rOJ/x1X_i\K$j4Il7_Z9#{R}=~VPMmj -TM/̤[O#̷d-eNkokufiJ1\%챼+o l+-m&Tp2k5yQSioW-k9""#4Ԕ_)u9.ېF:PϨ-*&D=N࿇J޹C.X<LJW=Vԯ5[aԚҴl GR@7*"c* #a]U`Ͷ }>g99ʑ;O>u=q\Էwm m9R2EsǸ3IbdbCir?xޫ gz-o i.|ictr F|?x8dZQ~O XckGQ,!cܝ(.(qEфjVSׯ rœ =GFּ7AsiaS{Ï gs)7Vc1a+g|AemB;eP߈>&]VX 53ͬ[hCEYSZZSGA,Pp1LY[ hXդbr}kfYe滝P[DV" 3\[:s5k}=+H7hu LbkyIͅXӼMf,*?SVͦ_H"25Ȣh*kF*,.⿃sβ., pV;>%.֌6w()xV-5F Ca8kJjR]sϯIF.T; kZK"ih-?9@?J,_o|g4"-Ba쑻g$/zz߇lu=:H@G^?Q_)xr7:Ihϖ}_E^FVƮ"Pw{Cie-6p~=z}'2*WV<)r) YN,vJt# +Q4]drFZ4C.q=:Ae>Ezdd>$[j:l׍ l. }N_5A G巗ۘ? O-u Ua 8 1_2I]10C? յ(lzt/̶P"1HF_PUFy߭|KD 'cS4ɒ8FGּNp<-XnCS\j֗ *qڽ@߷LV6bvÎTJ|SAU'ۭVD*W4ӳ<2[wn(=Qw&)[@dW@P2rz ƳIpTJZЫwe]{c8 gsPPrGJ+r ks-u0*_8 QD؄*q;eӎi3wk[gE9Zj2 +~1|8:gG5082r;9Ce q]Eyk(TEz Pӛv~Ub9 p=F?unlmDZ& aѺ{^?^ _+s㐈ݱ t>[dB7\A&wF5ղ{9N:].H#{y`̎>\ZY>wpUgy\!;+y#w[7ʈIM-΃dݨ\HbA-.noSWAe0]Řʲm}8(E$ߓJ$t椒MzRW:֭οt}pFzGdqU VG;ҙ =sPH9'G#dcr?7j([ym4~K9f®A٪f ~bV hpݞFt[쭁ls* 0xvulFMr4wЬ-~^pj=BX~qUʍR!HW9ycҖVR,X3Xd1u*yOڢwM| 4eUY=΄)K+A6WQjMBYarVCG9lZ..$W(:+5k О=+8LR+RTM $t{SHdِxK:߅#75Jg 7dq E@aqVnI`6wGa\uE3ڑ=袆4#HJgr<(UcT#w4QT+JB"_5C6Ԭ:r" ~skC6E":Xc8Ү1nh]\֍Ӷ3EQey>R0:T&sVl؝%Dd@ R\  S 8A nose1ail_fiR=6$D_rC=F=6$D_rCJFIFHH.Photoshop 3.08BIMHH8BIM x8BIM8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@8BIM8BIM Opi JFIFHHAdobed            pO"?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?TI%)$G[ȽfE/ȶ[hd2?~C]O=ǏR<3͊\ATI%)ruݓUSvkWj4tddUUmآvf^׏]TI%)r_[utmg>>Oճ+zw~׉[rjmV,h}sh}s~G?Ѭ*N&][]Mϵ {nMlZ߳^jGx)$U-L74wXt7mmxސ >arjկ.O1qWq3/}ӕi?ʯkc]\:#9cU~Ӫ*3+ճ,s6q}`R+wcvYSۺW5esTgr 8T+{@c2+R^Wz}mb:6;!:zm/ש?r#(bȊ>J[>FE}66S)+xcjkcu;k'UWu<@͵:wЦ6]sUMj}=[KckZѫ;ֵsW:[mi8Y믲-ݟh22LɐB6~~8ʃZ~5gzuUyemQU bX&5x10zlh'ePu)e>⣐'v0@I&ysk{[, [fK'1ѹkcfv]W޴xi|)ާNLDM=RIH1ۘӹvN2W_}!/`N;:~q(?TJtS?[?F#ołpgj{a-}v5{, s/J+'VvQ.y˶8gn{JQF xe]jzGG=vٓ?E*I}WظxĩQP]U5Zՙ?:c>gMOzSB9z8ag5u|vz=|Gw+~EtƪJ/濝>AI${8BIM XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmAdobed           s!1AQa"q2B#R3b$r%C4Scs5D'6Tdt& EFVU(eufv7GWgw8HXhx)9IYiy*:JZjzm!1AQa"q2#BRbr3$4CS%cs5DT &6E'dtU7()󄔤euFVfvGWgw8HXhx9IYiy*:JZjz ?N*UثWb]bkϩ3/84%Wi9bݒ!9"e!Cy6u SN b_|]AeEryT):4g,XhЏG4%ȴ2̞_mƋ[jҤkI-kLWbv*UN*UثWb]8y{к/ uPI$YM=YG~ԭ+6S8-0,,d&GoRb @9E⑯‹,٥wpʛ[R*yz]C|bԵʟ49?j'EzxKE\I^6aZa}f 0MAßg(3iAyNYnHq VǙpZq' mK]mmR)l^Xяٓ r.a6[p9%Ail#E5 SkWbN*UثWbWdZ֤)^ku'xo?l=1_mQ] x;ܜ^kvڞ^Z8g3dyZ32q!բ $%8n)F>VH^-Ҵ]2;;jsY$^IH6beg."!mcv͚O <ɚuV41[>]2fVW3q##Gfg#Yh %HUP1?i͎4HHc1~Ԝd|uS~Wf-6O{|HԽBS^ɤP20LNp2G>_zWo-+ Oi2\|eK''̀}v*UثWb<0mgI>Lʼd_WN*UثWb_>s{ihqi,]SPZ%."oБ|\ A#}yKMZ{=: |$qP?Tzܗq<~}^\#.Z' ZFR{xPHG  QHq"8-Tng1#}G87W'K%4/1Z ` ֙y h!~F^?HX-RȲl]v*UثWN*UثWb^=]kʚG̓h\F"yD Qq_]J8>̭JZ<qi =䳳D4|`[P5[/ŘX`ӜG-?PLkR2څOJ-5jH3qsW&L]I{RLsAj:bݴ70m5K3Oԣ,-Hvl49a(A}FjUdVDIc%7ƭs!䁌,,`UثWb_N*UثV%j6]rl[jiPY"A^F?a9p@ɷ>9Y<.W]ƊUꐳДjߩ>ainGFvyVY.E@+<7q'krC&$5.i-zhyJo(y2gr!@Z,)XU " U"e;f1\l/bv:Z'uV. #5maӌRF ?/L1X=G6ΥثWb]N*UثW~aj 7@>+x;? U:$-|9KCJ e;PA#H4nJEDp2=?v&1ȓ}-JI=݊v*}gŕ򷺉A)"jFF$ь$( %so -5Y$4D OZͦ>fN?Ss搤 o'y]?(̾^NѯP_!~l!:ѿ5Z%L2%ʣ+˵U~-+ bz8b9#ciK3˼Pk%#NLUbT㓖C8w4x٢!~KN*Uk66>'knY&vwcxk̺o.&vCѭ w(:|6 ֗~}Q1>{aJw=5N~c6۳R h9I[iKUhcBfC?˫0p4,<̭'WԓeZ.94aE9[cWb]uئGpn+HB>%^\g,@'^`LHp;ثWb'TrS?O?h,} ӡ$.dÑwڒ&rˆȲv*@@I;* 1,$lM:JHAnPLHBsMN*oO?]Mnu ,Ȍ CBT:ſ/N|Lpb%†1BI$f'76s򑑳#CEWbZfURBY'b^huc,"EP(MnWiVX.eG <d4eqbiUOg ׂ+|9\eI_@FDQIRUتԒ9+YÏbYe?11Rt-Ď\y#zm_=FdӖ`jґd2:+ 3ov*|*i5Llebmis#NV9?O_ky7O%@4W7%\Pj#SϘ?k\tS9e?bey+sN*r/V7ξ..^ӭ?^aJ-cpk5 ,6%-/? cu7K~cVA:nsk#Qc }_d_fGr{+YX6\WcZ/o6©PߵL79_9x;c(rv)N*%/|-:3r AY[<ߧ!8Dp |mP@#cwnUثWb]M ZVJ8̹0E,щYD`2(; Y#(e˭>mC] 2qSI3PXއnf^>/eiLۇaQ{ϕk}^hhֱr qD;OSCn&V&TI;\R$e),2(de=Nȃc輻msXTՀ]ɍYph?oMvD,}Q~R~9!c EbN*HX9:8*EAb_ ~kJ_)~`j1ϐej{IhkSH>+n_n+s_b9v*UثUHErOJRxcד' I(j*0'V^gۑ)r2vCʶt-^$nnn1$⁢-478+.g66Uت[-\Ҥ<(fhcCTUO9 >X'aWvWi@j1QNB3'o`3G}s{G# gEٌ_N*U~A]>bӠ3jzg#Z%ޑUW?*͏4ۇ'!e5R*AKv*UثWbJ^WcOb(5+/u>y[VɩjTPqkAe>)?eybMe${FA;[y!@v,jax6O8UثT]4rjPyE2·d2c>&@ZߕU7TkJO5~Dc&w'л'ڸdgON*U(zb??.Gvz^_ OdQ!o DΫ`s?0bUVAo$k~u &D$kVFD D'd`fl->ϖtO-h.lH]'vwc~fXM?yn`kgY,ՒiQd}Asjb]v*N*Uث49yrAՕqŒh%T5Ic,C4"A7̿!7,gCOR?s.bԉlyrVYO}3A2vR,zÓ#z4~7%_c2..}GÛO,yG~VL,",Cw9#vf̀NqV7 b\lӠZT<$Jm+aX,`gkv*UثWN*UثU +;Im/ KYԤJ ⯜3+@u*\Dl!k\դTr XS?YOnHP<;]][H>t"\Uw~D~O7'յ1fOHdqoKp$F|,m/<˦ t_\&MVV6h"(žf[]oK)6J7 XuX5kH&nDiҬ)RZVhfVDWI 5Zŧ=jv_X*)A=Vfv{/35v*UFQG)FU^^0ɱXr+>5v*UثN*UثWb5 {Z[z_W1_dK<P|cwn ֏mμ29v*odTU^0ɱX}!s}gQ&b]3Dd  f  S BA Nasal-Dropsil_fiRA31F{Pms;3F31F{Pms;JFIF,ExifII*JP1h2iCanonCanon EOS-1Ds Mark IIIAdobe Photoshop CS3 Macintosh2008:05:20 15:40:18"'d0221  ?   0000G}g2008:05:07 18:57:122008:05:07 18:57:12Ho@BdU!9 XICC_PROFILE HLinomntrRGB XYZ  1acspMSFTIEC sRGB-HP cprtP3desclwtptbkptrXYZgXYZ,bXYZ@dmndTpdmddvuedLview$lumimeas $tech0 rTRC< gTRC< bTRC< textCopyright (c) 1998 Hewlett-Packard CompanydescsRGB IEC61966-2.1sRGB IEC61966-2.1XYZ QXYZ XYZ o8XYZ bXYZ $descIEC http://www.iec.chIEC http://www.iec.chdesc.IEC 61966-2.1 Default RGB colour space - sRGB.IEC 61966-2.1 Default RGB colour space - sRGBdesc,Reference Viewing Condition in IEC61966-2.1,Reference Viewing Condition in IEC61966-2.1view_. \XYZ L VPWmeassig CRT curv #(-27;@EJOTY^chmrw| %+28>ELRY`gnu| &/8AKT]gqz !-8COZfr~ -;HUcq~ +:IXgw'7HYj{+=Oat 2FZn  % : O d y  ' = T j " 9 Q i  * C \ u & @ Z t .Id %A^z &Ca~1Om&Ed#Cc'Ij4Vx&IlAe@e Ek*Qw;c*R{Gp@j>i  A l !!H!u!!!"'"U"""# #8#f###$$M$|$$% %8%h%%%&'&W&&&''I'z''( (?(q(())8)k))**5*h**++6+i++,,9,n,,- -A-v--..L.../$/Z///050l0011J1112*2c223 3F3334+4e4455M555676r667$7`7788P8899B999:6:t::;-;k;;<' >`>>?!?a??@#@d@@A)AjAAB0BrBBC:C}CDDGDDEEUEEF"FgFFG5G{GHHKHHIIcIIJ7J}JK KSKKL*LrLMMJMMN%NnNOOIOOP'PqPQQPQQR1R|RSS_SSTBTTU(UuUVV\VVWDWWX/X}XYYiYZZVZZ[E[[\5\\]']x]^^l^__a_``W``aOaabIbbcCccd@dde=eef=ffg=ggh?hhiCiijHjjkOkklWlmm`mnnknooxop+ppq:qqrKrss]sttptu(uuv>vvwVwxxnxy*yyzFz{{c{|!||}A}~~b~#G k͂0WGrׇ;iΉ3dʋ0cʍ1fΏ6n֑?zM _ɖ4 uL$h՛BdҞ@iءG&vVǥ8nRĩ7u\ЭD-u`ֲK³8%yhYѹJº;.! zpg_XQKFAǿ=ȼ:ɹ8ʷ6˶5̵5͵6ζ7ϸ9к<Ѿ?DINU\dlvۀ܊ݖޢ)߯6DScs 2F[p(@Xr4Pm8Ww)KmCC" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?ϥIz<Pu@p>zq.=`g8֍>vՌ\m}tkSq܏g}k^[g:}z=ztvvN$Fy?oBhK{{lf`%s}jP9OL qp?=<\ӷE%~Da9}rx)s߿bE O~t[mi}6rZ[_NWޅ ^{ }II˂߱{ q#]^nBw zu<;;hLtg+֟vB>8~zU;ݿ8o#=N_-<g~>߯ӿ=VvQ&<h2yg߱9۟A5`!p2ylzލߜ=:񦖽E׷R~#;$񎼓`^=?6E8= r:h]u%$w_"S<{p9?^{=={Ի?NԂ}G\weI~om;qn+޽) s?\99'=M̑R{Zj Q_/2 =;zr}R<=?~=,ޟ,SK^[˳sG|aǷN1ӿLJi뎣>C3ګ'kH?'=n?:g=) ۦnONOsRKiX.}r{Q~FLx랝qV03sMר=~x).-<יA}gZLwxlM)hjѫJrONY->E| W0tÎ70bGqՋWR^TF]% I>=S0;:v;?NO K?MRbmol. s=:c/~_#}sߎ-`Ǣ\BpK<o=zzgxi8fҍ,7ejIa [n%wx;QM<3(Eu1<'ҧ< ][]5A^q8>Ԁ`5x>?NRNhէVҔ*SgNQX-ŭUz֣[RtqjЭ:UΕHIn -uM&>apӟ {1|oCX$"檐FmGXZƃL0ŚVEfcʲ$LV;0a(A[ީ^N+]۲ml߈36Qe4T~[b&,>*Y5F)ME6x!lNyLW?mA~gjw:QPvg]j(1 $[Q9B/ )A6;|4xFtĂ=Nwz@bԸMIҴiٵt=NӬ[H"p$*1I&`^PZ żSA,S"+;в'$Ug_^R h)A.5@gs}h{ }_!(m>s4xi_l.e}(xuӪ6yB3O=HlJiumY|2qS~~c3]O8^F{t5V+U^r:)8{J9ݑw$tI{}NekRu1{wi6uӞZ=4O?/e߷zS8>ڤ-|_a{u iQ_M<HIT4 :t <x?n8it%?iW4^ls?_ǎ2OӚ67~\uRII=5kkz<>q휞?&1V)s{S]zSԮ@==#cP==)A؏J=?3PM~v+6]Hw7v*P=p} 趲)JخP=8㎼z CF=}{C8P_;oW>VHE\?8AO:sq=z䏯? ?`9ލ^bQNہz,c7+_Mn>$imi6F$11yk;T(o*366;`zW_L.1</$l QgXyi(KFJq7qrRA#/cygIB X40='JLujM)R>j xGÞ.MѴ( M>(T+xQ@`W/Ţ(tlĩNy21ۑĊFѡw .dn# x'>,Qp3 v+F%^;WK \¡XPl~P==5 m lIőb2Wqrle'g/u{}oGo`'=i;)_OywMkkg_.-c:LK&R KgR@s̯F7ρٚ [6mOI29'io65~p~,b&!;G@9돠ymai 1P9c$d_p'xi8s3)FrկӵLUj -V.0QyWh-uK3$ڕ)Ԯs W?W_l<xR)eh['Q$ y1]7FfG|:57'x;6(iZ5vNe~Ke6 pC#)|  C>KuY*\Bse;*hKB:_Ҟ FTp `<Ynp~5yRv-߅~ /0GS O)*تQ?aS4xzm× FQRTۛhNH8*d0޸cMWO!7vWI5ve.|S0R2aМx7OgÞkvWdT( `9w51EQ 9&̶]t;k9" (QHK+Jwp#\wPZbg ])8TU(UgN|iɫI88&zP:(ps²reM'6T)D*úߏ>& n5FP+ѦxHK]RYtX(rԟ5_u;~m2ZLjTL#3XM"$ Wn_>#֬6 Wß kƋCi,Wss6wc"ZO MhF{q '*|F}[k}<խ#վ!,K1\䲒k6cI =\$V?bqja0qS,-I7SCA$\WY:eKLYrYe5/kX:gptd֡jmp-NC -߈g| W%oߙcӵYdU_wC#G6h})5xR#_eC|jV1hsCnOmT]n4(Fy??O~ |FxgMOҴH7n*MjsljYv$ n_φ<#c{ xz)g^NA1KB;yoS,d*ȫ v :'Eҝ,UYTg*pji<u玞kx٥kyzk'[{Ev'~ (Lc<d5! `ǷWuٌ 1w3ϧ4:~=1e玝{=iYׯ-?u+B۩nNoʔ.TyOn1cxȩq>co~:U?"{ϒ3|aS;S`^h?@Pg_9ҽ8ʓǃz0NF8A\= s#ǜcn?ւ=A}_Ώ@RZY^]:s}pr1A8N zv:?~f~%mty=9zyyzួ*@8#ӌcM_?1|tEvϯW?R`=W ~t3y8=xG;ZvvѾJOM455肃IsCӑ[B 1׏5uݦl}RW h{s8Ƿ8Obs{#`ʙI͋ӯQNc{z{R1=n1Ͽj{0=9E{0|hao~uL&2A~kSTe6*]aRHsl-87̻JUXv" BUܪժ\הSIOfAa2.f6h0=\N+RV)ҥM{ҕa7ŵq$S%R\NAK4;8E. qN3:ı|fl}3޴@PsH<ׯ^_f+) a랽+qZM6延ik%F9EMnLq>Lc%<< $΢k"# r@<=)#o=lax9:w$/kh{^+]6t'6֖{wmk[G3+vc׌"񌑀HU6fIcG  x s0}XyR<ʢy,$| gyQrrKk7)7զ]=d.c$ F3iKJ1lngkwZ&"O#< |BqƠxl`xu|㖓kֹXL &x hPy'ir_j}IV ʾC_gm5GԚ7Vm+'f[#%N6?vJI=^W.YZ[}stĥ; $.FW_ۂEI4 TldH2NWrdvM{5fgWxO/<WOo,~*-H?ww:e؂t454.ao~ ß h^t?Z}xwBNҴ>1ֶ*ໜbMZ 1*"mڅUHq*!`0FF:t899N2˩Y՝|eYկ>immڜoNb+?0xue*T†]Ba)EF:P_ԓj9JoT2sCrx䁌W1 i*/NX%&heBC,n^9*8lc?<(N@_arNFһI/k[TρKoem?)/?gj>hATy;+krծ)׍6BZ bo(Ȯoylג墷NUHTd3p=+T<3~k?;5oĒ 0:d t:mxaw|f?~4ׅc]&5&B MN_?Fp7ęqRq6yW5G D22:8Y18*Nx|'֥N4Xx?Ǿ"_v~ ٶw)ðϰggkk%k/eBԯ'QOK Z$nӬO+],4 Acoq f EwliR G_g|lÙn,l#м)ssŨi˦XH4PHXZ!l><Py._`P]A#8`A^&s4ԚK[m.pHdiFSp6FKq_ȼ{xs\1 B,#FY 9vW+a8xҤeRS*Τ2>pG^ɸw+ɲҩc*fZ3f*U1XK:%ӄhƍ TC_?hωG-ߦj0*::@_\ȑ}P̻{z:]ğ^x egծf; (nkGl`FyG|&mpYyg }fr!ftrl,|q&W&cVsnSrmZZ乏~$exqY<,z>]S N 0*i*0()$Ǟ1'9zsl>8Oq8ϥKF;sM}Q?Csǡϧ46=z?b>z/֗i>T V~<cy=(8Rs֧?ʍЏק"<WB><6q'M=GJL1Gҁs?W~g֗>#㟨# 3{稦l<~`'Gn܎?Ϯy9 ߌw_Nw֟+?rM4qcrznӭ!B:y=@|׸ؠjkkߦZ*}=9捃Ӿ:cN9zA|k})1:F^0?Xj}ϿӡM)xcׯCzS}uv?w4=לum,ק43z8{ ~DJ{_RV,g3Oqߦ{Ւ_瞣2:uj=;_r=z{Z*vO_ßόzWC?Gqiyt[kKY{_x0m$4/EdrѪ]~|,W4 hVF]ksy*u]lNŘMz핕6pCmooC FC qT(#DPUFo_'~3qx`j5\Τ2ohJ];Ln&.\ʄ0_?X=X(xN3|vc4TnZJ1,Eu*Ӆcds{}H9sN*ƥN31vOUգw~wN).駞~ˆUUbjW6z7 qלu۰ĄXqqNJ V+2)$׃8qkgHHrGq^ |* F{eg+ԍJrN+=mm# 9=88V2[pd}ku-W0989?sSl#3` Ӝ漪#/O+nv;o0/:c.w{k]}b2Cq;A~u gog$u<x+u_1@Q z g$Hk̵_'s!` T ~x'M{~k[[uߦU>8.*Z73nK[os|[8mI' wg8q!|ߊi->TF 1NHG5k$|B˲),K;mqy__FFp>b> %p1b'3+fKh6܋ҡe ԃ-vJgmNoQ:]3RG rKHr>\-|9x^1,7[pf+8\g,Ӏ8sn-JZgCadYW,F<"Q W]zu^2IE`6eS2! 0]ĚuTdniM{e{iw=7V\۪n1I'mZӛnilnTx#OĞUNj%ԵhX'Q{15y6Aw=bXfo%>};zv#-]mwozRZAw% y/  S7/\?^aԼmi ̲_!:)gH\%E}b1 5cJPK/~Μ.nJI蓺qi?e418 a(IJ^֔]Y(9F쯴ĵo!m嵺]E*`|u C9<0M,js?;j7čn5SzVΊ.خ#88WG֭ةK;x EB*iTQEf ZPΛQvi'1y:4c0Ngg%枛Yag) <=9:cU_xE}=_Om#mK[iI#_12rGs~~ۿ.VO).u.\@ ĜzO_t/jrjmw3{s,) -Neu:a,NqP),U%Z;_{8SZ'{?f7~YU\M(<$PjZI%HK;U|]^<5%^2̳.xf A\7# XhRJ|mg*<DAVb'ǿ6mψu"m|Cjᶐj}MAtܪm|\r1;ի;vδs|k&\Ⱉ;FY)ʆ71F'R ෕Uq )`qm -<"ZCxl^e<Qs\0nF79,+ Cy8p_f9T ׫\=1#霌gQǯ'O\sV:c4Ҡq8Sxe+;^}/L9=ܜc9sCNq~qqKkO"<xLg_OT?h?ǻ|/Üd3})|z>ϯIz@ןo# y2z#;Y A\z ;㎕6;tҍzVXD׶_Ȍg'Cߡq2GBz9|cXځƧD]-X};:z~}Y8YEA 'z1`s9(-MSrG?A_˿zO\~9) ~RsK)MݿO]Ԅsӟ6OF@8ӧSFP9T ,HzxǩJ]tM}vߩ\zvL~4Lq< w`W1@ zd1uU ߒJV{=/ӿCZuiU9QRWmYm:gz{'_>y P>):=A#քƧD_+loOx <~Cן=^>/>҅$3S'g#;c?jvrqcw}>G=1?)|?/h/m9ۄw 'N3׏ӡirsֲ.v1`_q@8 NRN:}]wXMԒI]6VJ=?[R+|89#9 v'ؚ!Qp >8'vGzȀIExa($|ͭᙦMX,c}=OI{QR&X{.]O2U*ҧJQV{{+h=_9+dڍiwn\֝wBlXҠc(rY 8dn. -*]5t 2.o`K(J7|.# #̘0 bb>SHc*@Z[5jH8=̒;#iw`g$q09ʝۜ*RrzFihrmypN}ZP動V|]SkH|{Um>/x-"($΍Q__R&C|u+WjEtoSNChKk\Ő"]^X\X}c"2%_ {$ r v=zuQ z[I?NLnFmn<%"gb2yE=W09rQ3 YMBQXz>Zv[{6=\3_EabÞKUR8IHi/]j~2RE2+Go{S*A#0$(?j \½Ų] Syg'Ȇ_=c.N1մx:g }h~Pğ0.,@5_H y̤r #s^9WӻRe ;T+_r^; 1aC/^N)qR'U[qIewOSI.hw9Y5=>t+wEp'#p\sHi [B+܎Asf??E^0~I$Sh{nm=0y*PA9iZL*vw_[> 1S OZ+S-4Wn]p\\R9E;XyYWemO؃xPxKCizƟr\Y^H|kwV~X,~]Wt׵)>j+x伸I' )c) i79Ƥ "N[5/opjkSRWSH5(odеt Uyhfa3NjO0t_\z}Lv_A ?>4NL*ė_hjVzvVs"m1I+UTPI,yMnmF*?z<2:8x"uM;ArG>*G)BX|.j0QN-FS_Y՚~tQa_8vpZ@X.I⿌+&Z)"H>$UM/ĺsHܾ>yQvC~<e/i>-+HيO貮ǐ(xD=#hJ5/i $MJٌ,zrL,iH߃_0xǾ25ei9Nӣ}S|sMv+(XmBGx~Zm1[$v֖)H`$V𢪬ilU+Ip/L3|IKrb)SJym3:XZ`hצ ;6}fNlGW2J#cs8j&'qjaGjЫU]{71#+➁jf"˧iZkA&qh ,Fd?dߋcy9?8-n5 mcšVi3CkiB qr GҴr%ITy[u`OˁzcƒhI J x-}> ۆhi,J }cH]Akᯧ9GRɸ^ᥖareIF41VXΌ<_+Cp(קǿ\~'$3 3\:9vaGuN2gCZ2NqN,x0yO611RgU('װ]Zdﵓ뭯I&۵m+c|8?4v|!.=; neGvq, ʪ\ź,>f(?@~(>?x{_o}9յHcܢ9 P;w?P>S żcy<|f\uEe0[+ݤV_Y*QRxsi,}*MK6[-%RMFM~X>N"F:<9 w$P 1ndk.'[~x^)PK\ZvNa7[ۙO-K`a}.8+ Yj0,zZ#ouMs8?Nr֧ø>!T9)PRʲ%gK ;F0$ 2 i/ڕ#Ü1YKO#n^z1,#}yi ~orTŜYKc`2#DTWTNU<;ɨJ҄WġJ*QeC?_Z4$ĺ2!:is;6Hg"?U}*խlcNaY(II qMs"FU2ƨ_n +IhYAV. H-2^C[]Z5ݔW%b6&"9%HXΣaZ VGEh V3vTkA~ό4=&G{ҵM3m(s*K#; rnjnkYcq(9ES^ 'FnJީB|o-P&WP1'kP tgiFI 9S%>񭿊t]b\ݦ剢8Hf#qXdSW{YW t錂=ʞcct~[~$mEZXyaku||$8oGfTE~mƗsYĤf[{M:[[QfuV+[K<'UpoV Rx>q~pW0T9jqRjqM?C.65*`8UYFR:tjJRaSMQ*njb"AKqp_~_R#L=4ݧQU{-J([khiB*r˒19\u&+Pa*¾JV*R(J/Ogf& ~cq9naFS tkR$ŭi&M}1~viAU9^ p}O~?ĊL 8_9Tﴺϵ=~=_֊ }ӵ3n43&g 9G p: In^Մ &p$ 0A=O#'OURb_ N#r@'O;;{m|cc$cPqvi%Vn?KrYӓou.}4W# xzhIcոgǫmnds,H Mŵ;^Mt~)(5gzY._u>C$ e\@·BpĞ wğϯj3ܼ6 l1+ЕRcېkuk7ܬdݑÆdx9n6i#Tk%cn 9zdu̳/ɲ||74px<.U^ p"[\NѝO :ܫ,cqJjԓJ1"J֣][YC%̰!VYHI@O1y-Ingyi}<:Q@pp 52jM3|()oh>vX91@_FW_B8t1\oR\1Td:sG rjKJ0ϥ3Aeu|;E|? etgWIⱉ5x\5j+Gc;q?0r)*J A I :7u]&]^]SO2,TZZ'iY .XQ6y#w1 T, [33_'1xw19ӌ{8SKoYdnpȳRUq2Җ3{^Y$(n<"eհyxw qѥNhfU4iy3)W Jе3[Ӥ@c`1;9'r }3[ 훆 I wuϧ8+𗍼e;x?Ěχnw/f9Izan"00G< ICxKv#PۥjdtU&Ο?gg\4 8,㜮JYNc*yƚTNy6:ah^VV'(~/ xa57No^#iU~)i;B7YB6ouY1<d FG9ݜr+RIxY"̃;Q$X9^?)gۗg٭/ic-mNL)&aH{9gE$~>#̊I:@*rGmPFAVn' 1odE |Ѳgd:gN)-ngST!rOe<:nv_˄LlTpGlՎ*aںzݴzo{tu!ԚUޭ3߈V$yhpI,pyg9N|"мG^$Ӵq?4Y.ij$&8aȄ((ʹj%wt瓎}$1OVwM7ڴ-k+!ӭCvHs$0'|E_Q|;gcAymnaHW(?|s#m{M\FIdfP3ӣwRzޙχْv6:9~9Yt3;;cU%$Zn]$ikYԔ1VSoNQi)BIkN[~E9WVeӼ]JI`<]93zj NԣK:c"{yV?f*ޝt|m o>4ӾXs[{O_-7 :q9kM$ymd W\Ml1J7Tej >ZTg_maRr9w9UPrx$dW|24OjJ"2O#>t[QL#B䁅-?fOKW~_NI g`aHg$|_Rx-4{ xt:` 6}5xpW0RRpƊ%Ji'#  2g|UeSV:IO'RB  IJʭj9IB+o _M/+B- {D1DSw#,y$+T1Ekn. u6I2.l?Mx~2,j7 qQGQ[߆VuY.wvt#ڿHfy&yY׭7R*iխRRRR);of^A_MУңFR9b)’QT쒳?%u|]o y,FhNO=[A)D|R񍱓Wo~6hAx :SkIp +bg $qdu͖9|r__es{O*h*SM:kV֌"Ne6$gƿ)NA.>7\|nw4 7|)+^l.,u|_x5)4[-?:Y*,ƢkJ]yvR+yl0f>2=j*jpvc&ed>l.563'6|˂%kضFU! 6mv[H֬@VWI6\[w˘]bI0O>wEa Zt{OxKӒH}z_jQlKI;[ZQqyt;zg?g_ ,lFpE}JfR :(0t!%iGQqT祮yJ\ڽx&Ya'|(VMO]U-_k&)ROYv#[?+1 *|`2.0d [k>=L1Gi_1YWo1%iec&˗JRUf@ˈ8`2drH9 !ԧcVISm+[MzpQiU=jn֗wN3TBeI,* ʑ9 5jMapU8q^{X5Ҽ|lA9*;d!FAgהхRU9 0zH91F=ޮֻ|\{Q)Iik%u_NU5R{E$:IF_ܨ',9Gqowcm 0[)߆WtxEi1H |(f-#hB+o~|Q &sl%s3=ć9GPc.UdA-Z(Y$9Y#8'/g|apŪh-aֺ2,ukp #wÁTL_`ӛ8TՍ:m­>t 8sO=x˅a},} tqxz))SJrVF7Û2I;~_|/z^qkZ^76]dv-9S/cu] 8Umea*@*!R2E~5| n x͖^ bִF1d^͡X6{m|)_o~6{m KmurbR\6ʿwKL 8hT$_ƢQ:r;B8T9Ϥ'25>&LL19 JL67ӣ5kЋX] S]JUgB:pjn8סk@(+nC)5Yr pTN@xY"Jd6FlvxgNq|n[ ZhJ.wI?$n!}lfW9S,U(QIi]I'E6zy=r==8M1n?D$~'zw_տ?{^GxYN԰Vuv\g;OCtiA.coQ'ͷi'xNs^ZE[HBpܒ3 u@ =bn-`be2Ã9`3eN25+JMˮU? i(FRq/k'u>1_뺄rXv?1 yGIui'i sN\I<\K!˒@ I y5H}Ȃqc1l%jtZyӥN9ԛcF*RIE^ODq4pԪb1!J(JJ$B Rcml \*VEs9ݫOK[p(30d~w5k6 jR'tS=FyojےzNz=zv{]WPfX.֦.W|RZfxr^56uO_fk1dQL5FَOBp~Ogv? n${Jz'{Ԋ}L$NtR?ڿZz_ogD!U'YT xvϹ?!Ng^nIn :?^\?:]l~dvs#r]^Vs?9ߏҦ{n>Lt W#_ס۵+: +YV{[Ie3%x$E< _~||clhps"kpĄVTAxQx5g'$'8sz :xQx'ӹ=Nx '_*<$2)TIJ]Pt ӚxLE64U6į3wu :rU24ySl1xc0]5):R1#|!|#-ˆ37$&#_^iVio:*Uli,ž.Ir KMn%Ӆ瀭(Q|glNm(c3tn+kR3;S?Kv#=AI-Ť+Ig 9g ~<֚yԢD1 Ȑ`Hr;!c /Pr+O Wkn zw#gֿ~ slO Id\eUJJTzrTBm*U&o=Lφ&qOo誘L'SѓqupتRj5RPZ&QM?|ytdF3x'9 xVdReq9(82v^pڍO.р"C6u_Z쵀F5B$qzv 5^tB#$J1rY5gwͳγ SR2*cF2Ji79h4OxfC9W9e6QYvc>/&/ߋ:̚f֩:}?FRw\2jKqJ -($>p`徝y OvK iFXTljh ~?Y/ j:kgz xfWOu x٣@)0W~< >"[xDϫ^KoNmg..ouSMoqM~we_dW$u&ݵh9%P]Dt\~bWSʱ|U O|&]Yv0ƩңӥMa0F<.5}O *[@yc-]N._1,t/-C asx ԟUt>EM~ѧV 8T4?Is،]Ա_*T:yЧ^4c^\aZ ѭFNRd?4ŒGi.| 3KC:^s^^џU wauivݛ][au\ŨHi;`s i{t۫7hYuhptb U'$ {OQKMs%%otl?tV9mR',$c5/mTTe;5,Lcq8ԧ(&UN57$.em:iό&mn ju/? ށ Zd[xrXCx e%7ŽoByzcMUNXi:7|=݌lesKiy kP^$'diT֫PQgZPJU)*J9'f($n۾9]So s8fPMB9&kQI7|AO_u=#|?P}IӼ+شG5j1YZniFuy$\[62e5Gdm鸶A 0@lIl~{}őxSsNǜ/jnpu 9%z9}G _*1VQՒV~@#E/&MSfYHߐNJ` Oڵzu͖ 2dY6I'v W8(6mh{&մҺM=RqM>%gZ=>}׼wesb& "܄R3ʁgpb6gՀ>(%.l.-~-|{dķ~WGMK .Fछ))Sro{GFt&JV:J3m&_6$~#v}׊9:[xE- t $wCjP^=<}2֣Wњv 4hy9 Q"2|?,_{\MվxetV&I<=0%6D HgoCVKYǡKyvll5"C#̶}6%Df1"n/P6*hUS:WJI](L0^=r_󝆢ՠI=tmz}IBe&҄I.dsS\%-I#QJ`HUX6z kZӠ6pP erHcp8brX'lO?^_[ f,Iڄ_+ci+ԒҒjXm{1*Y\%~ ֜'Z>.ٍxhEV/j5N8'>^z߇✩SH={xI^z_f}:RL\tMc>RQ.O_|ׯԄFG#?OU<u%f۫mdhw؇61^O(@1?^^qfֲfk?;]H@'SR䑌c#קniޒK˭ؗ>/$! <81p~? Y ǯ?g`wOz6I7k+H[ CIt˝>Uy-`ex捑сon8N&4A7]vcjO=i t{_xOx<8sQ'..?ce幝fwURUԍS<#yXR;.U'%MQrx,l[:KF2nj2WOIYls-%8mܓ; UX\+iISwa*8݅z:4={]оumCH}ԶFO[(FFp+J"F$&ޛLsk8m?ļVK <]<etkamt0VVX< ?ŒhEB'x VMԄW!1x<^[һcNmƴ>\>ce3&FO͂@boʬ$o' 33_͍ω|Kzk䟵ςO\uYIifbA,I!FHmNszsf.`lT]jY' F2iZ彾)a$o^|IσRic[8oHʮ,ɦOCV_n flɯ/|m޿KqcveE/Ϙ1ܝU,7\cn@8ԌtPO O⟌7KS-ܪlEn1(0ZI"N\WG_C,ˊ,xa+c1I,SsS K O*r.RT1ࣈiG+9GWL1ew xMfcXjc'18 EJ'8T?e|Ab~-iQ?qcg|"@qE_GSf⟇ ]m띸Tދ;\ SOkܯVV[]tdٻi٫?iMwj];6Wm6˒vvzF1sZk#5q%7qs۞שO$e``319bx$bUas.p8!F9k͎U66Wkuvn#X$nݤMr־ a2őyd++Rx,8~w}h40՘_'ц;`F[6Td!d܊13$REyۦȌȇ%Kr0y'8Zs>E$FfZQԡkY߳nۥRMMn=~=K^ .'m6Ҥ &tJ }? h6_}ZFl|oXh*"D"b|y+v(we;pW A|˜s՛iRFֲ*UC`eGU rQ|kI&]hǙRe44^ە7V+_.Rҵ^!Q>b* 6CyGr r+矋vOu"ޑj3X`py9lɉIS p>8F?Yܗ=B,DʡdRgp-Nr뭍8gfU^곲^{qiԛiIJIs,<~p< jٓevs\\1pvsQO'=54/>b <߿}`Ԩ]&ҵܚ=vOw*Bi]]=wy.{M;UkOAues*2)WP>M7d_E|1]u4K[K縶!qm+y2F Nd.N1_GǍ8 wbp@+H$mk 7u}rē.s"i ^\<'l{bC&02?>(9%G%gm77rm_[w?<[Gz'.AK^E{!kVK%4PT,ەKu'/ZuPWFQ]K4Yl*UF|1K +׼Cwe"E71*$M12xdoi $Cy"-TF%+_/)ԅIV^ϙ+|QSVvO.iU5khm[%fZ>&cW4hh;V"w)*& x/71|FG,䷒+$1xM U'ӮYnBf/X#VFY'^vSx xYfv =@)'P'? xQjv:V.i7ҬZy %;P(&?bi 7)ETQ %٧t1XZqTS mZW|Vt?; |+Lle:-*V3[xy^V8fD<߿? Z(X2h71ǖ_9O2Yt' 7<-VJRcS=nҗ-V|VQ>6\AխE' J[{ݫ6?$|>da?f+ )WC >Ŋ߈ 4'YM-֍Z[1+Bj1qMX^ǀx\鱨pexz/ bhPpNc:֧{9Arrlݷ|l aJ6RnohDb֯:U$8s^qy9/!-סi0HsԜqL cd$/z ^5@'8'>Og>f6",0mTeEт/'2~ qS,Ti*nJ(vPfҋmӚ"jk"idFV-#=FI aLx*N М=*eAz`:2q׶:{{_U*TRB!JF*tBQccIY%d>/_^+Z#RzfUVT97)snRnN&8{֞_;U7?R'zޭ;jr9 U};b qdA1qWgNGCF=8$?6۾f竽O[iEN^:xTA s=3Q8G}^ӯ]/d9B<3 SQ8G@=~ 9NG1K?)tI>]/_Vzi/`@@9D(E֥*F2>uלTBĎ s^wN.nwi[K}G`=q1N>y;SX{B`Vg BN r>\\IoKw󲊛}* <}8?;anzO >c\Xٻc8Oc #NMO:u릛[ntkFխ{jk_mnΈ S01x?^nu`d8x'IeO˷ X#R|W뫷mky?tԤ##`rG׎:ÿGn2?np0s=ԁONˎ6SBow'%7*E{4E" 郻#ԏÞ|A/#^)KFh4dy T,zK6|A{i%,RՄhbυs㐅#o 25e{0g_iZgʓ R9?>2gYc%YPQJ$y:oN-o*3=9$T-`+,<1Bq9>5&CeQw>z&ITdvbWF38䞙 #Ԟmnvl| ե{{nӯu509cs8Y;At+{sWn)y$ʑG{Qcn9 W\񲔜yo[vޚn^>6P|>vKMu}7g\έ U/'s}ܑߩ9? aTH[8"-C/pS0ps1r9*($JC!H-z 3qּLZi])J>nڧjn+4ӓmRdژD$2Y O`#טt0Jpmed8h2j**EH'|W]UKFֲkG0r2ZVѳ*rӍ7VZխ3>msϩH͵1ut0 M[PdfmvkSQ $20cG uލ:2$I-%f;o_=/OH|72=:]3VkxuY-K/XԄ2M&8L2ƺX.i?wm+: /R)F^q= }Sx Jm8ͯNI$՝⹏js' /m{9$:(MVOQм9&kuKvԧӟ巴k -NXn7?hx/xY#Դ;fejDg)f*U+%R*t pQU ]o|ꕚXV䝛RٴJɽ./U3 ;H@…9G}2OJ#;w~P9A< ayK]W[oe&ѫݛjͽZUm@'gPRznǦAǭpH#H1 ʷvpqx% sby{+˳]o'{ߢ'ti'v}}[mi4$-  I,p/P3'#bq!j#-ʟ@ Zanp p$$ dpy<8W~Z۳zﯡO'4Wm+^mGȆ020~`F9Bspø:? I 9Z;a{)ɥehkki{42Ԍ=N=8ϭItf+2 $9<yӢ}> 6?ƟZ'{ Qg$„+iP%$ٕi#X|W\ c q.TWMU6a*CqWp]NMUNQtiKWsx|3QU*KiyF'%koNX\σRjA-l&yRa?Ҵp+gN,X.G:Ic%F8$izA#Qlt< wƲ*т8?)m 'Zom6+(o`ŃeJ, 8ƫu;NM[Y'vkwefպ+&1ߖ >U̹is6{-]kդ"g {ߎH ' W!Z3#dhܞ'9BB<Ԑk;|~mn䚳 `ym˝wڧ8)Ӭջq^jk\hQnͨ8ԯiivv9fi݇Q@㑀:WB->wNM9rVwj-t_æ٭G\*^=$s9zsǼmvna8ו՗vF2뜜w9 I ,I\t,sҝi>T_Vt}˻trMY;i}6VZz6:sA(;Ym s g=+Fǀ7c-c@k# FvI>${ڟ1@bY9b')'nI| ^9j*oTӺKMK/'&TIַvz5]܏K\6Nڱ.QdR#r< 8A'WfC#UIekM**# &B^Hڸt$*tk[4ZFhO6ӔnԬꛕMl2]Ee@GB.ґ YzUF3U#idG#*XyhKm*6i;j-ʪm9ڡ|bM/13YULIuYI&ʝ1^dR٫ki+{٥>p9Tmu.<6qcRA(ς[%m4/o-䴃tsr2BJ,70NAήjH9RbdYfM.#*zGHuyW.tѧVKgmE*4y=\OuͧOwv$%cT2 *@'mHxЭכ,S[6ࡧ*d0Z˷˂o6%$1A @ ^4mr; elyL` ۷ B۱+ce E%fm-m7ѭֶV%.UxR[i;&ӿC"]6QntE*%#;GB_bHJ{գB. ︅fa;↿Βs,0AD {U"x'# `Tz6q5Ž+=irfˑT:=1~jUy9TWjKɻ&՛57牋-gv{[Rsƻ>4{-h.IQ/(1668tb}_Z퇏t=[ŚE˥xj+H[LvyԯnJKKSp6!-Ҽc@ӿ.4OkW[Oim0[CHZ`K%FMޟ%-Wz::ҝ> +O)D`AZorIoeBPy+SNPk\MTז-j-˚ 5֪V^sTcԜ*p(NҲJ*M%i>z,~Í <5n6a=Ci3:w1$xs'oǺ ׇ 3⳨!6ZjFz",]Bu "In#h]]xܸ$[ W6NpWoP0ML**qN1\$EMt3_ J =s1tXL(Quiw\?h%dAR%lk,JN~<.~SrT`%^zWV3C)xX qi_h͝wfNg~|s[|)ϱ,C晿2ʰXV̛&&R29ŮIN?a^fX2~~&)N1*ʹ%V2R*iՌiH{~vv$h¨Qp8NFnI1#$| uOq1׊VA-g'9:w9FiVon_T;;.I%-Z%W^I 1E p_(go =kӌ _f!r>l;/A^[ʥM8<&rVJJtEj{Uc!8'i rv9IV] 0~;N1#!ׯҨ<;X(#5ˈ\2p 2F6\եg$շVWKYuJcRwm&UmRwFElI1`x,0g8W4T \<޺ YNC0scFB5dS288|6Qqqy+k_tv/M)prpj3qVtVWv8 N:IXa.>b+c"PwqFUbX 'jW̕W a!VDlđ\Wj<+Ќv[&V YLe;8iletRyI?%'VvW5{a3IeR*\b02B0;  ZNbQ7o2,(v!11!\O81D ,6oBo*pK#nUo,0rBES101S #A/אRҿOujhug}ݚrH]Z1 {^IZ|_UnkN*LVkHbۤs7*7lmܹ# &Uso\H-<76no5Xɷ v/v+MfPc ʊHbAhj{]n@c5_̈ɼ'd,i_&ڛc8!~3\;UֱGss$w!\H`kkm^$NT2xGK[ZZڳyMy-Ց2V϶ѢG XHJid %fx7-~~|u?no!f/n.4-OBPp\qrE)v. <HԱUV?guEŮd`}m|]IӏN\M5R2]ex٧קx2*o* j:6I?yn 庲x\2HbeF+x9ֵ-kŖ:67ڵ><[- ү-H"7mlE[=b_g|5+T_xye Nc*Y V;)=*X>x}uQEx[M \f\;NiWYG 6{m vavF-Tp"mV29BHI 5*E)7[ܻZs9{${+89^1mۚ>/t%%ɫ\yg̒xwV֭&-t{+}M沒K}6ɶ#)qw1֯-ݽhM2y-m^ٮdh4Wi.xu?'|MRu_ @,Oky4ˋ{ &JK5,k*&x6Q^\\iGýFH|Lx.nZܛt."dCi,-uW}^ԣgIrNZm'(JMJW~勣# =&-H8ef+oxa3^jM`:ۤچD5-&m 11ECpH?'YmOwk뮑K?(76׳s˫,Q:G4vonv•,tZP9dm8jiilۗ=Obf qŸ8bN@JA %\NpHPNx#'y pA1#aym:+D2 I*Td Ϧh8kE]wK]-g}Y)QrtnM]_޵Zf}  s`dp:h܀G9P3^<20k\BA'zEViVI=\w6lr88=Hek? o5NJMjommfW颽_S1m.㌎ x$n@A G=ܫrA9''zA ܌Z{F2 Aٺ \1zA8Nz2sem[ioK-/}RvZ][}@pzw鎞dNA 8zǗv98G^3g8d=QHq29'8;I<tNnI-~*{]m+uw3dpRw $OLpNT<_k1|"UO.&ˏ$H9䉢@AF OoDZeۄA@HҒᖓ$ VT6HPznbyVAdaOUspp\fq-!8Wmg;n8:V]>uOC>{ZYk$w6k7u7Ss~Ne x!O+PrYU6G]ãc{ O{WW*wfMw\6>~mĻ>l1:ci]Nz5Y4?yk=גr\[EY֊6B0 +ry ᜕BA%@8皼gcΌ x\nR5jW$xF0r2n09891e F .θϮ 1_?kI^[k44eiWF4Z1zGw~m4V˙RKRm3')bH%Id2l0Kpd$ᐁ`CvQr;Jp_ۂ:ec#':{0Gy݊K;*ᔌp: _1IJ+u+Jv}>"QJ>hky-vՉ≭hYDVf5ٹv>X# t=JĐĈI1/0I2`w`jF(,67dO$XcBB (7e\-5JޣSQ.WӒ~]%.nDVQ# (b9&T7@V 1|Akۭn->v  cEfF@X(~@F"(^j*l`*C F((ah=ƭƹi|J‰)Vie2?,hG!Wz9\#O5ԛZҴ]{I}cjR䓄#F 5%w'vm9h76u"Lۙd6X~}$xj9Gi. ğ0eIsX+um$P@ ;Xr%78 r'R3kg$;:Lr aHʫ$dNy++Sq|M'd՞kiVJ'Siѥ5N˛Zп ubN9;!)4N$QȖ0AL[T_ou{u8m?>tZ .&7T(2O$HPX__ WM^[B,@ {;`d\ oRMpcE4{9t>`y%RZM-JFdl% )5qE%GsjJksNrƧUmͲ)b\FN.JNXK7kv{'~:z^X[ji>$[=Cz.,ڂ]G#XO 4 7خ֩W[}Ż N%a_PwXl:{Ewq[';m_W<'}oI]kL2C}=޵'bkaUmJ:v]Ks3>[5nI'v FSx$g nqQiY$v~F <>)NS(6ܖEۺ$;O֫ajx/ CHHtck>5on'3n{g%:ωcx ᵹm֚ݝz$O䱲ɭܛ[ۋXmh`U KI:tII9%mwZ$ӲkKu$EFW~/ VE2$ѱum}EuU܃d=85# V3jgsχ{EW cm#, |}MjG^qw4ݴ30##<@^3:PqDq䦧NOV1xu{S8^o[.XǂT8)R8zQ =IjSnMc/$9 8B׌ 炽3=_ Nwg*+"p0Js|íZKۙQs=;#\;Ө献@ƚ$.xqϩ,y xG+>O?_o6--en7xr8'ӊ?y9!0@#=!$}A^zc\k_^kO ;ܶjnXz1'N!axt>cW0yzc8u'9xs=6sGo={%].N[MR޷E98YhX"*ѫJQrRJS.iJ/hCF GbTrRJ8#w8X6E W,Jˢ鮝m:|[쮮ػmEC`$ *3dme<|$r$g'q<W؃WsM v6:`,PyqW:Ʌw#V NӀIFk8cqO.wmOF&6N6J]'mmٶ}p$*\r-1)?ދZ<X1,#=d`kXRgr N9?{&7IJ2 .]_v#Mz|yi}ߕv{^vg6'%&{-2_k+ia nl1$s4Ĉv9c<|p*,r rxOfV/*ƹ`wmUS8szF83.k>k]].}漦"*澜Wv^K6F8 w9ӱuzYLJY9< VIl`cY޴ۇ偕`m$Fx8$uqnk9`.۷GA?/js6ӻm;[k+_Ӷ0`ݤQK+wdvz.K督?$ppk-KHtlwq9MFf*Ba#R ˌ ^ejѕ8!LF%8כ^%~Mw[^j;bsQ㮟 Y+oWZ+ߔYe)I 䘢ܢBFAdګ;2A,F H# K#ܕ^y}S^ %H[hAJ 0 "U,*oH,();|7RWzk=n-v=yF[ɨ۽馮;;_@3C<1CC T MAΪJ6C;F T b>n]Qo.ZIexFѤp4r=׫W<ȒIHdXv!ۅT d)|i8'vM}$W7*^b\WI5u{+;(/w ?(ė@F%f|3Dӭd'1(`bFpxG'4XǷTSjI`ـۀ1"š ƪkwI "C9m'C~ME8B Yu&h-_]յHIխSziJuJ 4I*֊޲,kko6R0r rXcs\_/EC! jB)_$(9x3৿PҾ|+57 xK!(ne'w:ɽPQ+Uឃ᫿xm7Q̓%o "Jv6T!9*L׊(bRP(γi?f;VqRM7?8† ^Tpѭ*IBW^{]+pSqK(Y?uMsLRK\M1ExX#i*7ÏŸjj~"ռEwukIoq;D3$6Z-YhOęByzkB4R~΅*NԜy}OSn|0ZG~Y^q8MNJ'^ť)Mr&}3w\i,6G/W{eѬB|sI$%Qwϭx|Myf׮Tk"zỹ*LFK Bnh6oFΖ'hӌW!>y'kr&^W@BN>eYUTJQj[uT)6{#qUUS<.(2Ir)8+{rn*zcSxu(Vݣ<[x[wXy,}:o _}cIEwӵ{e_]Y^F$A<1Mw<vdj/4x.+ZUZX,nu@F3#f$@tumgWIY꺄$nYGZj#&!# EerG𑫍ʣpVgwnmTRzr=`}W%W O)Z6N qW_5-[/ #RXWoTKy K,=. H\Z.TWZ_{ /tkkԼ9a)Rzt[lL!cd̏~x}[F{.ͣؖ ZJKd|;]"Xmώ|Z}R?Gh>=NwM%-%M s2M^t8'/JάuwNVjmɧPtj[v?s}UzՕg]]ԟ25%*&"s9bO:S ʾi!qOPawcc BTA=yd}y e|v$''rƑyf̛cf3ܑ29Fq_ if:8%zUԄԩԣ)J5gץ-rL%|(MӭSmu*U-K>`l<7Oc|T5}GOB3SNc8v3Tp}xۧ<]jqׯy]uctUm/KM!l1s=~!d䑍^=kl>lus6 r@NgjN{_w_AڼU쒺;ͮt#qO\ 2~G$};Q=;r 'Qt Ǩ##風s=O$cx*Ax1IX=O~q$qϠzǠ5>?7}+vݫzhR9ǧyd1#_~˛PzAUwͥ{_={wHb߹~ujp$߃܌DY t<\g?1'A6i[udzA3R<;qs/mxy~_#2  W%JoTrzx'$r.vcso}i+]Zʓlae7V!`G\W_@NtIԭEl3;|1q_ 1Yl'6/Ц%:Yasif^w K(B!˰q^30£v"(7RI*':u0Xxl=8 .T8rĎ)d#* g8*II: :]p}A8 sSnAAy<K]5i-mwOM&Rwfk3U˜:61qsp:GoB~W%N2lsPlR(@Fs1q\Ύ~i3Aygی2y8j۫%OK~ߞ\]ז{ּwclpm>$c e!ȮU|,@P`wר %F3HL1FA2>7T N+ŵMeh1b$`c!I:"jVMJZgMk]^mhzT`8.Wn[)%kfVVz,Ed dvUTgt ٰ[w[I*3++;s1rʉȁR$Kh`cgbp>v7I<0E N6f3cAJqc=5ʽmmYݽk6ۭCTZ^ZkT>;/LЭhೆHl(ps4H u}-=;RB$1M$U*7BGJ4g9Fy^O{wn"(VQקNڳм?V^0)X $s9u?[LBll1p$$k36X`9MWV~!<<.LntݕD40xy[9P[>=~Қ3\iO =guψ5mm+FeAXeO7ϲUFT\Ն0N ӍHO˖)I9ԕ6ZiwdKZZRq3D+9J _c).y]8⟉?e_O*Ah4#}gZeRXQ7q; @sAk>;?xSJ6NH Uw쟳 y4wM/m_K(HJ⮢MK\m"K]>lyqÐ[{1Y phi?R› ڴ]Dac 7yr=+yTDqo cĚēIv-&1[BA x.۟hd,fe-UZ/6I!R̻TI㳌+v<5<*'J9y[rg$Tcee[Po</ѩyIsbm:FWQr8rQ?x]΅w⧈ SN0[S{ ݃6cwi 7jKx㿌\JNJeacr&oc<*y#UTT>rFtjQ5*UjVQqS(ulW<^6rdhTTXu F:ӥ )EΦ&hV~h2Jᵛ{]_Zw-k۽~(ckgo} USE 1в}K: GO XKI# {;x.tHu]7rO%l#rW>$1|YLJfuϙ퍶f B$~mʫc*Ɯ[X\T*MiT0IZ5yt2_?R^MI:j4֪qOw}tq~sR뺩CiByzfBfY0Oڛz^ktXxjk tS {[w7 ]F. 5!`_gd{T(DICXI\z[O1X;r87>nUdKuwYрA`y<3 1"a'=[1ֳ7@28Jz+.m{kkuk[Un%dg烟^sXW6!=}9usoO8@1\mLv^\5mmfwvb".1oFz-mmmm;7ݔVV#p=}?8GVWJV,Xuۯ'{Y& y^۷g˧v;g>u@5S+J)-vC%UgiyOMjZ=l͂1J0Hxv.|>3Y/lOE8_ZLFy Fz)4@c9G}g q%u[5W:3NհUy"կN5ϗ;?ı$RIi9!:`緹Ngtgeiy ?k&`l%qcWWGnQfT0 MB5bG[^rń͟,F:uO2Jz g$zq܌ۿ>Ԗf$&qڒ9VNo0M."RZ)J]6?t }+<"5 xø{ RZ}j0:^[˼W:񋆹rcy*6ʬLSb.؄jmk.w{~=xs88~Oӷ|"WR?6O_s@ϰS/͕ݴ=U8FN&sx ϨgYfkFI5S/aqwƬڶ5u>g|9Y2y1~' vJ8FW2qvVlHaxQ{p%zt>s*Ћ9'9q끎(yp`=rz$u^ǴkV鿥Kt<J6W-t_$ST LOL|dO,Iy2O|*X@rG gӌ g8.z秶=tM'moe)Y]_]dڵ-tbA g`Fc@;ӵon@$dS-:{H z\89-%w'ˢݛJo1A# tǶN\%PRQ뿂^mn $3`©,zxd@b `lr}=NVzYǢ}znc(*Sn-Qr徺ф$ǀ>@{u2>Lfp`Ӧ|}^9cHe=&V9RqRq3, RHـ3A9~5ˏ0xB/ UbztҫNJҌWWە2n658&+)SF*8Δ&fZY4?ҼG[F/,ٕP@8!Id`9m!;H'S?r?`3_7ĽKᯏ-fo 2[C{n!Jq9x?:"-մRH6qepluZs ῈK#[+ѧe0毆ӎυaTuZv_$#!8n@ uG# @ y+Zкǀrr2NyqYwj 9;XI23=k)᭫m5WoǺOc2֪Z$hӿWC&oA1<v7Z!Y򩱸$oQ< ׍ 4*FX-}FN085un l 8'r8 l:oʴo{dӮw{T^Zv)qk(eU%H-+!yϵ}KWdCBP8$(ϡ.HiBug,:!q~|~&x[c+s<+B?s.7uIV=%zu4rnӲZy>dl|V1/o43q@ʘ+ή/n\<JwaPb701_H?$Y) @F @R2 5ZnPjTaF\Qy[=VImRI8RQ&K[4P Q`m3, 180Fx?D-%L@A 9 瑑]OTxQބ;F~pI9SמĎ~ +*&P<>aqۅINMs-۽۾NSnK(G~4ZKǑX rWS-zdrPp[# dQg3@bBۻe As5>56'!7-L0MpjVv4Jɯ]4ZO27ɹ2Vmo՛TΟ|5oz@φWpm>iYQKdif@^^ KP,)Rȭ$x$>Z_%|Q?Z^ZƗZچVLeXgyBOÊ3UkUyܧ^P)է8ӄm)ƪ8*4pWR:aJ*եRtjԓQ'r.[Q4ӿ~z xUΛ4Zn?m⹒khTxKic$+P}k^Yk [/`I D $d6WIo m:ioޫ$t e$2|?OӇ be.yf(8Ԯb֧4jVZ2QRNQNZ|1I6H/qD'Zx:J䌚s4nMI{ŏ0~|2ico]FY<6i5Ds=-~aU?m|M>m/AoKhHq=}J@`+?i?Wկ<=e|: :ܬ6";9ay!!ZLTfLW<2]KR(u )>uoCB0xaxq6!KL+$JZRWQG )ەZ/RQJs!/LlMԴ4U&ݔcWu}%@f?:.}g j)ԴRs Z}ě[g˺W3oxTRQ;1o1OYı9|}O%po-C &ZEId %n|ɎKV4[Sjoq=i1 ;jةi#TӭΖY0W0YycN^ޭZKE$%[EvT!6}c3h¢U\9bTӍdm}]h7^Bjzv[[a Indef˵{c& !S6k xĺܐz:,ww6Ij״[Yrc֡4agl[q #Nž%_thn#ތ{KA*!w_G&mY$6nt.auݦ*MAܣ r&#B⸷0_(aR)ӡ9Q%i'{է)$w0XY`-_7+Rqj=9vQ6"U'1tf _ZxKGž9MtOKŚ79l< pWIwOcLU٣fU'_卵ņ`ަmr+dFY6K唞;6[J,VcbV"TuQ+EJN/NU1*mB$q*'Zqٵ%kENJ;F .kڴڤv2]]Ga=̦7[#hcf2a8?OʪK%A?ktlIz_%꺫=s-x`sl(+O9=Z̀R}G8µ*0=rqz9uuZuӥE}= PD{Aצr};2#$g09'篢,-BОz@F^q9(98l=:GzO lK-7WYrn]Vi{jףz5ec-2(h׸?~9V`@m#$d0AI fۓNC0l=tia==zu$uT̲fd*`p#$՜eJ$vz­W/6?Rjtxz54Z2Rtȿ^Zw%aCpsTu8^WaOiBR 14f9Bo\8p+EFxUdqusk<7op$&5$1|ːG<ֿ_ῤ',ӧ T8fTdqJ׆"-n8*p -OKJyUXJ_o ˇj'Eo:IFH &y=W "!V ЂH{{rG@85AvG$we0*VhVUmgE|Y3;𖲗W:M[{z,Ipх+|z d嘧G =S,&,(85{^upUikeW[?I\_$qԢ8Y!Ge,u$hPN麋S]`*3*ddG#"Ek\E# 8![s<`~"~~4TΐMYDYđ#TrN98LWMi4cA"28' 5g\cÜgcÙ3I'/Tm){.2|mݫ-K[;[B N@9JCbBG ~IlḂ$ù'JVh,7:s?i]}Q唹mIvFZm:9Yn _[]kл G 1nzDiS=FK}8 7q Pk%27ԑ pIϠ=N5p)QWi;[ˢhiI[-_{hy<7njHBuf=N1W}yE Տ#I5gBZו% ?.F_,xg u$2bM|+rk:;X$,]YQIq,qed|iEm5mzY;X-2S[k`6Df6l6|ѸYHz?74XPBIeq19uʶUZdek5˄0Ҥdcj9bsTU$n؉|UKնt]lfA,6EhWKʻ]N^jB|Nm%NsBJHJ^nM/gO[ʤIGөZq\*56mtjͻh|G6uxfH|Weao,+}*W"HV%ebbib}'úNt?-on2)y#oYd Hl??>7-5Śo4[wogPA c]ok Fdv޿~,jwo/oo5{[i>|8Zbw\4(>uf8XZ)4'O ܩ$JϢm.|}gNvn6&IIenW<ͬwߦZiV%F"ѴSS{ yBW ۳@ৄWUծ+9n-ēi~M5lY]YIϙyW/ғq*Im(2WI^ӓ\*ۿ >UZfxW,V>T%* M1@Cw䇶9`OS7/~(:SJȬVJQm=9N' 8b*&Zj7NFzcD5 >-R~ר\PZ^,ڶBR|g-B#ruúKO@ӵoj5-28eiM{Y5q$p.zEDWtS|{5gTYRN# ^pAġw s#~Q\V߾~5;)'_Ozy;(#h AOU_F2HSlp{$}-oSY.N=FOu*N < 秹=J+ 4Wׯɞ|wWЕ’#0 )F7>sQTV/Ӝߚݴ{[Wxr9tΚ*  I=ԜV$I%w;NQj_[~FE͐$S{W3hJU}ۮ3WZ5O'wueM<>uX Ss$?kLEsF* H8 .!Άgٮ/,ӚnXz:-K:ݭ(TD8x{WXLZ2 z5-(ISd/=o屾Z6 NIǖpFGixHę98UIϩ;+v.%=̥EVʅ7J{+(9O&ҕG +ǙAS>4TUœSN9Ri6zVH"cMYfnH_ yz})5; /Oc\mI$vݴH""9 @$Q^c9iQFNSPR*JqW^դ>{(10JUi׫g~ju(ӭVo{ӽ9sA$}ú~c [fy죘hH,фSK~POй[tk̼;x[1Vpu*h\n]}7 f#`^pdf5?vqj*URI'&_乆a 177]K +8Yk^ygT2\3 s 1 rq]A͘Pcpw=XKrpJ+\6zoV1%V+G{*i(͒1%HGJȻ*$2W 0~^x#ʲQkGsEի[b>0 k2~bNx:کRBA@HIZ_Y+|%:MrV]u׫Ǭ(#szeF>y`79$ rr1alE|Zy'Swz2j͹Ejӧb<2 Ǯ8A+GN!t T# (\JQm}b&o[)7{7u FbyLX|U~l|98Z%ww.f>Xil-#eg$dknk_ϫM_fk{rӓMww[[qyqURFA8 G`-f\숺#4!υf(3h$ڍVo{z; rSe޷ӕ<Wʹ٠3y VdkK)g /r]cO> |F\^zlh#.-px(_ ʊc4W.e_ZlL!siW_uUvI~y?eezwJ6*OVIl3#4b`DZK5$Ry6潽4mrL2NkW^)R4=ku56h//o%ȋO%P2[ITĥӅ(!׫VVs\y_+IrV-έuNRj卬w k̤ڼRI[/şڝ-֑caosbhAiMmi,J2[b~]j-Kw;Em>gIuA]1W<>ANSSmIɾUw~{)u!)-:5Jߩ4ψZo61N'xwI̊8]&UyL3__>?F_ [㔼&C^o,Y-1B,$|dџRN4RQj4Qkғnk;ӄ8VITrmJmeg/[gc!hgen;gHv#y HaPj'F5}>{xx3v["B>ӭ d&9$͉!ܾQE+j7{<ݻg{2WIE(<n%9/6Ek zZ]~#8®-[R2X7lrks-vE$m#O !x'\-kI}WXQhƗ{cew$"6HRϒ[ GytmJ*pԱ4WY+>SE.)΅FUvy;n+|d|\=V}=NSͅ;݅+{pdN<֐=Q_9v}_ZX: V߰nis쒊I$?9eUzqUJ(Z޺S{$$If!vh#v$,:V l05$,4a$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ 4$$If!vh#vH #v#v:V l05H 55/ / / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ 4$$If!vh#vH #v#v:V l05H 55/ 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ /  4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / 4$$If!vh#vH #v#v:V l05H 55/ / / 4$$If!vh#vH #v#v:V l05H 55/ / 4^4 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ NormalOJQJ_HmH sH tH ^@^  Heading 1&$$$d%d&d'd@&a$ CJOJQJF@F  Heading 2$$@&a$ CJOJQJD@D  Heading 3$@&5CJOJQJF@F  Heading 4$$@&a$ CJOJQJ@@@  Heading 5$@& CJOJQJL@L  Heading 6$@&5B*OJQJhtH uV@V  Heading 7$$@&a$5B*CJOJQJhtH uP@P  Heading 8$c@&^`c CJOJQJ> @>  Heading 9 $@& 5>*CJDA`D Default Paragraph FontVi@V 0 Table Normal :V 44 la (k ( 0No List B%@B Envelope ReturnOJQJh$@h Envelope Address!@ &+D/^@ CJOJQJ8>@8 Title$a$ CJOJQJ:B@":  Body Text CJOJQJ4 @24 Footer  !.)@A.  Page Number&@& TOC 1.. TOC 2 ^.. TOC 3 ^.. TOC 4 X^X.. TOC 5  ^ .. TOC 6 ^.. TOC 7 ^.. TOC 8 x^x.. TOC 9 @^@: : Index 18^`8: : Index 28^`8: : Index 3 X8^X`8: : Index 4! 8^ `8:: Index 5"8^`8:: Index 6#8^`8:: Index 7$x8^x`8:: Index 8%@8^@`8:: Index 9&8^`86!6  Index Heading'XC@X Body Text Indent(7^7` CJOJQJ\R@\ Body Text Indent 2)0^`0 CJOJQJ4@4 Header * !L#L Table of Figures+p^`p(W`( Strong566  Footnote Text-@&`@ Footnote ReferenceH*TS@T Body Text Indent 3/v^v`CJ<P@<  Body Text 20 5CJ\@@@ N List Paragraph 1^@@"@ 3N 0 Balloon Text2 CJ^JaJZo1Z 2N 0Balloon Text Char CJOJQJ^JaJmH sH tH PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] ^E^E%%y% %0CCCCCCGGIIIINN .2?LNY_emwz}yCCʰS5 ,>BIG^"%0EuCKOT = G(,y./9@jGiLLO=ShVWGW]WWX~XXXzYYYHZZZ[Z[[M\S\\\]+]L]i]]]]]^^^ ____(`<```AaSaaaaabwbbbHccc d#dRdUdXdndddddddeeHeKeNexeeeeeeeff3f6f9fQfqftffffffflqsxxxy,y=yQyzyyz{%{1{w{{{{{{{||$|*||||||},}}} ~+~?~~~~~~~+1Wft.H]zр-El'B^G3ɈY,Hdԏ (D`|А$@\x̑ <XtȒ8TؓPlܔ0Lhؕ,HdԖ (D`{ė4Plq-Pl˚~ܛ3OtܜQ!AUߧ Ȩ UڮȰ4%)T 8*hO*i(*%  eQ"4Sg~  E!h%l''*,.624J78:~=ACFPKM^      !#$&'()*+,-./123456789:;<=>?@ABCDFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABDEFGHIJLMNPQSrrr4sLsOsn.0\^E__CCCC !%,!!!l$$,R$ A/`43&@ #, (    %2 3  "0?`  c $X99? %2`  %  3  "0?`  c $X99? % V  # "` %" bB @ S D#" ? bB @ S D#" ? bB  S D#" ?bB   S D#" ?bB  @ S D#" ?bB   S D#" ?bB   S D#" ? bB   S D#" ? bB  S D#" ? bB  S D#" ?bB  S D#" ?bB  S D#" ?\B  S Do"?P  # #" `?P  # #" `?P  # #" `?P   "? J  # "?J   # "?J ! # "?J " # "?~ # S :A time_24hr_700#" `?B S  ?O !"r3sMs,ttuJKLturstn^E!t!t!htd!t^!t,1t#Wt y+it t+ t !&"Ft9&t r#rCtY"#Y"Ct#Ct" "ti iPt""7t 7t"""(t!BFBtFt Ft0-(-t rx&&a'g'''((**C-D-..//c0d0001222s7t7T8V8T9V9,:-:::;;x<y< ="=/>1>BBCCOPQPMUQUuvwx/x:xbxnxxxxx2y:yFyOyyyyyyyyyyzzz(z.zTTOYemW_}PWaf))7.:...........//_/c/////0 090<055====!>'>O>W>??M@V@@@@@.A:AKAPAAAzBBCCDDDDDDDDDDDDDDDFEGE\E_ETUDDDD_E^ b   * , a c TTDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEEEEECECEEEEE_E], .Bv,Q ;ΐl*n@1) mp pFS$+!Q L z>IQK  0tɊ  7 qS oc  RTs)  5C S( " } U^!J! 2}5 9  \: T: b; F-<  F Q>tHvC>D3G 2H Z=II U{J #AK@O[zUM 0O)N 73OH f3R $RʵhCT N7)tT6pdJX֗$WlY l *l mmo _xo 8X$p 6hwp \t 8xym?}> d}RWF} d~ 0^`0o(.0^`0o(. hh^h`OJQJo(0^`0o(.p0p^p`0o() hh^h`OJQJo(^`OJQJo(hHh808^8`0o(.h^`.hpLp^p`L.h@ @ ^@ `.h^`.hL^`L.h^`.h^`.hPLP^P`L. hh^h`OJQJo(0^`0o()0^`0o(. hh^h`OJQJo(h88^8`OJQJo(hHh^`OJQJ^Jo(hHoh  ^ `OJQJo(hHh  ^ `OJQJo(hHhxx^x`OJQJ^Jo(hHohHH^H`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hH hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo(0^`0o() hh^h`OJQJo(0^`0o(. hh^h`OJQJo(0^`0o(. hh^h`OJQJo( hh^h`OJQJo(0^`0o(. hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo(0^`0o(. hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo(0^`0o(. hh^h`OJQJo(0^`0o(.hh^h`B*o(hH. hh^h`OJQJo(0^`0o(.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo(h^`OJQJo(hHh ^`o(hH.hpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH hh^h`OJQJo( hh^h`OJQJo(0^`0o(.0^`0o(. hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo(ss^s`o()qq^q`.A LA ^A `L.  ^ `.^`.L^`L.^`.QQ^Q`.!L!^!`L. hh^h`OJQJo( hh^h`OJQJo(^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. hh^h`OJQJo(0^`0o()0^`0o(.0^`0o(.^`o(. ^`hH. pL^p`LhH. @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PL^P`LhH. hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo(0^`0o(. hh^h`OJQJo(0^`0o(. hh^h`OJQJo( hh^h`OJQJo(hh^h`o(. hh^h`OJQJo( hh^h`OJQJo(hh^h`o(. 88^8`hH. L^`LhH.   ^ `hH.   ^ `hH. xLx^x`LhH. HH^H`hH. ^`hH. L^`LhH.0^`0o(.h ^`OJQJo(h ^`OJQJo(oh pp^p`OJQJo(h @ @ ^@ `OJQJo(h ^`OJQJo(oh ^`OJQJo(h ^`OJQJo(h ^`OJQJo(oh PP^P`OJQJo( hh^h`OJQJo( hh^h`OJQJo(0^`0o(. hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo( hh^h`OJQJo(0^`0o(.0^`0o(.h88^8`OJQJo(hHh^`OJQJ^Jo(hHoh  ^ `OJQJo(hHh  ^ `OJQJo(hHhxx^x`OJQJ^Jo(hHohHH^H`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hH hh^h`OJQJo( hh^h`OJQJo(]j[*h3g*lhbqS[zUM3R(W"2H!Q wO>lD3Gd~mp\t_xo}$>}5?}L )tT1{+X@L/t1F-< g\Bv F}my.HvC8xQ>$RhCTTs)C 7*m+0O)N2Z=II8X$pocsa[Y]*,z^[b;J! "lYpE;"/?8?B0DOjDqDxME&F/H H ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ Oh+'0 , L X d p|Medication AdministrationLo-Se-Ca Foundation 1D46E5EAPatrice Patterson52Microsoft Office Word@@@tI^@G_@>jDv0=՜.+,0 hp  Lo-Se-Ca FoundationMD Medication Administration Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F@x|Data ;1TableBWordDocument SummaryInformation(DocumentSummaryInformation8MsoDataStorer| #v|O4WOCCF2==2r| #v|Item  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q